Development of atopic dermatitis and its association with prenatal and early life exposures by Roduit, Caroline
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Atopic dermatitis and skin disease
Prenatal animal contact and gene expression of innate
immunity receptors at birth are associated with atopic
dermatitis
Caroline Roduit, MD, MPH,a Johanna Wohlgensinger, PhD,a Remo Frei, PhD,a Sondhja Bitter, MD,b,c Christian Bieli, MD,
PhD,a Susanne Loeliger,a Gisela B€uchele, MPH,e Josef Riedler, MD,f Jean-Charles Dalphin, MD, PhD,g Sami Remes, MD,h
Marjut Roponen, PhD,i Juha Pekkanen, MD,i Michael Kabesch, MD,j Bianca Schaub, MD,k Erika von Mutius, MD, MSc,k
Charlotte Braun-Fahrl€ander, MD,b,c Roger Lauener, MD,a,d and the PASTURE Study Group Zurich, Basel, and Davos,
Switzerland, Ulm, Hannover, and Munich, Germany, Schwarzach, Austria, Besanc¸on, France, and Kuopio, Finland
Background: Cross-sectional studies have suggested that
prenatal farm exposures might protect against allergic disease
and increase the expression of receptors of the innate immune
system. However, epidemiologic evidence supporting the
association with atopic dermatitis remains inconsistent.
Objective: To study the association between prenatal farm-
related exposures and atopic dermatitis in a prospective study.
We further analyzed the association between the expression of
innate immune genes at birth and atopic dermatitis.
Methods: A total of 1063 children who participated in a birth
cohort study, Protection against Allergy-Study in Rural
Environments, were included in this study. Doctor diagnosis of
atopic dermatitis was reported by the parents from 1 to 2 years
of age by questionnaire. Gene expression of Toll-like receptors
(TLRs) and CD14 was assessed in cord blood leukocytes by
quantitative PCR.
Results: Maternal contact with farm animals and cats during
pregnancy had a significantly protective effect on atopic
dermatitis in the first 2 years of life. The risk of atopic
dermatitis was reduced by more than half among children with
mothers having contact with 3 or more farm animal species
during pregnancy compared with children with mothers
without contact (adjusted odds ratio, 0.43; 95% CI, 0.19-0.97).
Elevated expression of TLR5 and TLR9 in cord blood was
associated with decreased doctor diagnosis of atopic dermatitis.
A significant interaction between polymorphism in TLR2 and
prenatal cat exposure was observed in atopic dermatitis.
Conclusion: Maternal contact with farm animals and cats
during pregnancy has a protective effect on the development of
atopic dermatitis in early life, which is associated with a lower
expression of innate immune receptors at birth. (J Allergy Clin
Immunol 2011;127:179-85.)
Key words: Prenatal, farm animal, Toll-like receptors, atopic
dermatitis, gene-environment interaction
Atopic dermatitis is a chronic, inflammatory, pruritic skin
disease, often occurring in early infancy, that affects up to 20% of
the children in industrialized countries.1 Asthma develops in ap-
proximately 30% of children with atopic dermatitis, and allergic
rhinitis in 35%.2 According to the International Study of Asthma
andAllergies in Childhood (ISAAC), the prevalence of symptoms
of atopic dermatitis in children 6 or 7 years of age during a 1-year
period varied from less than 2% in Iran and China to approxi-
mately 20% in Australia, England, and Scandinavia.1 The etiol-
ogy of atopic dermatitis is complex and involves an interaction
between genetic and environmental factors and the immune sys-
tem. The hygiene hypothesis has contributed to the understanding
of allergic diseases, suggesting that lack of microbial exposure
might be a risk factor. A protective effect of microbial exposure
on asthma has been described.3-5 However, epidemiologic evi-
dence supporting these associations with atopic dermatitis
remains inconsistent.6-8
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In addition, recent cross-sectional studies have shown that the
protective effect of farm exposures on allergic diseases could
already be effective during pregnancy.9,10
Although it has been suggested that an altered stimulation
of the innate immune system might influence the development of
allergic disease, the underlying immunologic mechanisms of
these protective effects of farm exposures remain unclear. Acti-
vation of the innate immune system is mediated by pattern
recognition receptors, such as Toll-like receptors (TLRs), which
are present on immune cells and recognize pathogen-associated
molecular patterns. Previous studies have suggested that gene
expression of these receptors is upregulated by exposure to
environmental factors rich in microbial compounds.9,11 More-
over, several findings indicate that environmental factors associ-
ated with high levels of microbial components may interact
with existing polymorphisms in TLRs on the development of
allergic disease, and direct associations between single nucleotide
polymorphisms (SNPs) in TLRs and allergies have been
shown.12-15 Recently an association between a TLR9 promoter
polymorphism and atopic eczema has been reported.16 However
the direct correlation between the presence of allergic diseases
in children and TLRs or CD14 expression was not made. Defining
whether there is a difference in gene expression would facilitate a
better understanding of the determinants of atopic dermatitis.
In this study, we longitudinally analyzed the effect of prenatal
environmental exposures related to the hygiene hypothesis on the
development of atopic dermatitis in the first 2 years of lifewithin a
prospective birth cohort, the Protection against Allergy-Study in
Rural Environments (PASTURE)/Mechanism of Early Protective
Exposures on Allergy Development (EFRAIM) study.17 Because
gene expression of innate immunity receptors reflects both ge-
netic and environmental influences, we further examined whether
TLRs and CD14 expression in cord blood samples from these
children was associated with the development of atopic dermati-
tis. In addition, we investigated whether the interaction between
polymorphisms in TLRs and prenatal exposures has an impact
on gene expression and on atopic dermatitis.
METHODS
Study design
The PASTURE/EFRAIM study is a prospective birth cohort study involv-
ing children from rural areas in 5 European countries (Austria, Finland,
France, Germany, and Switzerland), designed to evaluate risk factors and
preventive factors for atopic diseases. The design of this cohort has been
described in detail elsewhere.17 Briefly, pregnant women were recruited dur-
ing the third trimester of pregnancy and divided into 2 groups. Women who
lived or worked on family-run farms where any kind of livestock was kept
were assigned to the farm group. The reference group was composed of
women from the same rural areas not living on a farm. In total, 1133 children
were included in this birth cohort. The questionnaires developed within the
PASTURE study group used questions on various exposures from ISAAC,18
the Allergy and Endotoxin (ALEX) study,3 and the Prevention of Allergy
Risk factors for Sensitization in children related to Farming and Anthroposo-
phic Lifestyle (PARSIFAL) study.5 Questionnaires were administered in inter-
views or self-administered to the mothers within the third trimester of
pregnancy and when the children were 2, 12, 18, and 24 months of age. The
study was approved by the local research ethics committees in each country,
and written informed consent was obtained from all parents.
Study population
Children from the PASTURE/EFRAIM birth cohort with data available on
atopic dermatitis at least once between 1 and 2 years of age and on farming
status (n 5 1063) were included. Among these children, 905 have data
available on mRNA analysis in cord blood samples and between 961 and 987
on polymorphisms in TLRs, depending on the SNP.
Definitions
Children were labeled as having doctor’s diagnosis of atopic dermatitis
when the parents reported at least once in the questionnaire at the age of 12, 18,
or 24 months that the child had been diagnosed with atopic dermatitis by a
doctor. Farmer children were defined as children whose parents answered
positively to the question, ‘‘Does your child live on a farm?’’ and whose family
ran the farm. Maternal farm-related and pet exposures during pregnancy were
obtained from the self-reported questionnaires at the third trimester of
pregnancy. Prenatal exposures to barn or stable were defined as an exposure
of at least a quarter of an hour per week. Contact with farm animal species was
assumed if the mother reported contact at least several times per month in 1 of
the pregnancy trimesters. Consumption of farm milk was defined as a
consumption of at least on average 10 mL farm milk per day. Data on
potential confounders, such as smoking during pregnancy, sex, mode of
delivery, birthweight, gestational age, maternal education, and breast-feeding,
were obtained from the self-reported questionnaires at the third trimester of
pregnancy, at 2 months, and 1 year of age. Maternal atopy was defined as ever
having asthma or hay fever. This information was self-reported.
Expression of Toll-like receptors and CD14
Blood samples were collected from the umbilical cord at birth. For the
assessment of mRNA, the blood was collected in a PAXgene Blood RNA tube
containing an RNA-stabilizing solution (PreAnalytiX/Qiagen, Hilden,
Germany) and then frozen to2808C within 24 hours.19 In a central laboratory
(Zurich, Switzerland), the RNAwas isolated by using the PAXgene 96 Blood
RNA Kit (PreAnalytiX/Qiagen) supplemented with RNase-free DNase
(Qiagen). The mRNA was reverse-transcribed into cDNA by using the
TaqMan Reverse Transcription Reagents (Applied Biosystems, Foster City,
Calif). Quantitative real-time PCR was performed on the 7900HT Fast
Real-Time PCR System by using theMicro fluidic card TaqManArray system
of Applied Biosystems. The data presented are normalized values for the
endogenous controls (18S ribosomal RNA and b-2-microglobulin) using the
comparative (delta delta cycle threshold,DDCt) method according to the man-
ufacturer’s instructions (Applied Biosystems). TLR3 expressionwas excluded
from the analyses because the expression levelwas less than the detection limit
on most of the cord blood samples.
Genotyping
Genotyping was performed by means of matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry, as described previously.20 De-
rived genotype frequencies were compared with the expected allelic popula-
tion equilibrium based on the Hardy-Weinberg equilibrium test to control
for technical genotyping errors. cDNA was amplified in duplicate by using
an iCycler (Bio-Rad, Hercules, Calif), with 18s as a reference gene.
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Polymorphisms in TLRs were selected as previously described.21 These SNPs
were as follows: TLR1/C-2299T (rs5743594), TLR1/T-2192C (rs5743595),
TLR1/A742G (rs4833095), TLR2/T596C (rs3804099), TLR2/T-16934A
(rs4696480), TLR4/C8851T, TLR4/A8551G, TLR4/T-1607C, TLR5/T1845C
(rs5744174), TLR5/C1173T (rs5744168), TLR5/A1774G (rs2072493), TLR6/
T-2079A (rs5743789), TLR7/A1796T (rs179008), TLR7/C12318T, TLR8/
C10907A, TLR8/A-4824G (rs3761624), TLR9/T-2622C (rs5743836), and
TLR9/T-2871C (rs187084).
Statistical analysis
Data analysis was conducted by using SAS software version 9.2 (SAS
Institute, Inc, Cary, NC).
General estimating equations (GEEs) were used to investigate the longi-
tudinal effects of prenatal farm exposures, gene expression of TLRs and CD14
in cord blood, and genotypes of SNPs in TLRs on atopic dermatitis from age
1 to 2 years, taking into account the correlation between repeated measures in
the same individual. The associations between the different SNPs in TLR and
atopic dermatitis were corrected for multiple testing by using the false discov-
ery rate (Benjamini procedure; P <_ .05 is significant).22 To test for effect
modification, we calculated terms for interactions between farm exposures
and TLR expression and the different centers in the GEE model, and they
were not significant. For gene expression, geometric mean ratios (GMRs)
with 95% CIs were calculated by exponentiation of the regression coefficients
and their 95% CIs. Estimates of cumulative incidence of atopic dermatitis in
the first 2 years of age were calculated by the discrete time survival analysis
among 3 groups of children categorized by the tertile of gene expression.
The discrete time hazard is the conditional probability that a child will develop
an atopic dermatitis onset in a period given that atopic dermatitis was not re-
ported in an earlier period. Linear regression was performed to analyze the as-
sociation between prenatal exposure and mRNA gene expression in cord
blood, and when heterogeneity between study centers was significant, the
model was adjusted for center as a random effect estimate, and as a fixed effect
estimate when there was no heterogeneity. To test for gene-environment inter-
actions, interaction terms were included in the models. Adjustment was made
for the following potential confounders: farming status, maternal atopy, sex,
number of older siblings, smoking during pregnancy, and study center. Birth
weight, mode of delivery, maternal education, exposure to stable in the first
year of life, breast-feeding, and consumption of farm milk in the first year
of life were added to the model but did not change the results, so they were
not kept in the final model. A P value below .05 was considered statistically
significant.
RESULTS
General characteristics
Among the 1063 children included in this study, therewere 508
farmers and 555 nonfarmers. The proportion of children having a
doctor diagnosis of atopic dermatitis at least once between 1 and 2
years of age among the total study population was 17.8%. The
characteristics of the study population showed no differences of
the distribution of farmer and nonfarmer children among the
5 centers (Table I). Among children in the nonfarmer group, the
frequency of mothers with allergy and those smoking during
TABLE I. Characteristics of children
Total study population
N 5 1063
Farmer
n 5 508
Nonfarmer
n 5 555
Characteristics n (%) n (%) n (%)
Girl 517 (48.7) 249 (49.0) 268 (48.5)
Center
Austria 209 (19.6) 99 (19.5) 110 (19.8)
Switzerland 226 (21.3) 101 (19.9) 125 (22.5)
France 191 (18.0) 91 (17.9) 100 (18.0)
Germany 233 (21.9) 109 (21.5) 124 (22.4)
Finland 204 (19.2) 108 (21.3) 96 (17.3)
Mother with atopy history* 310 (29.2) 118 (23.3) 192 (34.6)
Mode of delivery: cesarean section 185 (17.6) 86 (17.0) 99 (18.0)
Birth weight
<2500 g 16 (1.5) 9 (1.8) 7 (1.3)
2500-4500 g 1019 (96.0) 484 (95.3) 535 (96.7)
>4500 g 26 (2.5) 15 (2.9) 11 (2.0)
No. of siblings*
0 383 (36.0) 129 (25.4) 254 (45.8)
1-2 567 (53.4) 291 (57.3) 276 (49.7)
>_3 113 (10.6) 88 (17.3) 25 (4.5)
Mother smoking during pregnancy* (at least in 1 trimester) 140 (13.2) 43 (8.5) 97 (17.5)
Prenatal farm exposures
Work on a farm during pregnancy* 406 (38.3) 364 (71.8) 42 (7.6)
Farm milk during pregnancy* 445 (42.0) 372 (73.5) 73 (13.2)
Farm milk during pregnancy: unboiled* 358 (33.8) 296 (58.5) 62 (11.2)
Work in stable during pregnancy* (at least 15 min/wk in 1 of the trimesters) 541 (53.2) 443 (89.3) 98 (18.8)
Work in barn during pregnancy* (at least 15 min/wk in 1 of the trimesters) 402 (39.6) 342 (69.1) 60 (11.5)
Contact with farm animals during pregnancy* (horse, cow, pig, or poultry,
at least several times per month)
3-4 species 120 (11.7) 96 (20.0) 24 (4.4)
1-2 species 508 (49.7) 345 (71.9) 163 (30.1)
0 species 394 (38.6) 39 (8.1) 355 (65.5)
Contact with any pets during pregnancy* 666 (62.7) 419 (82.5) 247 (44.5)
Contact with cats during pregnancy* 472 (44.4) 349 (68.8) 123 (22.2)
Contact with dogs during pregnancy* 344 (32.5) 241 (47.7) 103 (18.6)
*P < .05, based on x2 test between farmer and nonfarmer.
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pregnancy were higher compared with the children in the farmer
group. Among farmer children, the number of siblings was higher
compared with nonfarmer children. For the other characteristics,
mode of delivery and birth weight, there were no differences de-
pending on the farming status. We observed that a small number
of mothers (n5 42) from the nonfarmer group were working on a
farm (from neighbors or relatives) or were in contact with a farm
animal during pregnancy. The maternal contact with pets was
higher among the farmer than the nonfarmer group.
There was no difference with respect to farming status between
the total study population and the subgroup of children with data
available on gene expression of TLRs and CD14 at birth (data not
shown).
Association between prenatal farm exposures and
atopic dermatitis
The cumulative prevalence of atopic dermatitis was lower in
farmer children than nonfarmer children between 1 and 2 years of
age, even though it was not significant (Fig 1, A). Among chil-
dren with mothers working on a farm during pregnancy, this
cumulative prevalence was significantly lower compared with
children with mothers not working on a farm (14.4% and
20.0% at 2 years of age, respectively; Fig 1, B). The longitudinal
analyses accounting for repeated measurements (GEE) showed
that prenatal farm animal contact was associated with a lower
risk of developing atopic dermatitis in the first 2 years of life
(Table II). The consumption of farm milk or unboiled farm
milk during pregnancy was not associated with atopic dermatitis.
Contact during pregnancy with horses, cows, pigs, and poultry,
for which we observed a negative association with atopic derma-
titis, was included to calculate a score of the number of species
the mother had contact with during pregnancy. The risk of devel-
oping atopic dermatitis was reduced by a factor of 0.7 among
children with mothers having contact with 1 to 2 species and
by a factor of 0.4 with prenatal contact with 3 to 4 species com-
pared with the reference group with no prenatal contact with farm
animals. For each additional farm animal species the mother had
contact with, we observed a reduction of 20% in the development
of atopic dermatitis (adjusted odds ratio [OR], 0.80; 95% CI,
0.65-0.99; Fig 2). Moreover, we found a significant negative as-
sociation between prenatal contact with cats and the presence of
atopic dermatitis in the first 2 years of life (adjusted OR, 0.68;
95% CI, 0.46-1.00).
There was no significant association between the different
SNPs in TLRs and atopic dermatitis after correction for multiple
testing (data not shown). The protective effect of prenatal contact
with farm animals and cats might differ between the genotypes of
SNPs in TLRs (see this article’s Table E1 in the Online Repository
at www.jacionline.org). The analyses for a gene-environment in-
teraction showed a significant (P 5 .02) effect modification of
1 SNP in TLR2 (TLR2/T-16934A) on the association between pre-
natal exposure to cats and the development of atopic dermatitis
early in life and a marginally significant effect modification
(P 5 .09) for prenatal exposure to farm animals. We observed a
strong protective effect of the prenatal animal (farm animals
and cats) exposures only among children with genotype AA in
TLR2/T-16934A (Fig 3). We did not observe a significant gene-
environment interaction for the other SNPs in TLRs. However,
the significant protective effect of contact with farm animals
and cats during pregnancy on atopic dermatitis was more
pronounced among certain genotypes. Because we found differ-
ences between the distribution of genotypes between Finland
and the other centers, we repeated the same analyses excluding
the Finnish population, and we observed strongly comparable
results (data not shown).
Association between gene expression and atopic
dermatitis
We observed a negative association between the gene expres-
sion of TLRs and CD14 assessed in cord blood and the develop-
ment of atopic dermatitis in the first 2 years of life (Fig 4). Gene
expression of TLR5 and TLR9 in cord blood was significantly re-
duced among children with atopic dermatitis compared with chil-
dren with no dermatitis (adjusted GMR, 0.66; 95% CI, 0.48-0.89;
and adjusted GMR, 0.73; 95% CI, 0.56-0.96, respectively). The
same trend was observed for TLRs 1, 2, 4, 6, 7, and 8 and
CD14, even though it was not significant. None of the potential
confounding factors (maternal atopy, sex, siblings, maternal
smoking during pregnancy, study center, or farming status) had
a major influence on the results. Survival analyses showed that
children with a level of TLR5 or TLR9 expression in the upper
tertile had a risk reduced by around 50% of developing atopic
dermatitis compared with childrenwith an expression in the lower
FIG 1. Cumulative prevalence of atopic dermatitis between farmers and
nonfarmers (A) and between mothers working and not working on a farm
during pregnancy (B). P value based on the x2 test. Dr, Doctor.
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tertile (TLR5: adjusted OR, 0.56; 95% CI, 0.37-0.83; TLR9:
adjusted OR, 0.53; 95% CI, 0.36-0.80; Fig 5).
Association between prenatal exposures and gene
expression
There were no significant associations between contact with
farm animals or pets during pregnancy and gene expression of
TLRs and CD14 measured at birth after adjustment for farming
status, maternal atopy, sex, and study center (data not shown).
However, we observed a slight trend of an enhanced gene
expression of TLR5 and TLR9 with the increasing number of
species of farm animals the mother was exposed to during
pregnancy, even though it was not significant (GMR for TLR5
expression, 1.25; 95% CI, 0.92-1.70; GMR for TLR9 expression,
1.13; 95% CI, 0.80-1.59; ratio of prenatal contact with 4 species
compared with no contact). The different SNPs in TLRs did not
reveal a gene-environment effect on the gene expression of these
receptors assessed at birth. When TLR5 or TLR9 expressions
were included in the model of the association between exposure
and atopic dermatitis, we observed a reduction of the direct effect
of exposure on atopic dermatitis. This indicated that an effect of
exposure on atopic dermatitis might be mediated by TLR5 or
TLR9 expressions.
TABLE II. Association between prenatal exposures and the development of atopic dermatitis in the first 2 years of life
Prenatal exposures Crude ORs 95% CI Multivariate adjusted ORs* 95% CI
Farming status 0.83 0.59-1.17 0.85 0.59-1.21
Work on a farm during pregnancy 0.65 0.45-0.94 0.83 0.55-1.25
Farm milk during pregnancy 0.72 0.50-1.02 0.86 0.56-1.33
Farm milk during pregnancy: unboiled 0.72 0.50-1.04 0.93 0.62-1.41
Work or stay in stable during pregnancy 0.76 0.54-1.08 0.84 0.47-1.51
Work or stay in barn during pregnancy 0.85 0.60-1.23 1.09 0.71-1.66
Contact with farm animal during pregnancy
Horse 0.65 0.39-1.07 0.64 0.39-1.06
Cow 0.74 0.53-1.04 0.79 0.49-1.27
Pig 0.43 0.21-0.89 0.54 0.26-1.11
Sheep 1.01 0.61-1.65 1.15 0.68-1.95
Hare 0.84 0.53-1.32 0.96 0.61-1.53
Poultry 0.66 0.43-1.03 0.76 0.47-1.21
Horse, cow, pig, or poultry
3-4 species 0.40 0.19-0.82 0.43 0.19-0.97
1-2 species 0.71 0.49-1.01 0.71 0.45-1.15
0 species, reference 1.00 1.00
Contact with any pets during pregnancy 0.63 0.45-0.89 0.65 0.44-0.96
Contact with cat during pregnancy 0.58 0.41-0.82 0.68 0.46-1.00
Contact with dog during pregnancy 0.78 0.54-1.13 0.71 0.48-1.07
*Adjusted for center, atopic mother, sex, smoking during pregnancy, and farming status (not adjusted for farming status for, as exposures: farming status and working on a farm
during pregnancy). Interaction test with center: not significant for all of the exposure variables. Boldface values: P < .05
FIG 2. Association between prenatal farm animal exposures and atopic
dermatitis. OR, 0.80 (95% CI, 0.65-0.99) for atopic dermatitis with each
additional farm animal species, P 5 .04, adjusted for center, atopic mother,
sex, smoking during pregnancy, and arming status (GEE analysis). Test of
interaction between center and prenatal exposure to farm animal was non-
significant; P 5 .81.
FIG 3. The effect of prenatal contact with farm animals and cat on atopic
dermatitis by genotypes of TLR2_min16934. Reference group: no prenatal
contact with animals. OR adjusted for study center, mother with atopy,
sex, smoking during pregnancy, and farming status. P 5 .09 for interaction
term between TLR2_min16934 and prenatal farm animal contact. P5 .02 for
interaction term between TLR2_min16934 and prenatal cat contact.
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DISCUSSION
This study shows that children with mothers having contact
with farm animals and cats during pregnancy have a reduced risk
of developing atopic dermatitis in the first 2 years of life. The
interaction between polymorphisms in TLRs and environment on
atopic dermatitis reveals a slight effect with a SNP in TLR2. We
also show that children with higher gene expression of TLR5
and TLR9 at birth have a decreased risk of atopic dermatitis
compared with children with lower expression of these receptors.
These results suggest a role of the innate immune system in me-
diating the protective effect of prenatal exposures on the develop-
ment of atopic dermatitis in children, along the line of recent data
obtained in the mouse model.23
Several epidemiologic studies have shown that environmental
factors rich in microbial compounds such as the farming environ-
ment have a protective effect on allergic disease.3,24 Nevertheless,
in the previous studies on allergic disease and living on a farm, the
association with atopic dermatitis remains unclear.4,25-27 In our
study, we observed a protective effect on atopic dermatitis in chil-
dren when the mother was working on a farm during pregnancy
and especially when she was exposed to an increasing number
of different farm animal species. These results from longitudinal
analyses support the previous cross-sectional findings of a protec-
tive effect of prenatal exposure to a farm environment on atopic
sensitization and on atopic dermatitis, asthma, and hay fever.9,10
Moreover, our findings support that gene-environment inter-
actions play a role in the development of atopic dermatitis in
children and suggest a biological underlying mechanism for this
relationship. Because TLRs are acting as the first line of defense
against microbial compounds, the level of gene expression of
these receptors might be amarker of the influence of the genes and
environment on the development of atopic dermatitis.
As previously suggested in studies showing that the expression
of innate immunity receptors was increased in children exposed to
environments rich in microbial components, these results show
that the innate immune system might modulate the development
of allergic diseases.11,28 Moreover, in a cross-sectional study, Ege
et al9 observed a positive association between maternal contact
with farm animals during pregnancy and the gene expression of
receptors of the innate immune system in children 5 to 13 years
of age. Similarly, 1 previous study reported a decreased TLR2
and TLR4 expression in cord blood in relation to maternal allergy
but did not examine allergic outcomes.29 In our study, the negative
association between the level of gene expression assessed in cord
blood samples and atopic dermatitis was not influenced by adjust-
ing for maternal atopy.
The strength of this study is the prospective design, which
avoids recall bias and gives the opportunity to study the effect of
timing of exposures and the influence of innate immunity at birth
on the development of atopic dermatitis.
The development of atopic dermatitis occurs usually in the first
year of life.30 For this reason, we defined children having the
disease when diagnosed in the 2 first years of life. Because a def-
inition of atopic dermatitis based on symptoms could lead to an
overestimation of the prevalence of the disease, we used doctor
diagnosis of atopic dermatitis.Moreover, we repeated the analysis
with a definition based on symptoms as the outcome and observed
a similar tendency of an association with the gene expression of
TLRs at birth (data not shown).
Toll-like receptors, part of innate immunity, are the first line
of defense against microbial compounds, and are therefore
biomarkers of enhanced exposure to microbial substances.
TLR5 and TLR9 are both receptors for bacterial components.
TLR5 recognizes bacterial flagellin,31 found on nearly all motile
FIG 4. Association between the development of atopic dermatitis in the
first 2 years of life and the gene expression of TLRs and CD14 at birth.GMR,
Ratio of the TLRs geometric mean in children with atopic dermatitis com-
paredwith children without atopic dermatitis. *Adjusted for farmer, mother
with atopy, sex, older siblings, smoking during pregnancy, and study
center.
FIG 5. Cumulative incidence of atopic dermatitis, stratified between tertiles
of gene expression of TLR5 (A) and TLR9 (B) at birth. A, TLR5. The cumula-
tive incidences of atopic dermatitis by age 2 years were significantly differ-
ent between the tertiles of TLR5: P 5 .003. B, TLR9. The cumulative
incidences of atopic dermatitis by age 2 years were significantly different
between the tertiles of TLR9: P < .001. cb, Cord blood.
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bacteria, and TLR9 recognizes oligodeoxynucleotide containing
unmethylated CpG motifs present in bacterial DNA.32 It was
shown that TLR5 activation and TLR9 induce maturation of
antigen-presenting cells to a TH1-biased immune response.
33,34
Several SNPs in genes encoding for TLR have been shown to
be associated with allergic diseases, especially with asthma.12-14
In 2 studies, associations between SNPs in TLR2 and TLR9 genes
and atopic dermatitis have been reported.16,35 However, previous
studies on the gene expression of these receptors related to the
development of allergic disease had mainly shown an association
between the level of expression and exposure to environmental
factors rich in microbial substances but not with allergic diseases.
A previous study demonstrated that a polymorphism in TLR2was
associated with the frequency of asthma and allergies among
farmer children.12 Our results showed a slight effect of gene-
environment interaction on atopic dermatitis, with the same
SNP in TLR2.
Maternal contact with farm animals and cats during pregnancy
and a higher expression of the receptors of innate immunity at
birth have a protective effect on the development of atopic derma-
titis in the first 2 years of life.
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bers. We also thank Henriette A. Smit from University Medical Center
Utrecht, The Netherlands, for her support and Letitcia Grize and Christian
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University Children’s Hospital Munich, Germany, for help with statistics.
Clinical implications: Prenatal exposures influence the develop-
ment of atopic dermatitis in children.
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TABLE E1. Associations between prenatal contact with animals and the development of atopic dermatitis in the first 2 years of age,
stratified by genotype
Contact with farm
animals: horse, cow,
pig, poultry Contact with cats
Atopic dermatitis Atopic dermatitis
Gene SNP Genotype Frequency % (N) OR* 95% CI OR* 95% CI
TLR1 tlr1_cmin2299t CC 69.8 (683) 0.84 0.64-1.08 0.61 0.36-1.04
(rs5743594) CT 27.6 (270) 0.91 0.59-1.39 0.94 0.45-1.97
TT 2.6 (25) n/a n/a
tlr1_tmin2192c TT 63.8 (629) 0.75 0.55-1.03 0.55 0.34-0.91
(rs5743595) TC 30.8 (304) 0.74 0.47-1.16 1.28 0.60-2.73
CC 5.4 (53) n/a n/a
tlr1_a742g AA 53.9 (531) 0.69 0.49-0.97 0.50 0.29-0.86
(rs4833095) AG 38.0 (375) 0.81 0.55-1.20 1.1 0.51-2.35
GG 8.1 (80) n/a n/a
TLR2 tlr2_t596c TT 31.5 (303) 0.85 0.60-1.22 0.65 0.35-1.19
(rs3804099) TC 50.1 (481) 0.70 0.50-0.99 0.67 0.36-1.27
CC 18.4 (177) 1.05 0.70-1.59 0.61 0.20-1.84
tlr2_tmin16934a! AA 28.2 (276) 0.58 0.34-0.99 0.37 0.15-0.93
(rs4696480) AT 45.9 (449) 0.93 0.67-1.29 0.79 0.38-1.62
TT 25.9 (253) 0.91 0.63-1.34 0.9 0.49-1.73
TLR4 tlr4_c8851t CC 86.9 (855) 0.81 0.64-1.02 0.68 0.43-1.10
CT 12.6 (124) 0.86 0.52-1.43 0.62 0.26-1.48
TT 0.5 (5) n/a n/a
tlr4_a8551g AA 88.2 (863) 0.77 0.62-0.98 0.68 0.42-1.08
AG 11.3 (111) 1.00 0.56-1.80 0.78 0.32-1.93
GG 0.5 (5) n/a n/a
tlr4_tmin1607c TT 72.9 (707) 0.87 0.67-1.12 0.60 0.37-1.00
TC 24.2 (235) 0.77 0.50-1.20 0.95 0.43-2.12
CC 2.9 (28) n/a n/a
TLR5 tlr5_a1774g AA 71.5 (691) 0.82 0.63-1.07 0.74 0.45-1.21
(rs2072493) AG 26.6 (257) 0.77 0.55-1.09 0.57 0.23-1.40
GG 1.9 (18) n/a n/a
tlr5_c1173t CC 88.7 (874) 0.76 0.59-0.96 0.66 0.41-1.06
(rs5744168) CT 10.8 (106) 1.05 0.62-1.78 0.82 0.23-2.84
TT 0.5 (5) n/a n/a
tlr5_t1845c TT 32.7 (318) 0.75 0.40-1.41 0.92 0.37-2.25
(rs5744174) TC 50.0 (486) 0.78 0.59-1.05 0.51 0.30-0.88
CC 17.3 (168) 0.82 0.53-1.27 0.85 0.31-2.29
TLR6 tlr6_tmin2079a TT 63.9 (621) 0.74 0.54-1.02 0.54 0.33-0.88
(rs5743789) TA 30.3 (294) 0.9 0.60-1.33 1.41 0.59-3.38
AA 5.8 (56) n/a n/a
TLR7 tlr7_a17961t AA 69.1 (679) 0.86 0.65-1.13 0.78 0.47-1.29
(rs179008) AT 15.8 (155) 0.76 0.49-1.16 0.64 0.24-1.73
TT 15.1 (148) 0.66 0.35-1.24 0.5 0.16-1.53
tlr7_c12318t CC 85.4 (836) 0.8 0.63-1.02 0.76 0.48-1.20
CT 8.4 (82) 0.93 0.52-1.66 0.70 0.18-2.70
TT 6.2 (61) n/a n/a
TLR8 tlr8_c10907a CC 53.7 (527) 0.92 0.68-1.25 0.72 0.39-1.32
CA 24.1 (236) 0.63 0.43-0.94 0.58 0.22-1.22
AA 22.2 (218) 0.8 0.47-1.35 0.80 0.36-1.80
tlr8_amin4824g AA 65.1 (643) 0.8 0.58-1.11 0.67 0.38-1.18
(rs3761624) AG 20.2 (199) 0.91 0.63-1.31 0.47 0.21-1.04
GG 14.7 (145) n/a n/a
TLR9 tlr9_tmin2622c TT 76.4 (750) 0.83 0.66-1.04 0.55 0.35-0.87
(rs5743836) TC 22.3 (219) 0.75 0.42-1.35 0.93 0.35-2.49
CC 1.3 (13) n/a n/a
tlr9_tmin2871c TT 30.8 (300) 1.08 0.75-1.54 1.03 0.50-2.13
rs187084 TC 50.8 (495) 0.65 0.44-0.94 0.61 0.35-1.07
CC 18.4 (180) 0.8 0.57-1.12 0.38 0.14-1.09
n/a, Not applicable.
Boldface values: P < .05.
Reference group: no prenatal contact with animals.
*Adjusted for study center, mother with atopy, sex, smoking during pregnancy, and farming status.
!Interaction test with P < .1 (P values for interaction term between tlr2_tmin16934a and farm animal contact, .09; and between tlr2_tmin16934a and cats contact, .02).
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Prenatal and early-life exposures alter expression of innate
immunity genes: The PASTURE cohort study
Georg Loss, MSc,a,b* Sondhja Bitter, MD,a,b* Johanna Wohlgensinger, PhD,c Remo Frei, PhD,c Caroline Roduit, MD,
MPH,c Jon Genuneit, MD,d Juha Pekkanen, MD,e,f Marjut Roponen, PhD,e Maija-Riitta Hirvonen, PhD,g
Jean-Charles Dalphin, MD, PhD,h Marie-Laure Dalphin, MD,h Josef Riedler, MD,i Erika von Mutius, MD, MSc,j
Juliane Weber, MD,j Michael Kabesch, MD,k Sven Michel, MSc,k Charlotte Braun-Fahrl€ander, MD,a,b Roger Lauener,
MD,c,l and the PASTURE study group! Basel, Zurich, and Davos-Wolfgang, Switzerland, Ulm, Munich, and Hannover, Germany,
Kuopio, Finland, Besancon, France, and Schwarzach, Austria
Background: There is evidence that gene expression of innate
immunity receptors is upregulated by farming-related
exposures.
Objective: We sought to determine environmental and
nutritional exposures associated with the gene expression of
innate immunity receptors during pregnancy and the first year
of a child’s life.
Methods: For the Protection Against Allergy: Study in Rural
Environments (PASTURE) birth cohort study, 1133 pregnant
women were recruited in rural areas of Austria, Finland,
France, Germany, and Switzerland. mRNA expression of the
Toll-like receptor (TLR) 1 through TLR9 and CD14 was
assessed in blood samples at birth (n 5 938) and year 1 (n 5
752). Environmental exposures, as assessed by using
questionnaires and a diary kept during year 1, and
polymorphisms in innate receptor genes were related to gene
expression of innate immunity receptors by using ANOVA and
multivariate regression analysis.
Results: Gene expression of innate immunity receptors in cord
blood was overall higher in neonates of farmers (P for
multifactorial multivariate ANOVA 5 .041), significantly so for
TLR7 (adjusted geometric means ratio [aGMR], 1.15; 95% CI,
1.02-1.30) and TLR8 (aGMR, 1.15; 95% CI, 1.04-1.26). Unboiled
farm milk consumption during the first year of life showed the
strongest association with mRNA expression at year 1, taking
the diversity of other foods introduced during that period into
account: TLR4 (aGMR, 1.22; 95% CI, 1.03-1.45), TLR5 (aGMR,
1.19; 95% CI, 1.01-1.41), and TLR6 (aGMR, 1.20; 95% CI,
1.04-1.38). A previously described modification of the
association between farm milk consumption and CD14 gene
expression by the single nucleotide polymorphism
CD14/C-1721T was not found.
Conclusion: Farming-related exposures, such as raw farm milk
consumption, that were previously reported to decrease the risk
for allergic outcomes were associated with a change in gene
expression of innate immunity receptors in early life. (J Allergy
Clin Immunol 2012;130:523-30.)
Key words: Innate immunity, Toll-like receptors, CD14, prenatal,
childhood, farming, farm milk, nutrition
Innate immunity is the pivotal system that facilitates interac-
tions with microbes at the interfaces of an organism with the
environment.1 These immune responses aremediated in large part
by Toll-like receptors (TLRs) and CD14, a group of transmem-
brane and intracellular proteins that recognize pathogen-
associated molecular patterns.1,2
The development of innate immunity is determined based on
genetic and environmental factors and possibly a combination of
both. Environmental exposures rich in microbes encountered
during pregnancy or early life have been shown to be associated
with upregulating mRNA expression of innate immunity recep-
tors3,4 and with a decreased risk for allergic diseases.5,6 Variations
in innate immunity receptor genes can influence the mRNA ex-
pression of these genes7 or receptor-mediated cytokine produc-
tion and have been shown to be associated with asthma and
allergic disease.1,7-11 Furthermore, it has been reported that poly-
morphisms in innate immunity receptor genes modified the effect
of environmental exposure, such as contact with animals or farm
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milk consumption, on allergic disease occurrence.7,11,12 How-
ever, these previous investigations were limited to cross-
sectional analyses and often lacked reproducibility.13
Studies also found that introduction of complementary foods,
such as fish and cow’s milk, or the diversity of foods introduced
early was inversely related to allergic outcomes, proposing that
exposure to a variety of antigens, including but not limited to
nutritional sources, early in life might be essential for the
development of immune tolerance.14,15
The development of asthma and allergic disease might be
mediated by the innate immune system and its orchestration of
complex immune cascades.1 The first stages of life seem critical
for the maturation of the innate immune system,16 but little is
known about the development of gene expression over time and
the relevant environmental exposures influencing it.
The Protection Against Allergy: Study in Rural Environments
(PASTURE) study17 offered the opportunity to prospectively in-
vestigate the development of gene expression of innate immunity
receptors from birth to year 1, taking into account polymorphisms
in receptor genes, and to analyze the environmental and nutri-
tional exposures influencing gene expression.
METHODS
Study population
PASTURE is a large prospective birth cohort study conducted in rural areas
of Austria, Finland, France, Germany, and Switzerland. The study team
contacted 2871 women, of whom 1772 (61.7%) were identified as eligible for
participation (Fig 1). Potential participating families were contacted in the
third trimester of pregnancy. Exclusion criteria were living on a farm without
livestock, maternal age of less than 18 years, premature delivery, genetic dis-
ease in the offspring, no telephone connection, and insufficient knowledge of
the country’s language. Women living on a farm where livestock was held or
whose partners actively run a farm were considered farming women. A subset
of the population living in close neighborhoods in likewise rural environments
not occupationally involved in farming activities were selected as the compar-
ison group (nonfarmers). For more details, see the Methods section in this ar-
ticle’s Online Repository at www.jacionline.org.
Those 1133 (63.9%) subjects willing to participate were included in the
study (530 farming and 603 nonfarming women). For mRNA analyses, 938
(82.3%) cord blood samples and 752 (72.8%) blood samples from year 1 were
available. The study population and the populations with available mRNA
measurements at birth and year 1 did not differ in respect to farming status,
but slightly more Finnish than French women provided blood samples. No
differences were seen with respect to age of pregnant mothers; educational
level; number of older siblings; smoking status; pet ownership; family history
of asthma, hay fever, and eczema; or prevalence of farm milk consumption.
Questionnaires
Extensive questionnaires were administered by means of interview to the
mother of the child within the third trimester of pregnancy and 2 and 12
months after the birth of the study child. Questions were based on previously
published studies18-21 and designed to assess respiratory and other health
issues of the mother, agricultural exposures, and potential confounders, such
as active and passive smoking, parental education, and family size. In addition
to the extensive questionnaires, the mothers kept a weekly diary frommonth 3
to year 1 of the child’s life to record, among other items, the introduction of a
variety of food items. Relevant pregnancy variables were farming (living on a
farm vs not), maternal farm work (mother working on a farm during preg-
nancy), contact with a stable/barn (stay in stable/barn during pregnancy at
least 15 minutes per week in 1 trimester), contact with a number of farm an-
imals (horse, cow, pig, and poultry: 0, 1-2, or 3-4), maternal/paternal history
of asthma or hay fever (doctor’s diagnosis and self-reported symptoms for
both outcomes), smoking during pregnancy (in any trimester), and farm
milk consumption during pregnancy (never, only boiled farm milk, or any un-
boiled farmmilk). Variables during the first year were farming (child living on
a farm during first year of life), regular visits to a farm, regular stays in a stable/
barn (child stayed in stable/barn at least 15minutes per week), smoking during
lactation, duration of breast-feeding (never, <_3 months, 3-6 months, or >6
months), duration of exclusive breast-feeding (never, <_3 months, or >3
months), and child’s farm milk consumption (never, only boiled farm milk,
or any unboiled farm milk during year 1).
Measurement of mRNA expression in cord blood
and at year 1
Blood samples were collected from the umbilical cord at birth and at the
age of 1 year. For the assessment of mRNA, the blood was collected in a
PAXgene Blood RNA tube containing an RNA-stabilizing solution (PreAna-
lytiX/Qiagen, Hilden, Germany) and then frozen to2808C within 24 hours.22
At the central laboratory of the Children’s Hospital of Zurich, the RNA was
isolated with the PAXgene 96 Blood RNA Kit (PreAnalytiX/Qiagen) supple-
mented with RNase-free DNase (Qiagen). The mRNAwas reverse transcribed
into cDNA by using the TaqMan Reverse Transcription Reagents (Applied Bi-
osystems, Foster City, Calif). Quantitative real-time PCR was performed on
the 7900HT Fast Real-Time PCR System using theMicro fluidic card TaqMan
Array system (Applied Biosystems). The data presented are normalized values
for the endogenous controls (18S rRNA and b2-microglobulin [B2M]) by us-
ing the comparative (DD cycle threshold [DDCt]) method, according to the
manufacturer’s instructions (Applied Biosystems). TLR3 expression was ex-
cluded from the analyses because the expression level was less than the detec-
tion limit in most of the cord blood samples. Extensive quality control
measures have been incorporated in the PASTURE cohort study, particularly
for laboratory work but also for field work.17 Genotyping was described in de-
tail elsewhere.11 For detailedmethods, see theMethods section in this article’s
Online Repository.
Statistical analyses
Differences in environmental and farming characteristics between farmers
and nonfarmers in pregnancy (mothers) and during year 1 (children) were
tested by using the Pearson x2 test.
To quantify the results obtained by using real-time RT-PCR of mRNA of
CD14 and TLR1, TLR2, and TLR4 through TLR9, the comparative threshold
method of Giulietti et al23 was used. This method expresses the measured
number of PCR cycles of the participants relative to 1 participant. We chose
a nonfarmer with results of greater than the detection limit for all mRNAmea-
surements in cord blood as a reference. The results provide a multiple of
amount of mRNA in comparison with the reference. Because the distribution
of the gene expression levels were skewed, the calculated variables were log
transformed (natural logarithm), resulting in an approximately normal
distribution.
The transformed data were used in linear regression models to calculate
associations between mRNA expression and single nucleotide polymor-
phisms (SNPs) in innate immunity genes and exposures in pregnancy and the
first year of life (expressed as geometric mean ratios and P values). Maternal
exposure during pregnancy and child’s exposure in the first year of life were
combined to also test the effects of continued exposure of farming, farm milk
consumption, contact with a stable, contact with pets, and smoking on mRNA
expression at age 1 year. A solid food scorewas developed to test the influence
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of early introduction of a variety of solid foods on mRNA expression. The
time of first food introduction was subdivided into 4 periods (introduced in
months 3-6, 7-9, or 10-12 or never in the first year of life). Early introduction
of a food item was defined as the period when at least 25% of the children re-
ceived the respective food to generate dichotomous variables with sufficient
numbers for analysis. The crude association of early introduction of each solid
food item with mRNA expression was then tested and, if significant for at
least 1 receptor, added to the solid food score (the final score included yogurt,
butter, vegetable, fruit, meat, nut, fish, chocolate, and cereal with and without
gluten).
Multivariate models were developed as follows. Pregnancy exposures
were related to mRNA expression in cord blood, and exposures during year
1 were related to expression at year 1 in crude regression models. Maternal
history of asthma or hay fever, sex, and center were chosen as covariates a
priori and were included in all multivariate analyses (paternal history was
also tested but did not change models). Variables significantly associated
with mRNA expression of 2 or more receptor genes or significantly associ-
ated with expression of 1 receptor gene and significantly associated with
mRNA expression in simple multivariate analysis of variance (MANOVA)
were included in a final model: the pregnancy model included maternal
smoking during pregnancy and farming (unboiled farm milk consumption
was not included because of colinearity with farming), and the year 1 model
included maternal smoking during breast-feeding, education, the solid food
score, child’s farm milk consumption, and duration of breast-feeding. Heter-
ogeneity between centers was tested by means of meta-analytic techniques.
If heterogeneity was present, final models were additionally adjusted for cen-
ter with a random effect estimate, and if not, center was included as a fixed
effect.
To avoid spurious findings because of testing multiple TLRs, the overall
association of exposures onmRNAexpressionwas additionally calculated in a
MANOVA, adjusting for the same covariates as the regression models.
MANOVAs provided omnibus tests that inherently correct for multiple
comparisons. Levels of significance in all ANOVAs were evaluated based
on Wilks lambda. To assess the development of mRNA expression from birth
to year 1, the difference of normalized mRNA expression from cord blood and
year 1 was calculated (diff-mRNA), and regression models were developed
accordingly. Finally, interaction terms were included in the final models to test
for gene-environment interactions of child’s farm milk consumption and all
assessed genetic variations of innate immune receptors on the effect onmRNA
expression. All statistical analyses were performed with STATA/SE 10.1
software (StataCorp, College Station, Tex), and P values of less than .05 were
considered significant.
Ethical approval
The ethical boards of the 5 study centers approved the study, and written
informed consent was obtained from the children’s parents for questionnaires,
blood samples, and genetic analyses.
RESULTS
Farming mothers were significantly more exposed to stables,
barns, and farm animals and more often consumed farm milk
during pregnancy than nonfarming mothers (Table I). Parental
history of hay fever or asthma and maternal smoking was more
common among nonfarmers, whereas farm families more often
kept a cat or dog and tended to have a higher number of children.
A higher proportion of nonfarmers breast-fed for longer than 6
months, and they were less likely to never breast-feed. Similar re-
sults were found for exclusive breast-feeding. At year 1, farm and
nonfarm children showed similar differences in environmental
exposures as observed for their mothers during pregnancy.
More farmers introduced unboiled farm milk within the first
year of life (29.0%) compared with nonfarmers (4.5%), and
they introduced a higher number of different solid foods early
within the first year of life.
Pregnancy exposures
In univariate analyses maternal farming in pregnancy was
significantly positively associated with cord blood mRNA ex-
pression of several receptor genes and in a simple MANOVA
(Table II). Significant and positive associations were also found
for maternal consumption of unboiled farm milk; however, this
variable was strongly correlated with farming. Smoking during
pregnancy and male sex decreased the expression of the receptor
genes. Multifactorial MANOVA showed that mRNA expression
was significantly greater in neonates of farmers compared with
that seen in neonates of nonfarmers (P5 .041). For individual re-
ceptor genes, a significantly higher mRNA expression was found
in farmers for TLR7 (adjusted geometric means ratio [aGMR],
1.15; 95% CI, 1.02-1.30; P 5 .021) and TLR8 (aGMR, 1.15;
95% CI, 1.04-1.26; P 5 .005; Fig 2).
Number of pregnant women contacted: 2871
Eligible: 1772 (61.7%)
Inclusion criteria not fullfilled or missing data†: 
1099 (38.3%)
Not willing to participate: 639 (36.1%)
Recruited : 1133 (63.9%)
Farmer: 46.8%
Diary and year 1 questionnaire completed: 1033 (91.2%)
Farmer: 47.7%
mRNA data in cord blood:
938 (82.3%)
Farmer: 47.6%
mRNA data at year 1:
752 (72.8%)
Farmer: 49.3%
FIG 1. Selection of PASTURE study population and participants for mRNA analyses. "Inclusion criteria:
living on a farm with livestock, maternal age greater than 18 years, term delivery, no genetic disease in
offspring, telephone connection, and sufficient knowledge of the country’s language. !Selection criteria:
pregnancy questionnaire was completed.
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Exposures during the first year of life
Children’s consumption of unboiled farm milk during the first
year of life showed the strongest association with mRNA
expression at year 1, upregulating mRNA expression of CD14,
TLR4, TLR5, TLR6, and TLR7 when compared with no farm
milk consumption, whereas other farming-related exposures
during year 1 showed no significant associations (Table III). Early
introduction of several food items was associated with mRNA ex-
pression of individual receptors (for details, see Table E1 in this
article’s Online Repository at www.jacionline.org). When sum-
marized as solid food score, an increasing number of items was
significantly associated with TLR4mRNA expression (Table III).
After adjustment for all potential confounders, mRNA expres-
sion of TLR4 (aGMR, 1.22; 95% CI, 1.03-1.45; P 5 .020), TLR5
(aGMR, 1.19; 95% CI, 1.01-1.41; P 5 .034), and TLR6 (aGMR,
1.20; 95% CI, 1.04-1.39; P5 .015) was statistically significantly
upregulated by unboiled farm milk consumption compared with
no farm milk consumption (Fig 3), whereas the association of
the food score and mRNA expression was no longer significant
(see Tables E2 and E3 in this article’s Online Repository at
www.jacionline.org).
We also examined relations of prenatal exposures to mRNA
expression at year 1, but no significant associations were observed
(data not shown).
The correlations of mRNA expression of single innate immu-
nity receptors between cord blood and year 1 were poor, with the
highest and only significant correlations for TLR8 (Pearson
correlation 5 0.35, P < .001) and TLR1 (Pearson correlation 5
0.31, P < .001). When exposures were related to the difference
in mRNA expression between year 1 and cord blood, results
were similar to findings with only year 1 expression as the out-
come, although they were less pronounced (data not shown).
Among the tested continued exposures from pregnancy to age
1 year, only raw farm milk consumption was found to be signifi-
cantly associated with increased gene expression of 1 receptor
(TLR6) in unadjusted models.
Polymorphisms in TLR1, TLR4, TLR6, and TLR8 were signifi-
cantly associated with gene expression of the respective receptors
at birth and similarly at year 1 (see Tables E4 and E5 in this arti-
cle’s Online Repository at www.jacionline.org). We also tested
whether polymorphisms modified the association between a
child’s unboiled farm milk consumption and gene expression of
innate immunity receptors, yet only 2 SNPs in TLR8 (TLR8/
C9008T) and TLR9 (TLR9/T22622C) showed significant interac-
tions (P for both interactions 5 .007).
DISCUSSION
This study shows that farming status of pregnant mothers was
associated with increased gene expression of innate immunity
receptors at birth (overall and individually with TLR7 and TLR8),
whereas increased gene expression at year 1 wasmost strongly as-
sociated with child’s consumption of raw farm milk during the
first year of life (TLR4, TLR5, and TLR6). Several genetic varia-
tions in genes of the innate immunity receptors were associated
with expression of the respective receptors, but only 2 SNPs in
TLR8 and TLR9 significantly modified the association of unboiled
farmmilk andmRNA expression of the respective receptor at year
1. Changes in gene expression of innate immunity receptors
caused by farming exposure and unboiled farmmilk consumption
might be involved in explaining the reported protective effects of
farming-related exposures on the development of allergic disease
in children.5,6,21
In contrast to previous cross-sectional studies,3,4 the present
analyses allowed us to prospectively relate a variety of exposures
during pregnancy and the first year of life to the expression of in-
nate immunity genes. Early life is a critical time window because
TABLE I. Environmental and farming characteristics of pregnant
women and children in the first year of life by farming status
Farmer,
no. (%)
Nonfarmer,
no. (%)
P value
for
differenceNo. Percent No. Percent
Population at birth 530 46.8 603 53.2
Male sex 266 51.4 294 51.4 .988
Center
Austria 105 47.7 115 52.3 .389
Switzerland 107 44.2 135 55.8
France 94 46.3 109 53.7
Germany 112 44.1 142 55.9
Finland 112 52.3 102 47.7
Education
Low 116 21.9 86 14.3 <.001
Medium 234 44.2 253 42.0
High 180 34.0 264 43.8
Maternal history of asthma 38 7.2 61 10.1 .080
Maternal history of hay fever 108 20.4 196 32.5 <.001
Maternal farming exposure during pregnancy*
Contact with stable 464 89.6 107 18.9 <.001
Contact with barn 362 70.0 65 11.5 <.001
Contact with >2 farm animals 208 39.2 64 10.7 <.001
Contact with cats and/or dogs 430 81.3 233 38.6 <.001
Farm milk consumption 406 76.6 98 16.3 <.001
Only boiled farm milk 94 17.8 27 4.5 <.001
Any unboiled farm milk 310 58.7 70 11.6
Smoking 46 8.7 112 18.6 <.001
Child’s farming exposure during first year
of life*"
Population at year 1 493 47.7 540 52.3
Child living on a farm 486 98.6 10 1.9 <.001
Regular visit to farm 487 99.0 77 14.4 <.001
Regular stay in stable 332 71.7 40 7.6 <.001
Contact with cats and/or dogs 402 81.5 188 34.8 <.001
Farm milk consumption 283 57.8 51 9.5 <.001
Only boiled farm milk 141 28.8 27 5.1 <.001
Any unboiled farm milk 142 29.0 24 4.5
Unboiled farm milk
after month 10
78 16.0 15 2.8 <.001
Unboiled farm milk
before month 10
60 12.3 8 1.5
Early introduced solid food
items (food score)
0 51 10.3 102 18.9 <.001
1-3 191 38.7 214 39.6
4-6 174 35.3 157 29.1
7-11 77 15.6 67 12.4
Smoking during
breast-feeding
18 (3.8) 35 (6.8) .034
Any breast-feeding
>6 mo 240 48.7 285 52.8 .027
3-6 mo 118 23.9 96 17.8
<_3 mo 89 18.1 120 22.2
Never 46 9.3 39 7.2
>_2 Siblings 235 47.7 111 20.6 <.001
*There are minor discrepancies in percentages because of missing values in variables.
"Percentage of population at year 1.
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it has been shown that the neonatal TLR system undergoes rapid
and differential development during the first month of life.24
Maternal involvement in farming during pregnancy was an
exposure associated with expression of several innate immunity
receptors in cord blood, whereas specific activities, such as
working in stables or barns or contact with farm animals, were
not. Maternal farming might thus be an overall indicator of other
activities, including consumption of farm milk during pregnancy.
In previous cross-sectional studies3,4 higher gene expression of in-
nate immunity receptors at school age in farm compared with non-
farm children has clearly been observed and might reflect
continuous exposure of children growing up on a farm over several
years. However, the previously reported association between pre-
natal farmanimal exposure and innate immunitygene expression12
was not found in this prospective study. The gene expression of in-
dividual receptors significantly upregulated by farming varied be-
tween studies,3 likely reflecting the different composition of the
respective environments. TLR-binding ligands were mainly as-
cribed to microbial origin.1 Recent evidence suggests that the di-
versity of the microbial environment and not individual
microbes is important to confer protection against asthma,5 and
TLR-mediated innate response pathways are believed to be impor-
tant in promoting regulatory pathways that inhibit the allergic im-
mune response.25 Nonmicrobial ligands were recently shown to
trigger TLR4 signaling. The major house dust mite allergen Der
p 2 functionally mimicked MD-2, the LPS binding component
of TLR4, triggering TLR4 signaling in the absence of MD-2,26
whereas the heavy metal Ni21 directly activated human TLR4.27
The expression of TLRs and CD14 at birth and at year 1 was not
closely correlated, suggesting that environmental exposures encoun-
tered by the infant induce substantial changes in innate immunity
during the first year of life. Food is a main source of the infant’s new
exposure during early life. Breast-feeding has recently been shown
tomodulate innate immunity responses during the neonatal period.16
In thepresent study the infant’s consumptionof rawfarmmilkduring
the first year of life was the exposure most strongly upregulating the
expression of TLRs, whereas duration of breast-feeding had no sig-
nificant effect.Also, the child’s contactwith stables, farmanimals, or
pets was not associated with receptor gene expression. It is possible
TABLE II. Crude association* of exposures during pregnancy and mRNA expression at birth (n 5 938, only significant associations are
shown)
Exposure during pregnancy
mRNA expression, GMR (95% CI) P value of simple
MANOVACD14 TLR1 TLR2 TLR4 TLR5 TLR6 TLR7 TLR8 TLR9
Farming 1.08"
(1.00-1.16)
1.09"
(1.00-1.18)
1.17"
(1.04-1.31)
1.16!
(1.06-1.28)
.041
Farm milk consumption
No .047
Only boiled farm milk
Any unboiled farm milk 1.10"
(1.01-1.20)
1.14"
(1.03-1.26)
Maternal farm work .301
Contact with stable 1.11"
(1.01-1.22)
.174
Contact with barn .376
Contact with number of
farm animals
0 .206
1-2
3-4
Cats or dogs .450
Smoking 0.85",§
(0.75-0.97)
0.86"
(0.74-0.99)
.279
Male sex 0.89",§
(0.81-0.98)
0.90",§
(0.85-0.98)
.002
Center <.001
*Geometric mean ratios (GMRs) and 95% CIs were calculated by using regression models.
"P < .05.
!P < .01.
§Associations were also significant after farming adjustment.
FIG 2. Adjusted association of farming/nonfarming during pregnancy and
mRNA expression at birth expressed as geometric mean ratios and 95% CIs
adjusted for maternal history of asthma or hay fever, sex, center (random),
and maternal smoking during pregnancy. Fully adjusted multifactorial
MANOVA of mRNA expression and farming P value 5 .041.
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that the intensityof exposure to stablemicrobes is too low to increase
expression of innate immunity receptors as long as children do not
walk around themselves in stables or barns.
Raw farm milk is rich in (mostly) nonpathogenic microorgan-
isms.6,28 It is conceivable that the microorganisms ingested with
raw milk influence the composition of the gut flora and stimulate
expression of innate immunity receptor genes.29 Whether in-
creased expression of TLRs associated with raw milk consump-
tion reflects a relevant pathway underlying allergic disease
development or whether it is merely an indicator of exposure to
microbes remains an open question. A recent cross-sectional
study found whey protein levels but not the actual counts of bac-
teria in farm milk to be associated with less asthma in children.6
However, the actual level of microorganisms in farm milk con-
sumed at school age might not be a precise indicator of the child’s
regular exposure to a diversity of microorganisms in raw milk,
which could be involved in inducing tolerance and protecting
against chronic inflammation.29
Several SNPs in innate immunity receptor genes were
reported to modify the risk for asthma or atopy, but results
were often not reproducible.1 Bieli et al7 described a modifica-
tion of the association between farm milk consumption at
school age and CD14 gene expression by the SNP CD14/C-
1721T; however, this could not be confirmed in the present
study, in which modifications by SNPs in TLR8 and TLR9
were found. Given the many SNPs tested, spurious findings can-
not be excluded, and further investigations are needed. A recent
genome-wide association study could not reproduce previously
TABLE III. Crude association* of exposures during the first year of life and mRNA expression at year 1 (n 5 752)
Exposure during first year of life
mRNA expression, GMR (95% CI) P value of simple
MANOVACD14 TLR1 TLR2 TLR4 TLR5 TLR6 TLR7 TLR8 TLR9
Farming .947
Farm milk consumption
No .079
Only boiled farm milk
Any unboiled farm milk 1.15"
(1.02-1.31)
1.27!
(1.09-1.47)
1.19"
(1.04-1.37)
1.24§
(1.10-1.40)
1.24!
(1.06-1.46)
Regular visit to farm .848
Regular stay in stable .943
Cats or dogs .772
Smoking during lactation 1.24"
(1.00-1.54)
1.29"
(1.00-1.67)
.406
Duration of breast-feeding
>6 mo .198
3-6 mo 1.15"
(1.02-1.29)
<_3 mo
Never 0.77"
(0.62-0.97)
Exclusive breast-feeding
>3 mo .229
<_3 mo
Never 0.75"
(0.60-0.94)
No. of solid food items introduced early
0 .018
1-3
4-6 1.25!
(1.06-1.48)
7-11 1.27"
(1.04-1.54)
All significant associations are shown.
*Geometric mean ratios (GMRs) and 95% CIs were calculated by using regression models.
"P < .05, !P < .01, and §P < .001: all associations with gene expression of individual receptors were also significant after farming adjustment.
FIG 3. Adjusted association of child’s farm milk consumption during first
year of life and mRNA expression at year 1 expressed as geometric mean
ratios and 95% CIs adjusted for farming, maternal history of asthma or hay
fever, sex, center, maternal smoking during breast-feeding, solid food
score, education, and duration of breast-feeding.
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reported interactions of SNPs and farming-related factors on al-
lergic outcomes in childhood and concluded that common ge-
netic polymorphisms are unlikely to modify the protective
influence of the farming environment on childhood asthma
and atopy.13 A similar conclusion might apply to interactions
of SNPs and farming-related factors on gene expression of in-
nate immunity receptors, given the low reproducibility of such
results.
As a further limitation in interpreting the results presented in
this article, it should be considered that mRNAwas measured in
whole-blood samples, and the observed effects cannot be ascribed
to a distinct cell type.
The farming-related factors that we identified to alter gene
expression of innate immunity genes (farming and raw farm
milk consumption) were also associated with a decreased risk
for allergic disease in previous studies.6,30 Regulation of the in-
nate immune system might be relevant to explain the protective
effects of these microbe-rich farming exposures. The present
study does not allow us to answer whether the upregulation
of innate immune receptors directly modulates the development
of allergic disease or whether it is a marker for the effect of
genes and the environment on allergic disease. Future analyses
of this cohort will allow us to disentangle whether the timing of
exposure or repeated exposure are more relevant in inducing
the protective effects observed in cross-sectional studies at
school age.
Farming-related exposures, such as raw farm milk consump-
tion, that were previously reported to decrease the risk for allergic
outcomes were associated with a change in gene expression of
innate immunity receptors in early life.
The PASTURE study group members (in alphabetical order by study
center):
Anne Hyv€arinen,a Anne M. Karvonen,a Sami Remes,b Pekka Tiittanena
(Finland); Vincent Kaulekc (France); Gisela B€uchele,d Martin Depner,e Mar-
kus Ege,e Petra Pfefferle,f Harald Renz,f Bianca Schaube (Germany); and Gert
Doekesg (The Netherlands)
From athe Department of Environmental Health, National Institute for
Health and Welfare, Kuopio, Finland; bthe Department of Pediatrics, Kuopio
University Hospital, Kuopio, Finland; cthe Department of Respiratory Dis-
ease, Universit"e de Franche-Comt"e, University Hospital, Besancon, France;
dthe Institute of Epidemiology and Medical Biometry, Ulm University, Ulm,
Germany; eLMUMunich, University Children’s Hospital, Munich, Germany;
fthe Department of Clinical Chemistry and Molecular Diagnostics, Philipps
University ofMarburg, Marburg, Germany; and gthe Institute for Risk Assess-
ment Sciences (IRAS), Division of Environmental Epidemiology, Utrecht
University, Utrecht, The Netherlands.
Key messages
d Farming status of pregnant mothers was associated with
increased gene expression of innate immunity receptors
at birth (overall and individually with TLR7 and TLR8).
d The child’s consumption of raw farm milk during the first
year of life was associated with increased gene expression
of innate immunity receptors at year 1 (TLR4, TLR5, and
TLR6).
d A previously described modification of the association be-
tween farm milk consumption and CD14 gene expression
by the SNP CD14/C-1721T was not found.
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METHODS
Study population
PASTURE is a large prospective birth cohort study conducted in rural areas
in Austria, Finland, France, Germany, and Switzerland. The study team
contacted 2871 women, of whom 1772 (61.7%) were identified as eligible for
participation. Initially, farming and nonfarming pregnant women living in the
5 rural areas were identified in the third trimester of pregnancy. Contact with
pregnant women was achieved either by study staff visiting birth preparatory
courses (Austria and Germany); by lists of pregnant women received from
hospitals (Finland) or insurance companies (France); by advertising in
hospitals, doctors’ offices, and shops in rural areas (Switzerland); or by
involving the midwives in distributing study information material at any type
of contact they had with pregnant women. Furthermore, articles in regional
newspapers and farmers’ journals and on the Internet, as well as spots on the
radio or television, were used to make the project better known among the
rural population.
Pregnant women contacted were asked to fill in a short recruitment
questionnaire, assessing eligibility and possible nonparticipation bias. Eligi-
ble women were then contacted by telephone and asked to participate.
To be eligible, pregnant women had to fulfill the following inclusion
criteria:
A. A woman was considered to be a ‘‘farming woman’’ if at the time of
recruitment she and her family lived on a farm where livestock was
held. No distinction was made between full-time and part-time
farmers. This criterion was also fulfilled when a family lived on a
farm only as a tenant without being involved in farm work at all. If
the family had moved away from the farm by the time of the child’s
birth, the status of the family was changed to ‘‘nonfarmer.’’ Because
it was clear from the beginning that the number of farming women in-
cluded in the study would not be very high (only approximately 400-
500), the type of farming was restricted as far as possible, and crop
farms, for example, were not included to avoid too much heterogene-
ity in exposure, which could lead to small numbers in any subgroup
analysis.
B. The nonfarming women lived in the same areas as the farming women
and were recruited at the same hospitals. To reduce differences in
other lifestyle factors, they were not taken from an urban hospital
(eg, Munich or Salzburg). As a limit for the size of the town in which
a nonfarming participant could live, women were included from towns
of less than 30,000 inhabitants only. However, women from smaller
towns but with relevant (heavy) industry were not recruited either.
In addition, in the Bavarian study center, where the large city of Mu-
nich was quite near and easy to reach, all families in which either the
mother or the father travelled to Munich every day for work (com-
muters) were not considered eligible.
C. Farming families not living on a farm where livestock was held (or
running such a farm) but just on a farm where exclusively poultry
was held or on an exclusive crop farm were not considered eligible ei-
ther as farmers or as nonfarmers (intermediate exposure).
In addition, the following exclusion criteria were defined:
! women less than 18 years of age;
! twin pregnancy/siblings of a child already included in the study;
! mother who intended delivery at home;
! families who intended to move away from the area where the study
was done;
! families without telephone connection; and
! insufficient knowledge of the country’s language.
Furthermore, after delivery, the following participants were excluded:
! premature delivery (before the 37th week of pregnancy, n 5 14) and
! serious genetic illnesses (eg, Down syndrome; n 5 2).
Those 1133 (63.9%) subjects willing to participate were included in the
study (530 farming and 603 nonfarming women). For mRNA analyses, 938
(82.3%) cord blood samples and 752 (72.8%) blood samples of year 1 were
available. The study population and the populations with available mRNA
measurements at birth and year 1 did not differ in respect to farming status, but
slightly more Finnish than French women provided blood samples. No
differences were seen with respect to age of pregnant mothers; educational
level; number of older siblings; smoking status; pet ownership; family history
of asthma, hay fever, and eczema; or prevalence of farm milk consumption.
Questionnaires
Extensive questionnaires were administered by interview to the mother of
the child within the third trimester of pregnancy and 2 and 12 months after
birth of the study child. Questions were based on previously published
studiesE1-E4 and designed to assess respiratory and other health issue of the
mother, agricultural exposures, and potential confounders, such as active
and passive smoking, parental education, and family size. In addition to the
extensive questionnaires, the mothers kept a weekly diary from month 3 to
year 1 of the child’s life to record, among other things, the introduction of a
variety of food items. Relevant pregnancy variables were farming (living on
a farm vs not), maternal farm work (mother working on a farm during preg-
nancy), contact with a stable/barn (stay in stable/barn during pregnancy at
least 15 minutes per week in 1 trimester), contact with a number of farm an-
imals (horse, cow, pig, or poultry: 0, 1-2, or 3-4), maternal/paternal history
of asthma or hay fever (doctor’s diagnosis and self-reported symptoms for
both outcomes), smoking during pregnancy (in any trimester), and farm
milk consumption during pregnancy (never, only boiled farm milk, or any un-
boiled farmmilk). Variables during the first year were farming (child living on
a farm during first year of life), regular visit to a farm, regular stay in a stable/
barn (child stayed in stable/barn at least 15minutes per week), smoking during
lactation, duration of breast-feeding (never, <_3 months, 3-6 months, or >6
months), duration of exclusive breast-feeding (never, <_3 months, or >3
months), and child’s farm milk consumption (never, only boiled farm milk,
or any unboiled farm milk during year 1). The time of exposure to stables
or barns was assessed by questionnaire in days per week and minutes per
day for farmers and in hours per month for nonfarmers. This separate informa-
tion was combined in a variable for both farmers and nonfarmers (time of
exposure in minutes per week). A mother or child staying in a stable/barn
for at least 15 minutes per week was defined as exposed. The cutoff (at least
15 minutes per week) was based on the distribution of exposure in the whole
population to provide sufficient numbers of exposed subjects for statistical
models.
Measurement of mRNA expression in cord blood
and at year 1
Blood samples were collected from the umbilical cord at birth and at age
1 year. For the assessment of mRNA, the blood was collected in a PAXgene
Blood RNA tube containing an RNA-stabilizing solution (PreAnalytiX/
Qiagen) and then frozen to2808Cwithin 24 hours.E5 At the central laboratory
of the Children’s Hospital of Zurich, the RNAwas isolated with the PAXgene
96Blood RNAKit (PreAnalytiX/Qiagen) supplemented with RNase-free DN-
ase (Qiagen). The concentration and purity of the RNAwas assessed by Nano-
drop (Thermo Scientific, Waltham, Mass). Samples with a concentration of at
least 20 ng/mL and a purity quotient (absorbance at 260 nm/absorbance at 280
nm) of between 1.8 and 2 were used for quantitative real-time PCR. Immedi-
ately after RNA isolation, it was reverse transcribed into cDNA by using the
TaqMan Reverse Transcription Reagents (Applied Biosystems). Quantitative
real-time PCR was performed on the 7900HT Fast Real-Time PCR System
with the Micro fluidic card TaqMan Array system (Applied Biosystems).
The data presented are calculated by using the comparative (DDCt) method
according to the manufacturer’s instructions (Applied Biosystems).E6,E7 In
brief, the Ct values of the target genes were normalized to the geometric
mean of the housekeeping genes 18S rRNA and b2-microglobulin (B2M) to
normalize the PCR for the amount of RNA added to the reaction because there
is variability in quantification and reverse transcription (DCt). In a second step
a nonfarming child was used as a reference to assess relative quantification de-
scribing the change in expression of a target gene (eg, TLR2) of a distinct child
relative to the expression of the same gene of the reference child (DDCt). To
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get the numeric value, we then used the 22DDCt calculation. TLR3 expression
was excluded from the analyses because the expression level was less than the
detection limit in most of the cord blood samples. Extensive quality control
measures have been incorporated in the PASTURE cohort study, particularly
for laboratory work but also for field work.E8
Genotyping
Genotyping was performed by means of matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry, as described previously.E9 De-
rived genotype frequencies were compared with the expected allelic popula-
tion equilibrium based on the Hardy-Weinberg equilibrium test to control
for technical genotyping errors. cDNA was amplified in duplicate by using
an iCycler (Bio-Rad Laboratories, Hercules, Calif), with 18S as a reference
gene. Polymorphisms in TLRs were selected as previously described.E10
These SNPs were as follows: TLR1/C22299T (rs5743594), TLR1/T22192C
(rs5743595), TLR1/A742G (rs4833095), TLR2/T1349C (rs3804100), TLR2/
T596C (rs3804099), TLR2/T216934A (rs4696480), TLR4/C8851T
(rs4986791), TLR4/A8551G (rs4986790), TLR4/G22570A (rs2737190),
TLR4/T21607C (rs10759932), TLR5/A1774G (rs2072493), TLR5/T1845C
(rs5744174), TLR5/C1173T (rs5744168), TLR6/T21928C (rs5743792),
TLR6/T22079A (rs5743789), TLR7/A17961T (rs179008), TLR7/C12318T
(rs1620233), TLR8/C10907A (rs3747414), TLR8/C9008T (rs2159377),
TLR8/A24824G (rs3761624), TLR9/T-2622C (rs5743836), TLR9/T22871C
(rs187084), and CD14/C-1721T (rs2915863).
Statistical analyses
The overall association of exposures onmRNAexpressionwas additionally
calculated in MANOVA (adjusting for the same covariates as the regression
models) to avoid spurious findings caused by testing multiple TLRs.
MANOVA provided omnibus tests, which inherently correct for multiple
comparisons. MANOVA can protect against type I errors that might occur if
multiple ANOVAs were conducted independently. Repeated univariate mea-
sures can dramatically increase type I errors. Furthermore, multiple univariate
measures do not equal a multivariate measure because they do not take into
account colinearity (correlations among dependent variables). Therefore a
MANOVA acts as an inherent Bonferroni correction by keeping the
experiment-wide probability of making type I error less than 5%. Levels of
significance in all ANOVAs were evaluated based on Wilks lambda.
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TABLE E1. Crude association* of food exposures during the first year of life and mRNA expression at year 1 (n 5 752)
Early food introduction
vs late or never
mRNA expression P value of simple
MANOVACD14 TLR2 TLR4 TLR6 TLR7 TLR8
Other milk products
(exclusive cow’s milk)
1.15"
(1.02-1.30)
.385
Yogurt 1.18"
(1.02-1.37)
.110
Butter 0.89"
(0.81-0.98)
.046
Vegetable 1.18"
(1.06-1.32)
.033
Fruit 1.16"
(1.04-1.29)
.010
Meat 1.13"
(1.02-1.25)
1.20!
(1.07-1.35)
1.20!
(1.05-1.36)
<.001
Nut 0.82"
(0.70-0.96)
.019
Fish 1.16"
(1.04-1.29)
.163
Chocolate 1.17"
(1.01-1.35)
.692
Cereal (gluten) 0.91"
(0.83-1.00)
0.90"
(0.81-0.99)
<.001
Cereal (no gluten) 1.13"
(1.02-1.26)
.064
All significant associations are shown.
*Geometric mean ratios and 95% CIs were calculated by using regression models.
"P < .05 and !P < .01, all associations with gene expression of individual receptors were also significant after farming adjustment.
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TABLE E2. Adjusted associations* of exposures during pregnancy and mRNA expression at birth (n 5 938)
Exposure during pregnancy
mRNA expression
TLR1 TLR2 TLR5 TLR6 TLR7 TLR8
Farming 1.05 (0.98-1.12) 1.06 (0.98-1.15) 1.15" (1.02-1.30) 1.15! (1.04-1.26)
Smoking 0.85" (0.75-0.97) 0.87 (0.76-1.01)
Male sex 0.90" (0.82-0.99) 0.90" (0.85-0.97)
Results from final adjusted models in Fig 2 are shown for variables with significant crude associations with mRNA expression in Table II.
*Geometric mean ratios and 95% CIs were calculated by using regression models adjusted for maternal history of asthma or hay fever, sex, center (random), and maternal smoking
during pregnancy.
"P < .05.
!P < .01.
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TABLE E3. Adjusted associations* of exposures during first year of life and mRNA expression at year 1 (n 5 752)
Exposure during first year of life
mRNA expression
CD14 TLR4 TLR5 TLR6 TLR7 TLR9
Farm milk consumption
No
Only boiled farm milk
Any unboiled farm milk 1.15 (1.00-1.32) 1.22" (1.03-1.45) 1.19" (1.01-1.41) 1.20" (1.04-1.38) 1.15 (0.95-1.39)
Smoking during lactation 1.04 (0.85-1.29) 1.11 (0.86-1.44)
Duration of breast-feeding
>6 mo
3-6 mo 1.10 (0.98-1.24)
<_3 mo
Never 0.74" (0.56-0.98)
No. of solid food items
introduced early
0
1-3
4-6 1.10 (0.92-1.33)
7-11 1.10 (0.88-1.37)
Results from final adjusted models in Fig 3 are shown for variables with significant crude associations with mRNA expression in Table III.
*Geometric mean ratios and 95% CIs were calculated by using regression models adjusted for farming, maternal history of asthma or hay fever, sex, center, maternal smoking
during breast-feeding, solid food score, education, and duration of breast-feeding.
"P < .05.
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TABLE E4. Crude associations of genotypes and mRNA expression in cord blood and at age 1 year
Receptor/SNPS Genotype
mRNA expression in cord blood mRNA expression at age 1 y
No. GMR 95% CI P value No. GMR 95% CI P value
TLR1/C22299T (rs5743594) CC 597 1.00 483 1.00
CT 242 1.21 1.09-1.35 <.001 193 1.19 1.06-1.34 .003
TT 22 1.41 1.04-1.92 .028 19 1.55 1.13-2.13 .006
TLR1/T22192C (rs5743595) TT 547 1.00 453 1.00
TC 271 0.68 0.62-0.74 <.001 208 0.61 0.56-0.68 <.001
CC 45 0.20 0.17-0.25 <.001 38 0.26 0.21-0.32 <.001
TLR1/A742G (rs4833095) AA 462 1.00 385 1.00
AG 337 0.74 0.67-0.81 <.001 263 0.69 0.62-0.76 <.001
GG 67 0.34 0.29-0.40 <.001 52 0.32 0.27-0.39 <.001
TLR2/T1349C (rs3804100) TT 746 1.00 601 1.00
TC 119 1.01 0.92-1.12 .824 97 0.98 0.88-1.09 .713
CC 0 1
TLR2/T596C (rs3804099) TT 267 1.00 218 1.00
TC 422 0.95 0.88-1.03 .225 353 1.00 0.92-1.09 .914
CC 158 0.94 0.85-1.04 .220 115 1.01 0.90-1.13 .910
TLR2/T216934A (rs4696480) AA 239 1.00 202 1.00
AT 401 0.93 0.86-1.01 .093 314 1.06 0.97-1.16 .192
TT 219 0.97 0.89-1.07 .589 182 1.00 0.90-1.10 .938
TLR4/C8851T (rs4986791) CC 758 1.00 604 1.00
CT 106 1.42 1.23-1.64 <.001 94 1.23 1.04-1.44 .013
TT 4 1.11 0.56-2.19 .762 2 1.40 0.50-3.94 .525
TLR4/A8551G (rs4986790) AA 762 1.00 611 1.00
AG 97 1.43 1.24-1.66 <.001 83 1.29 1.09-1.53 .004
GG 4 1.11 0.56-2.20 .763 2 1.41 0.50-3.96 .518
TLR4/G22570A (rs2737190) GG 89 1.00 71 1.00
GA 352 0.86 0.73-1.00 .056 270 1.04 0.85-1.26 .733
AA 367 0.78 0.66-0.91 .002 294 1.02 0.84-1.25 .816
TLR4/T21607C (rs10759932) TT 625 1.00 503 1.00
TC 201 0.95 0.85-1.07 .413 171 0.94 0.82-1.07 .336
CC 26 1.20 0.91-1.58 .198 20 1.21 0.87-1.69 .259
TLR5/A1774G (rs2072493) AA 610 1.00 503 1.00
AG 225 1.01 0.92-1.11 .859 174 0.92 0.82-1.04 .189
GG 17 1.20 0.90-1.61 .216 11 0.95 0.62-1.45 .814
TLR5/T1845C (rs5744174) TT 276 1.00 222 1.00
TC 426 0.94 0.86-1.03 .214 357 0.88 0.78-0.99 .030
CC 152 0.90 0.80-1.01 .085 111 0.93 0.79-1.10 .397
TLR5/C1173T (rs5744168) CC 766 1.00 621 1.00
CT 95 0.98 0.86-1.11 .753 76 1.04 0.88-1.23 .629
TT 4 1.05 0.58-1.89 .883 2 1.80 0.67-4.81 .241
TLR6/T21928C (rs5743792) TT 806 1.00 661 1.00
TC 50 1.26 1.05-1.52 .014 34 0.88 0.71-1.09 .238
CC 1 0
TLR6/T22079A (rs5743789) TT 539 1.00 449 1.00
TA 264 0.94 0.86-1.04 .227 204 0.90 0.82-1.00 .046
AA 50 0.75 0.62-0.91 .003 37 0.92 0.75-1.13 .437
TLR7/A17961T (rs179008) AA 599 1.00 475 1.00
AT 137 1.18 1.00-1.41 .054 121 0.97 0.83-1.14 .731
TT 127 0.89 0.75-1.06 .204 103 0.98 0.82-1.16 .803
TLR7/C12318T (rs1620233) CC 738 1.00 594 1.00
CT 70 1.12 0.89-1.41 .331 63 1.15 0.93-1.42 .202
TT 52 0.88 0.67-1.14 .325 40 1.12 0.86-1.45 .401
TLR8/C10907A (rs3747414) CC 468 1.00 361 1.00
CA 208 0.98 0.87-1.10 .705 173 0.95 0.82-1.09 .460
AA 187 0.79 0.69-0.89 <.001 163 0.81 0.70-0.93 .003
TLR8/C9008T (rs2159377) CC 658 1.00 531 1.00
CT 128 0.85 0.74-0.97 .015 105 0.71 0.61-0.83 <.001
TT 74 0.40 0.34-0.47 <.001 61 0.44 0.36-0.54 <.001
TLR8/A24824G (rs3761624) AA 562 1.00 461 1.00
AG 181 0.71 0.64-0.79 <.001 143 0.67 0.59-0.76 <.001
GG 125 0.32 0.29-0.37 <.001 97 0.29 0.25-0.33 <.001
(Continued)
J ALLERGY CLIN IMMUNOL
AUGUST 2012
530.e6 LOSS ET AL
TABLE E4. (Continued)
Receptor/SNPS Genotype
mRNA expression in cord blood mRNA expression at age 1 y
No. GMR 95% CI P value No. GMR 95% CI P value
TLR9/T22622C (rs5743836) TT 662 1.00 532 1.00
TC 189 0.94 0.85-1.05 .274 158 1.00 0.87-1.16 .957
CC 12 0.98 0.67-1.43 .899 10 0.84 0.50-1.41 .504
TLR9/T22871C (rs187084) TT 265 1.00 220 1.00
TC 437 1.01 0.91-1.12 .870 346 0.97 0.84-1.11 .633
CC 155 0.95 0.83-1.08 .415 130 1.10 0.91-1.31 .320
CD14/C-1721T (rs2915863) CC 130 1.00 102 1.00
CT 380 0.98 0.86-1.11 .721 296 0.99 0.86-1.14 .898
TT 294 1.04 0.91-1.19 .553 233 0.98 0.84-1.14 .778
GMR, Geometric mean ratio.
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TABLE E5. Adjusted associations of genotypes and mRNA expression in cord blood and at age 1 year
Receptor/SNPS Genotype
mRNA expression in cord blood mRNA expression at age 1 y
No. aGMR* 95% CI P value No. aGMRy 95% CI P value
TLR1/C22299T (rs5743594) CC 597 1.00 483 1.00
CT 242 1.22 1.09-1.36 <.001 193 1.19 1.06-1.35 .004
TT 22 1.46 1.08-1.98 .014 19 1.59 1.16-2.18 .004
TLR1/T22192C (rs5743595) TT 547 1.00 453 1.00
TC 271 0.68 0.62-0.75 <.001 208 0.62 0.56-0.69 <.001
CC 45 0.21 0.17-0.25 <.001 38 0.26 0.21-0.31 <.001
TLR1/A742G (rs4833095) AA 462 1.00 385 1.00
AG 337 0.74 0.68-0.82 <.001 263 0.70 0.63-0.77 <.001
GG 67 0.34 0.29-0.40 <.001 52 0.31 0.26-0.38 <.001
TLR2/T1349C (rs3804100) TT 746 1.00 601 1.00
TC 119 1.01 0.91-1.11 .892 97 0.98 0.87-1.09 .671
CC 0 1
TLR2/T596C (rs3804099) TT 267 1.00 218 1.00
TC 422 0.95 0.88-1.03 .184 353 1.00 0.92-1.09 .981
CC 158 0.94 0.85-1.04 .211 115 0.98 0.87-1.11 .796
TLR2/T216934A (rs4696480) AA 239 1.00 202 1.00
AT 401 0.93 0.86-1.01 .105 314 1.06 0.97-1.17 .182
TT 219 0.98 0.89-1.08 .695 182 1.00 0.90-1.11 .946
TLR4/C8851T (rs4986791) CC 758 1.00 604 1.00
CT 106 1.44 1.25-1.66 <.001 94 1.22 1.03-1.44 .020
TT 4 0.98 0.50-1.93 .950 2 1.42 0.50-3.99 .506
TLR4/A8551G (rs4986790) AA 762 1.00 611 1.00
AG 97 1.47 1.27-1.70 <.001 83 1.26 1.06-1.50 .010
GG 4 0.98 0.49-1.93 .949 2 1.44 0.51-4.04 .491
TLR4/G22570A (rs2737190) GG 89 1.00 71 1.00
GA 352 0.87 0.74-1.02 .089 270 1.08 0.87-1.33 .495
AA 367 0.78 0.67-0.92 .002 294 1.13 0.91-1.39 .273
TLR4/T21607C (rs10759932) TT 625 1.00 503 1.00
TC 201 0.95 0.85-1.06 .376 171 0.90 0.79-1.03 .138
CC 26 1.21 0.91-1.60 .191 20 1.02 0.73-1.44 .905
TLR5/A1774G (rs2072493) AA 610 1.00 503 1.00
AG 225 1.01 0.92-1.11 .813 174 0.92 0.81-1.05 .210
GG 17 1.27 0.94-1.71 .125 11 0.93 0.61-1.41 .719
TLR5/T1845C (rs5744174) TT 276 1.00 222 1.00
TC 426 0.93 0.85-1.02 .126 357 0.89 0.79-1.01 .072
CC 152 0.90 0.79-1.01 .072 111 0.92 0.78-1.09 .334
TLR5/C1173T (rs5744168) CC 766 1.00 621 1.00
CT 95 0.98 0.86-1.11 .716 76 1.01 0.85-1.21 .881
TT 4 1.11 0.61-2.02 .727 2 1.59 0.59-4.28 .359
TLR6/T21928C (rs5743792) TT 806 1.00 661 1.00
TC 50 1.30 1.08-1.56 .006 34 0.86 0.69-1.07 .176
CC 1 0
TLR6/T22079A (rs5743789) TT 539 1.00 449 1.00
TA 264 0.93 0.85-1.03 .165 204 0.90 0.81-1.00 .058
AA 50 0.74 0.61-0.90 .002 37 0.92 0.74-1.13 .419
TLR7/A17961T (rs179008) AA 599 1.00 475 1.00
AT 137 1.18 0.98-1.43 .086 121 0.99 0.83-1.19 .954
TT 127 0.88 0.73-1.05 .165 103 0.93 0.77-1.12 .423
TLR7/C12318T (rs1620233) CC 738 1.00 594 1.00
CT 70 1.11 0.87-1.41 .398 63 1.22 0.97-1.53 .087
TT 52 0.92 0.70-1.20 .539 40 1.20 0.91-1.59 .202
TLR8/C10907A (rs3747414) CC 468 1.00 361 1.00
CA 208 0.96 0.83-1.10 .525 173 0.98 0.83-1.15 .805
AA 187 0.80 0.70-0.91 <.001 163 0.79 0.68-0.92 .002
TLR8/C9008T (rs2159377) CC 658 1.00 531 1.00
CT 128 0.84 0.73-0.97 .018 105 0.71 0.60-0.84 <.001
TT 74 0.41 0.34-0.49 <.001 61 0.46 0.37-0.57 <.001
TLR8/A24824G (rs3761624) AA 562 1.00 461 1.00
AG 181 0.70 0.62-0.79 <.001 143 0.69 0.60-0.80 <.001
GG 125 0.33 0.29-0.38 <.001 97 0.29 0.25-0.34 <.001
(Continued)
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TABLE E5. (Continued)
Receptor/SNPS Genotype
mRNA expression in cord blood mRNA expression at age 1 y
No. aGMR* 95% CI P value No. aGMRy 95% CI P value
TLR9/T22622C (rs5743836) TT 662 1.00 532 1.00
TC 189 0.94 0.84-1.05 .265 158 1.02 0.88-1.20 .765
CC 12 0.90 0.62-1.32 .601 10 1.00 0.55-1.80 .997
TLR9/T22871C (rs187084) TT 265 1.00 220 1.00
TC 437 1.02 0.92-1.13 .670 346 0.96 0.83-1.11 .566
CC 155 0.94 0.82-1.07 .339 130 1.09 0.90-1.31 .368
CD14/C-1721T (rs2915863) CC 130 1.00 102 1.00
CT 380 0.97 0.85-1.10 .628 296 0.97 0.84-1.12 .632
TT 294 1.01 0.88-1.15 .900 233 0.96 0.83-1.12 .603
*Adjusted for center, farming, sex, maternal history of asthma and hay fever, siblings, and smoking during pregnancy.
"Adjusted for center, child’s farming status at year 1, sex, maternal history of asthma and hay fever, maternal smoking during lactation, siblings, and solid food score.
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Atopic dermatitis and skin disease
Development of atopic dermatitis according to age of onset
and association with early-life exposures
Caroline Roduit, MD, MPH,a Remo Frei, PhD,b Georg Loss, PhD,c Gisela B€uchele, MPH,f Juliane Weber, MD,g
Martin Depner, PhD,g Susanne Loeliger, MLS,a Marie-Laure Dalphin, MD,h Marjut Roponen, PhD,i Anne Hyv€arinen, PhD,j
Josef Riedler, MD,k Jean-Charles Dalphin, MD, PhD,l Juha Pekkanen, MD,j Erika von Mutius, MD, MSc,g
Charlotte Braun-Fahrl€ander, MD,c,d Roger Lauener, MD,a,e and the Protection Against Allergy–Study in Rural
Environments study group* Zurich, Basel, and Davos, Switzerland, Ulm and Munich, Germany, Besanc¸on, France, Kuopio, Finland,
and Schwarzach, Austria
Background: Environmental factors can affect the development
of atopic dermatitis, and this was described to be already
effective during pregnancy and in early life. An important early
postnatal exposure is nutrition, although its association with
allergic disease remains unclear.
Objective: We sought to determine prospectively whether early
postnatal exposures, such as the introduction to complementary
food in the first year of life, are associated with the development
of atopic dermatitis, taking into account the reverse causality.
Methods: One thousand forty-one children who participated in
the Protection Against Allergy–Study in Rural Environments
birth cohort study were included in the current study. Atopic
dermatitis was defined by a doctor’s diagnosis reported by the
parents of children up to 4 years of age, by questionnaires, and/
or by positive SCORAD scores from 1 year of age and according
to the age of onset within or after the first year of life. Feeding
practices were reported by parents in monthly diaries between
the 3rd and 12th months of life.
Results: The diversity of introduction of complementary food in
the first year of life was associated with a reduction in the risk of
having atopic dermatitis with onset after the first year of life
(adjusted odds ratio for atopic dermatitis with each additional
major food item introduced, 0.76; 95% CI, 0.65-0.88). The
introduction of yogurt in the first year of life also reduced the
risk for atopic dermatitis (adjusted odds ratio, 0.41; 95% CI,
0.23-0.73).
Conclusion: As early-life exposure, the introduction of yogurt
and the diversity of food introduced in the first year of life might
have a protective effect against atopic dermatitis. (J Allergy
Clin Immunol 2012;130:130-6.)
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Increasing evidence suggests that prenatal and early-life envi-
ronmental exposures can influence immune responses and the
development of allergic diseases. Atopic dermatitis is a chronic
inflammatory skin disease, and in 60% of children, the onset of
disease occurs during the first year of life.1
As early-life exposure, nutrition is a major environmental
factor that might have an effect on the immune system and could
be a factor that would lead to the prevention of allergic diseases.
Studies of the farming environment have shown that consumption
of unprocessed farm milk was associated with fewer allergic
diseases, although there was some heterogeneity of the effects,
especially with atopic dermatitis. In addition, this evidence was
based on cross-sectional studies of school-aged children only.2-6
First introduction of complementary food in an infant’s life and
its association with allergic diseases is another aspect of nutrition
raising much controversy. Food allergen avoidance during preg-
nancy or infancy has provided no consistent evidence of allergy
prevention7,8 and is no longer recommended.9 A systematic re-
view of 13 studies of the relationship between early introduction
of solid food and the development of allergies concluded that the
evidence of this relation is inconsistent and conflicting.10 Some
recent studies even showed that early introduction of complemen-
tary food, like the introduction of fish before 1 year of age or early
exposure to cow’s milk, might have a protective effect against
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allergic diseases.11-15 One study found a protective effect of the
introduction of any complementary food within the first 4 months
on atopic dermatitis but only among children with allergic par-
ents.16 Therefore more evidence with respect to the role of early
nutritional exposures is needed.
The birth cohort study Protection Against Allergy–Study in
Rural Environments (PASTURE) offered the opportunity to
evaluate the effect of prenatal and postnatal exposures on the
development of allergic diseases.17 We previously reported an in-
verse association between prenatal contact with animals and
atopic dermatitis up to 2 years of age.18 In the present analysis
we longitudinally evaluated whether early postnatal exposures,
especially food introduction and its diversity, were associated
with the development of atopic dermatitis, with data available
up to 4 years of age. One major concern with postnatal exposures,
especially with the association between feeding practices and
atopic dermatitis, is the potential bias caused by the reverse cau-
sality effect. This source of bias arises when the reason for intro-
ducing or not introducing a certain type of food is strongly
associated with the outcome. Among children with early symp-
toms of the disease, those with allergic parents, or both, introduc-
tion of certain complementary food, especially allergenic food,
tends to be delayed. We thus focused our analyses on children
with atopic dermatitis occurring after the first year of life, ensur-
ing that exposure occurred before onset of the disease.
METHODS
Study design
PASTURE is a prospective birth cohort study involving children from rural
areas in 5 European countries (Austria, Finland, France, Germany, and
Switzerland) designed to evaluate risk factors and preventive factors for atopic
diseases. The design of this cohort has been described in detail elsewhere.17
Briefly, pregnant women were recruited during the third trimester of preg-
nancy and divided into 2 groups. Women who lived or worked on family-
run farms on which any kind of livestock was kept were assigned to the
farm group. The reference groupwas composed of women from the same rural
areas not living on a farm. In total, 1133 children were included in this birth
cohort. The questionnaires developed within the PASTURE study group
used questions onvarious exposures and outcomes from theAsthmaMulticen-
ter Infants Cohort Study,19 the Allergy and Endotoxin study,2 and the Preven-
tion of Allergy Risk Factors for Sensitization in Children Related to Farming
and Anthroposophic Lifestyle study.20 Questionnaires were administered in
interviews or self-administered to the mothers within the third trimester of
pregnancy; when the children were 2, 12, 18, and 24 months of age; and
then yearly up to 4 years of age. Feeding practices and the occurrence of itchy
rash were reported by parents between the 3rd and 12th months of life in
monthly and weekly diaries, respectively. The study was approved by the local
research ethics committees in each country, and written informed consent was
obtained from all parents.
Study population
Children from the PASTURE birth cohort with data available on atopic
dermatitis up to 4 years of age, farming status, parental allergic history, and
feeding practices in the first year of life (n 5 1041) were included.
Definitions
Children were labeled as having atopic dermatitis when the parents
reported in the questionnaires that the child had atopic dermatitis diagnosed
by a doctor at least once between 12 months and 4 years of age, positive
SCORAD scores (>0) assessed at the age of 1 year during medical exami-
nation, or both. Among the 144 children defined as having atopic dermatitis at
the age of 1 year, 44 had only a positive SCORAD score, 50 had only a doctor’s
diagnosis, and 50 had both. Children with no atopic dermatitis but missing
information at 1 or more time points were defined as ‘‘missing’’ (n 5 129)
when the prevalence of atopic dermatitis up to 4 years was calculated. In most
children atopic dermatitis occurs early in life, and to be able to evaluate
exposures occurring before the disease, we used 2 different definitions of
atopic dermatitis depending on the occurrence of the disease: atopic dermatitis
with onset within the first year of life and atopic dermatitis with onset after the
first year of life. Farmer’s childrenwere defined as childrenwhowere living on
a farm onwhich livestockwas held andwhose family ran the farm according to
parental reports. Maternal farm-related exposures during pregnancy were
obtained from the self-reported questionnaires at the third trimester of
pregnancy. Prenatal contact with farm animal species was assumed if the
mother reported contact at least several times per month in one of the
pregnancy trimesters. Postnatal exposures to stables during the first year of life
were defined as the child’s exposure for at least a quarter of an hour per week.
Feeding practices were reported by parents in monthly diaries between the 3rd
and 12th months of life. Parents indicated for each food item whether it was
given to the child in the last 4weeks and, if so, how often. A diversity scorewas
calculated, including the major food items, which were defined as the ones
introduced in the first year of life to approximately 80% of the children or
more. The score included vegetables or fruits, cereals, bread, meat, cake, and
yogurt. The same food items were used to define the diversity score within the
first 6 months of life. For the association between single food items and atopic
dermatitis, we used as reference children for whom the item was not
introduced in the first year of life. When it was introduced for less than 15%
of the children, cutoffs to earlier time points were used. Introduction of cow’s
milk was defined as either exclusive consumption of milk purchased in a shop
(shop milk) or introduction of milk produced or purchased directly from a
farm exclusively or in combinationwith shopmilk and irrespective of whether
the milk was boiled or unboiled (any farm milk).
Data on potential confounders, such as smoking during pregnancy, sex,
mode of delivery, birth weight, gestational age, maternal education, and
duration of breast-feeding were obtained from the self-reported question-
naires at the third trimester of pregnancy and at 2 months and 1 year of age.
Duration of breast-feeding was categorized according to the number of
months children were breast-fed (not exclusively). Parental history of
allergies was defined as ever had asthma, hay fever, or atopic dermatitis,
which was self-reported.
Statistical analysis
Data analysis was conducted with SAS software, version 9.2 (SAS
Institute, Inc, Cary, NC).
The x2 test was used to evaluate the differences between the prevalences of
atopic dermatitis depending on parental allergic status and also to compare the
diversity score among subgroups of children. Generalized estimating equa-
tions were used to investigate the longitudinal effects of prenatal and postnatal
exposures on atopic dermatitis with onset after the first year of life, taking into
account the correlation between repeated measures (age 18, 24, 36, and 48
months) in the same subject. For the associations between exposures and
atopic dermatitis with onset within the first year of life, we used logistic regres-
sion because only 1 time point (age 12 months) was taken into account. From
these analyses, odds ratios (ORs) with 95% CIs were reported. To avoid re-
verse causality, with timing of introduction of food in the first year of life,
we limited the analyses to children with atopic dermatitis first occurring after
the first year of life. For the analysis comparing introduction of food before or
after 6 months of age, the analysis was restricted to children without skin
symptoms (itchy rash and diary data) within the first 6 months of life. To eval-
uate the relation between the diversity score and atopic dermatitis, we per-
formed nonparametric smoothing regression analysis. Family history of
J ALLERGY CLIN IMMUNOL
VOLUME 130, NUMBER 1
RODUIT ET AL 131
allergies is a dominant predictive factor of allergic diseases, particularly atopic
dermatitis. Therefore all models were adjusted for parental history of allergy
(ever eczema, hay fever, or asthma). For the association between food expo-
sures and atopic dermatitis, we stratified the analyses by this variable. To
test for effect modification between food item exposures and parental history
of allergy, we calculated terms for interactions in the generalized estimating
equation model.
All models were adjusted for study centers as a fixed effect because we did
not find heterogeneity between the centers (tested by means of meta-analytic
techniques). Multivariate models were further adjusted for farming and
duration of breast-feeding in the first year of life because these variables are
well known as potential confounders. Smoking during pregnancy and
maternal education were added to the model but did not change the results,
and therefore they were not kept in the final model. A P value of less than .05
was considered statistically significant.
RESULTS
Prevalence of atopic dermatitis
In total, 1041 children were included in this study. The
proportion of farmer’s children was 47.8%, and 558 (53.6%)
had at least 1 allergic parent; among them, 39.1% (218/558) were
farmer’s children. The general characteristics of this study
population were described in our previous analysis.18 The cumu-
lative prevalence of children with atopic dermatitis in the first
4 years of life was 27.1% (Table I). This prevalence was signifi-
cantly higher in children with 2 allergic parents than among chil-
dren with nonallergic parents (44.6% and 21.8%, respectively).
For 59.8% (144/241) of these children, the disease appeared in
the first year of life. The influence of parental allergy was more
pronounced in these children than in thosewith disease onset after
the first year of life (Table I).
Association between early postnatal exposures to
farm animals and atopic dermatitis
We did not observe an association between early postnatal
contact with farm animals (presence of the child in the stable in
the first year of life) and atopic dermatitis with onset after the first
year of life. After adjustment for prenatal exposures (adjusted
OR, 0.97; 95% CI, 0.53-1.75), unadjusted results were very
similar (data not shown). To separate the influence of prenatal and
postnatal exposures to farm animals, a variable with 4 mutually
exclusive categories was computed: childrenwith both exposures,
those with only prenatal or only postnatal exposure, and those not
exposed. The negative association between prenatal contact with
farm animals and atopic dermatitis was observed only when the
disease onset occurred during the first year of life (see Table E1 in
this article’s Online Repository at www.jacionline.org). By con-
trast, postnatal exposure was inversely associated with atopic der-
matitis with onset after the first year of life, but this analysis was
based on small numbers and not statistically significant.
Feeding practices in the first year of life
At 2 months of age, exclusive breast-feeding was observed
among 66.0% of the children, and 18.6% were not breast-fed.
About half of the children (46.4%) were breast-fed for more than
6 months (not exclusively), and no difference with respect to the
parental history of allergy was observed (data not shown).
For only 18 (1.7%) children, no complementary food was
introduced in the first year of life (Table II). These children did not
differ from thosewith complementary food introduced in terms of
farming status, parental allergic history, maternal education, or
duration of breast-feeding (data not shown). In the first year of
life, cow’s milk was introduced to half of the study population
(Table II). Of these children, 43.8% consumed only shop milk,
and 56.2% consumed any farm milk, and 118 (37%) of the farm
milk drinkers consumed unboiled farm milk.
About 80% of the children consumed vegetables or fruits,
cereals, bread, meat, cake, and yogurt during the first year of life.
A diversity score including these 6 major food items was
calculated, and more than two thirds of the children consumed
all 6 items (Table III). Significantly fewer food items were intro-
duced among nonfarmer’s children and thosewith at least 1 parent
with a history of allergy. The diversity score showed no difference
between children breast-fed formore or less than 6months. As ex-
pected, among children with allergic parents, the allergenic food
items, such as dairy products, egg, nut, and soy, were introduced
later (data not shown).
Association between complementary food
introduction and atopic dermatitis
The analyses of atopic dermatitis with onset within the first
year of life showed an inverse association with the introduction in
the first year of life for most of the food items, especially the
allergenic foods (see Table E2 in this article’s Online Repository
at www.jacionline.org). This negative association is most likely
due to delayed introduction of certain foods in children with early
symptoms. Analyses were restricted to children having no atopic
dermatitis in the first year of life but who had it later to avoid this
form of bias. The introduction of yogurt and shop milk within the
first year of life showed an inverse association with the develop-
ment of atopic dermatitis with onset after the first year of life
compared with no introduction, indicating a protective effect
(adjusted OR, 0.41; 95% CI, 0.23-0.73 and adjusted OR, 0.52;
95% CI, 0.30-0.92, respectively); unadjusted results were very
similar (data not shown). Analyses stratified by parental history
of allergy showed similar associations (Fig 1 and see Table E3
in this article’s Online Repository at www.jacionline.org). The
consumption of farm milk in the first year of life had a tendency
to decrease the risk of having atopic dermatitis but only among
children with no allergic parents (adjusted OR, 0.49; 95% CI,
TABLE I. Prevalence of atopic dermatitis, according to time of onset and parental allergic status
Total
(n 5 912), % (n)
No allergic parents
(n 5 426), % (n)
Only 1 allergic parent
(n 5 385), % (n)
Two allergic parents
(n 5 101), % (n)
P
value*
Atopic dermatitis up to age 4 y 27.1 (247) 21.8 (93) 28.3 (109) 44.6 (45) <.001
Atopic dermatitis with onset within the first year of life 15.9 (144) 12.9 (55) 15.0 (57) 32.0 (32) <.001
Atopic dermatitis with onset after the first year of life! 10.7 (97) 8.7 (37) 12.6 (48) 12.0 (12) .18
*Based on x2 test between parental allergic status and atopic dermatitis.
!Missing information for the first year of life for 6 children.
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0.21-1.18). Tests for interaction between parental history of
allergy and farm milk showed a P value of .08. Introduction of
vegetables or fruits in the first 6 months reduced the risk of atopic
dermatitis (adjusted OR, 0.56; 95% CI, 0.31-1.00).
A smoothed plot of the prevalence of atopic dermatitis in
relation to the diversity score (0-6) was performed to evaluate
whether the diversity of foods consumed during the first year of
life was associated with atopic dermatitis occurring after the first
year of life, showing a decrease in prevalence of the disease with
an increasing score (Fig 2). Dividing the diversity score into 3
different categories with the largest as the reference category,
we observed a dose-response association with atopic dermatitis
(Table IV). For each additional major food item introduced in
the first year of life, we observed a significant reduction of 25%
in the development of atopic dermatitis. Similar results were ob-
tained in separate analyses stratified by parental history of allergy
(adjusted OR for each food item introduced among children with
parents with no allergy, 0.70; 95% CI, 0.56-0.87; among those
with at least 1 parent with allergy: adjusted OR, 0.81; 95% CI,
0.65-1.01). The score was recalculated excluding yogurt to
evaluate the influence of the yogurt item in this score and showed
the same association with atopic dermatitis (Table IV). Moreover,
yogurt remained significantly associated with atopic dermatitis
after adjustment for the reduced score. Smoothed plots with a di-
versity score including all 15 food items also showed a decrease in
prevalence of the disease with an increasing score most strongly
with up to 6 items (see Fig E1 in this article’s Online Repository
at www.jacionline.org). When the major food items were ex-
cluded from the score, no association was observed (see Fig E2
in this article’s Online Repository at www.jacionline.org).
Additionally, we evaluated the association between the intro-
duction of food in the first 6 months of life and atopic dermatitis
with onset within the first year of life in the subgroup of children
and no symptoms of atopic dermatitis (itchy rash) within the first
6 months (60.3% of the children with atopic dermatitis with early
onset).We could also observe a decreased risk of atopic dermatitis
with increasing numbers of major food introduced in the first 6
months, indicating a dose-response effect (Table V). We also ob-
served similar results in separated analyses stratified by the paren-
tal history of allergy, as well as in unadjusted analyses (data not
shown).
DISCUSSION
Our study shows a strong association between the family
history of allergies and atopic dermatitis with early onset but not
with onset occurring after the first year of life. The previously
reported protective prenatal effect of exposure to farm animals
was limited to atopic dermatitis occurring during the first year of
life. The postnatal exposure to farm animals was not significantly
associated with atopic dermatitis.
Feeding practices in the first year of life seem to be associated
with atopic dermatitis. We showed that the diversity of food items
introduced in the first year of life reduces the risk of atopic
dermatitis later in life. Introduction of yogurt in the first year of life
showed a strong protective effect against atopic dermatitis with
onset after thefirst year of life independently of the diversityoffood.
TABLE III. Diversity score with major food items introduced in
the first year of life among all study populations and subgroups
Diversity score*
P
valuey
0-3 items,
% (n)
4-5 items,
% (n)
6 items,
% (n)
All study population 5.4 (56) 31.9 (332) 62.7 (653)
Farmer
Yes 2.8 (14) 27.9 (139) 69.3 (345) <.001
No 7.7 (42) 35.5 (193) 56.7 (308)
Allergic parents (>_1)
Yes 6.8 (38) 34.4 (192) 58.8 (328) .007
No 3.7 (18) 29.0 (140) 67.3 (325)
Breast-feeding >6 mo"
Yes 6.3 (30) 31.9 (153) 61.9 (297) .31
No 4.2 (23) 31.4 (172) 64.4 (352)
*Diversity score with major food items: vegetables or fruits, any cereals, meat, bread,
cake, and yogurt.
!P value based on x2 test.
"Missing information for 14 children.
TABLE II. Time of first introduction of different food items in the first year of life (n 5 1041)
3-6 mo, % (n) 7-9 mo, % (n) 10-12 mo, % (n)
In total introduced in
the first year of life, % (n)
Any food items (15 items) 72.2 (752) 25.6 (267) 0.4 (4) 98.3 (1023)
Any cow’s milk 7.2 (75) 20.1 (209) 26.9 (280) 54.2 (564)
Only shop milk (n 5 724)* 2.2 (16) 10.6 (77) 21.3 (154) 34.1 (247)
Any farm milk (n 5 794)* 6.4 (51) 16.0 (127) 17.5 (139) 39.9 (317)
Yogurt 14.1 (147) 38.4 (400) 26.8 (279) 79.3 (826)
Other milk products 6.7 (70) 30.5 (317) 36.4 (379) 73.6 (766)
Eggs 3.2 (33) 28.1 (292) 36.1 (376) 67.3 (701)
Nuts 0.6 (6) 6.2 (65) 17.6 (183) 24.4 (254)
Vegetables or fruits 71.1 (740) 26.5 (276) 0.6 (6) 98.2 (1022)
Cereals 32.9 (342) 44.3 (461) 10.7 (111) 87.8 (914)
Bread 16.5 (172) 59.1 (615) 18.0 (187) 93.6 (974)
Meat 25.6 (266) 55.6 (579) 11.8 (123) 93.0 (968)
Fish 4.8 (50) 28.7 (299) 23.4 (244) 57.0 (593)
Soy 0.9 (9) 2.0 (21) 2.3 (24) 5.2 (54)
Margarine 8.6 (90) 28.1 (292) 22.0 (229) 58.7 (611)
Butter 6.0 (62) 33.6 (350) 30.2 (314) 69.7 (726)
Cake 11.2 (117) 47.1 (490) 27.9 (290) 86.2 (897)
Chocolate 3.8 (39) 15.2 (158) 27.3 (284) 46.2 (481)
*Reference group: children who did not consume any cow’s milk in the first year of life.
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Our results suggest that the association between genetic factors
and prenatal exposures is stronger with atopic dermatitis with
onset early in life than with late-onset atopic dermatitis. In a
Dutch birth cohort study it was shown that filaggrin gene
mutations were associated with atopic dermatitis when the
occurrence of the disease was in the first year of life but not
after21 and that cat exposure increased the effect of filaggrin gene
mutations on atopic dermatitis, indicating a gene-environment in-
teraction.22 Epigenetic mechanisms in the development of aller-
gic diseases have recently raised much interest.23 Our finding
that the protective effect of prenatal exposures was not observed
in children with atopic dermatitis occurring after the first year of
life challenges the idea of epigenetic mechanisms underlying the
association between prenatal contact with animals and atopic der-
matitis with late onset. It might be that atopic dermatitis depend-
ing on the age of onset represents 2 different phenotypes of the
disease and that genetic and epigenetic mechanisms influence
mainly the early onset. However, our study was not sufficiently
powered to evaluate the independent role of postnatal exposure
to farm animals on atopic dermatitis occurring after the first
year of life.
Our results support recent studies showing an inverse associ-
ation between early introduction of complementary food, such as
fish and cow’s milk, and allergic diseases and highlight the role of
the diversity of environmental exposures for the development of
allergic diseases. We have previously shown that the diversity of
maternal exposure to different farm animal species during
pregnancy had a protective effect on atopic dermatitis early in
life.18 Moreover, recent findings have shown that the diversity of
microbial exposures might play a role in the protective effect with
regard to asthma.24 Bacterial diversity of the intestinal flora has
also been suggested to be associated with atopic diseases, even
though its association with atopic dermatitis remains unclear.25
Food is a major environmental factor, especially for infants who
encounter large quantities of new food components during their
first year of life. Diversity of food seems to be protective against
the development of atopic dermatitis. This was observed only
when the diversity score was composed of major food items.
This might be due to the fact that the number of children exposed
to the other items was too small to show an effect or that these
items had no effect. Our findings on the diversity of food intro-
duced in the first year of life might support the hypothesis that
exposure to a variety of antigens, such as food protein, during a
specific timewindow early in life might be essential for the devel-
opment of immune tolerance.26
The strengths of this study are the prospective design and the
detailed data collection of feeding practices in the first year of life.
Focusing the analyses on atopic dermatitis occurring after the first
year of life allowed us to avoid the reverse causality effect.
However, this focus also reduced the number of affected children
because the onset of this disease occurred in the first year of life
for most of the children, thus limiting the power of the present
analysis. Food exposures early in life might differently affect the
disease with early or late onset. However, when we restricted our
analyses to children without symptoms of atopic dermatitis
during the first 6 months but atopic dermatitis with onset within
the first year of life, similar associations with introduction of food
in the first 6months were found as in patients with late onset of the
disease.
Yogurt is produced by bacterial fermentation of milk by lactic
acid bacteria. Many of these bacterial strains have been selected
as probiotics. The strong protective effect of consumption of
yogurt in the first year of life on atopic dermatitis could be due to
these bacteria. In the present study, unfortunately, no information
on children’s consumption of yogurt with or without live
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FIG 1. Association between food item introduction in the first year of life and atopic dermatitis with onset
after the first year of life stratified by parental allergies. *Adjusted for farmer, center, breast-feeding, and
parental history of allergies (ever eczema, hay fever, or asthma). For dairy products: introduction in the first
year of life compared with no introduction before 1 year of age. For vegetables or fruits: introduction in the
first 6 months of life compared with no introduction before 6 months of age.
FIG 2. Association between increasing numbers of different major food
items (n 5 6) introduced in the first year of life and atopic dermatitis (AD)
with onset after the first year of life. *Diversity score with major food items:
vegetables or fruits, any cereals, meat, bread, cake, and yogurt.
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bacterial cultures was available. One of the first randomized
controlled trials, which was conducted by Kalliom€aki et al27 in
pregnant women with a family history of allergy, showed a
50% reduction in clinical eczema among the probiotic group.
Even though several other studies and meta-analyses on probi-
otics and the prevention of allergic diseases have been conducted,
most of them concluded that there is insufficient evidence to
recommend probiotics for prevention. Recently, a Finnish study
observed that probiotics were protective for allergic disease
only among children born by means of cesarean section.28 In
our study we observed the same protective effect of the introduc-
tion of yogurt on atopic dermatitis when analyses were restricted
to children born by means of vaginal delivery, arguing against
effect modification by mode of delivery in the present study
(data not shown).
Levels of metabolites produced by intestinal microbiota, such
as short-chain fatty acids (SCFAs), have been shown to be
increased in fecal and plasma samples after yogurt consump-
tion.29,30 Moreover, it has been suggested that SCFAs might have
anti-inflammatory properties,31,32 and thus it has been proposed
that factors that influence the intestinal microbiota and the pro-
duction of SCFAs might have an effect on immune and inflamma-
tory responses. Interestingly, more fecal SCFAs were found
among children from rural Africa compared with those from
urban Europe, providing indirect evidence of a role of SCFAs.
As among children from Africa, a lower prevalence of allergic
diseases was observed compared with the prevalence seen in
children from western Europe.33,34
The protective effect of cow’s milk in the present study was
mainly related to consumption of shop milk. Previously, cross-
sectional studies on farm milk consumption and allergies
suggested a protective effect of farm milk consumption on
asthma, whereas the association with atopic dermatitis was
more controversial.5,6,35 In the present study the relationship be-
tween farm milk consumption in the first year of life and atopic
dermatitis tended to be modified by parental history of allergies,
which has not been observed in the cross-sectional studies.6,35
A tendency toward a decreased risk of atopic dermatitis with con-
sumption of farm milk was observed only among children with
parents without allergies. These results could be explained by a
gene-environment interaction effect, which is supported by a pre-
vious study showing that a polymorphism in the gene encoding
CD14 modified the effect of farm milk consumption on allergic
diseases and CD14 gene expression.36With other complementary
foods, we did not have evidence for effect modification by
parental allergies in the association with atopic dermatitis.
Children exposed to complementary foods, especially yogurt,
and an increased diversity of foodswithin the first year of life have
TABLE IV. Association between the diversity score with major items introduced in the first year of life and atopic dermatitis with onset
after the first year of life
Atopic dermatitis with onset after the first year of life
No. OR* 95% CI P valuey
Diversity score with major food items" (0-6)
No. of items introduced in the first year
0-3 56 2.87 1.26-6.56 .01
4-5 332 1.72 1.06-2.80 .03
6, reference 653 1 –
For each major food item introduced§ 1041 0.76 0.65-0.88 <.001
Diversity score with major food items, without yogurt (0-5)
For each major food items introduced§ 1041 0.75 0.62-0.91 .003
Boldface values are significant (P < .05).
*Adjusted for farmer, center, duration of breast-feeding, and parents with atopy (eczema, asthma, or hay fever).
!P value based on generalized estimating equation analysis.
"Diversity score with major food items: vegetables or fruits, any cereals, meat, bread, cake, and yogurt.
§OR for atopic dermatitis with each additional food item introduced in the first year of life.
TABLE V. Association between the diversity score with major items introduced in the first 6 months and atopic dermatitis with onset
within the first year of life but no symptoms in the first 6 months
Atopic dermatitis with onset within the first year of life but no symptoms
(itchy rash) in the first 6 mo
No. OR* 95% CI P valuey
Diversity score with major food items" (0-6)
No. of items introduced in the first 6 mo
0-1 532 2.12 1.12-4.03 .02
2 190 1.76 0.85-3.69 .16
>_3, reference 319 1 –
For each major food item introduced§ 1041 0.88 0.73-1.05 .16
Diversity score with major food items, without yogurt (0-5)
For each major food item introduced§ 1041 0.85 0.70-1.04 .12
Boldface values are significant (P < .05).
*Adjusted for farmer, center, duration of breast-feeding, and parents with atopy (eczema, asthma, or hay fever).
!P value based on logistic regression analysis.
"Diversity score with major food items: vegetables or fruits, any cereals, meat, bread, cake, and yogurt.
§OR for atopic dermatitis with each additional food items introduced in the first 6 months of life.
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a reduced risk of atopic dermatitis independently of parental
history of allergies.
We thank all the fieldworkers and other PASTURE team members. We also
thank Leticia Grize and Christian Schindler from the University of Basel,
Switzerland, for help in statistics.
The PASTURE study group: Anne Karvonen, Maija-Riitta Hirvonen, Pekka
Tittanen, Sami Remes (Finland); Vincent Kaulek (France); Jon Genuneit, Mi-
chael Kabesch, Markus Ege, Bianca Schaub, Petra Pfefferle, Harald Renz
(Germany); Gert Doekes (The Netherlands); and Sondhja Bitter
(Switzerland).
Clinical implications: The diversity of food introduced in the
first year of life might decrease the risk of atopic dermatitis in
children.
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FIG E1. Association between increasing numbers of all different food items (n 5 15) introduced in the first
year of life and atopic dermatitis (AD) with onset after the first year of life. *Food items (n 5 15): any cow’s
milk, yogurt, other milk products, eggs, nuts, vegetables or fruits, cereals, bread, meat, fish, soy, margarine,
butter, cake, and chocolate.
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FIG E2. Association between increasing numbers of all different food items excluding major foods (n 5 9)
introduced in the first year of life and atopic dermatitis (AD)with onset after the first year of life. *Food items
(n 5 9): any cow’s milk, other milk products, eggs, nuts, fish, soy, margarine, butter, and chocolate.
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TABLE E1. Association between prenatal and postnatal exposures to farm animals and atopic dermatitis with different time of onset
Percent (n)
Atopic dermatitis with onset
within the first year of life
Atopic dermatitis with onset
after the first year of life
OR* 95% CI OR* 95% CI
Contact with farm animal
Prenatal and postnatal combined
Prenatal and postnatal 37.7 (345) 0.51 0.26-1.00 1.20 0.53-2.71
Only prenatal 22.8 (209) 0.61 0.35-1.08 1.09 0.56-2.14
Only postnatal 2.9 (26) 2.01 0.78-5.15 0.34 0.03-3.75
No contact, reference 36.6 (335) 1
Postnatal: presence of the child in the stable within the first year of life.
*Adjusted for farmer, center, parents with atopy, smoking during pregnancy, and duration of breast-feeding.
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TABLE E2. Association between introduction of food items in the first year of life and atopic dermatitis up to 4 years of age and with
onset within the first year of life
Atopic dermatitis up to
4 y of age
Atopic dermatitis with
onset within the first
year of life
Atopic dermatitis with
onset within the first
year of life but no
symptoms of itchy rash
in the first 6 mo
OR* 95% CI OR* 95% CI OR* 95% CI
Dairy items
Cow’s milk
3-12 mo 0.46 0.32-0.65 0.60 0.41-0.87 0.65 0.40-1.05
Not in first year, reference! 1.00 – 1.00 1.00
Only shop’s milk
3-12 mo 0.31 0.20-0.49 0.54 0.33-0.87 0.57 0.31-1.07
Not in first year, reference! 1.00 – 1.00 1.00
Any farm’s milk
3-12 mo 0.61 0.39-0.95 0.63 0.38-1.03 0.67 0.36-1.24
Not in first year, reference! 1.00 1.00 1.00
Yogurt
3-12 mo 0.31 0.20-0.46 0.52 0.34-0.82 0.60 0.33-1.07
Not in first year, reference 1.00 1.00 1.00
Other milk products (eg, cheese and quark)
3-12 mo 0.62 0.41-0.94 0.60 0.40-0.90 0.58 0.35-0.96
Not in first year, reference 1.00 1.00 1.00
Other food items
Nuts
3-12 mo 0.99 0.62-1.57 0.54 0.33-0.90 0.51 0.26-0.99
Not in first year, reference 1.00 1.00 1.00
Eggs
3-12 mo 0.76 0.51-1.12 0.55 0.38-0.80 0.61 0.38-1.00
Not in first year, reference 1.00 1.00 1.00
Fish
3-12 mo 0.45 0.29-0.69 0.52 0.35-0.77 0.51 0.30-0.87
Not in first year, reference 1.00 1.00 1.00
Meat
3-8 mo 0.75 0.49-1.14 0.71 0.47-1.08 0.77 0.46-1.31
Not in first 8 mo, reference 1.00 1.00 1.00
Cereals
3-8 mo 0.95 0.62-1.44 1.14 0.74-1.74 1.29 0.75-2.21
Not in first 8 mo, reference 1.00 1.00 1.00
Vegetables or fruits
<6 mo 0.46 0.31-0.70 0.81 0.53-1.25 0.67 0.38-1.15
Not in first 6 mo, reference 1.00 1.00 1.00
Bread
3-8 mo 0.82 0.57-1.17 0.80 0.55-1.16 0.63 0.39-1.02
Not in first 8 mo, reference 1.00 1.00 1.00
Soy
3-12 mo 0.78 0.35-1.75 1.13 0.53-2.41 1.16 0.43-3.13
Not in first year, reference 1.00 1.00 1.00
Margarine
3-12 mo 0.72 0.48-1.07 0.76 0.51-1.14 0.75 0.45-1.26
Not in first year, reference 1.00 1.00 1.00
Butter
3-12 mo 0.89 0.60-1.30 0.78 0.52-1.16 0.83 0.50-1.41
Not in first year, reference 1.00 1.00 1.00
Cake
3-8 mo 0.70 0.47-1.02 0.72 0.49-1.07 0.66 0.40-1.10
Not in first 8 mo, reference 1.00 1.00 1.00
Chocolate
3-12 mo 0.53 0.36-0.77 0.66 0.45-0.98 0.95 0.58-1.54
Not in first year, reference 1.00 1.00 1.00
Boldface values are significant (P < .05).
*Adjusted for farmer, center, breast-feeding (duration), and parental history of allergies (ever eczema, hay fever, or asthma).
!Reference 5 no introduction of any cow’s milk in the first year of life.
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TABLE E3. Association between introduction of food items in the first year of life and atopic dermatitis with onset after the first year of
life stratified by parents with or without allergies
Entire study population Parents without allergy At least 1 parent with allergy
No.
Atopic dermatitis,
with onset after the
first year of life
No.
Atopic dermatitis,
with onset after the
first year of life
No.
Atopic dermatitis,
with onset after the
first year of life
OR* 95% CI OR* 95% CI OR* 95% CI
Dairy items
Cow’s milk
3-12 mo 564 0.68 0.44-1.05 289 0.49 0.24-1.01 275 0.86 0.51-1.45
Not in first year, reference! 477 1.00 – 194 1.00 283 1.00
Only shop’s milk
3-12 mo 247 0.52 0.30-0.92 98 0.54 0.17-1.77 149 0.58 0.30-1.10
Not in first year, reference! 477 1.00 – 194 1.00 283 1.00
Any farm’s milk"
3-12 mo 317 0.88 0.49-1.57 191 0.49 0.21-1.18 126 1.50 0.77-2.89
Not in first year, reference! 477 1.00 194 1.00 283 1.00
Yogurt
3-12 mo 826 0.41 0.23-0.73 411 0.36 0.15-0.87 415 0.46 0.23-0.95
Not in first year, reference 215 1.00 72 1.00 143 1.00
Other milk products (eg, cheese and quark)
3-12 mo 766 1.07 0.59-1.91 373 1.25 0.47-3.34 393 1.00 0.47-2.13
Not in first year, reference 275 1.00 110 1.00 165 1.00
Other food items
Nuts
3-12 mo 254 1.35 0.79-2.31 135 1.49 0.66-3.37 119 1.28 0.62-2.61
Not in first year, reference 787 1.00 348 1.00 439 1.00
Eggs
3-12 mo 701 1.02 0.63-1.66 353 1.08 0.46-2.53 348 1.01 0.55-1.85
Not in first year, reference 340 1.00 130 1.00 210 1.00
Fish
3-12 mo 593 0.73 0.43-1.24 288 1.09 0.43-2.75 305 0.58 0.31-1.09
Not in first year, reference 448 1.00 195 1.00 253 1.00
Meat
3-8 mo 697 0.87 0.50-1.54 333 1.01 0.42-2.42 364 0.81 0.37-1.77
Not in first 8 mo, reference 344 1.00 150 1.00 194 1.00
Cereals
3-8 mo 700 0.72 0.42-1.25 304 0.79 0.35-1.80 396 0.70 0.36-1.37
Not in first 8 mo, reference 341 1.00 179 1.00 162 1.00
Vegetables or fruits
<6 mo 462 0.56 0.31-1.00 218 0.59 0.26-1.36 244 0.52 0.26-1.06
Not in first 6 mo, reference 579 1.00 265 1.00 314 1.00
Bread
3-8 mo 787 0.84 0.52-1.35 378 0.70 0.36-1.35 409 0.96 0.51-1.81
Not in first 8 mo, reference 254 1.00 105 1.00 149 1.00
Soy
3-12 mo 54 0.92 0.39-2.17 18 0.88 0.12-6.65 36 0.92 0.38-2.21
Not in first year, reference 987 1.00 465 1.00 522 1.00
Margarine
3-12 mo 611 0.69 0.41-1.16 267 0.62 0.24-1.62 344 0.74 0.40-1.34
Not in first year, reference 430 1.00 216 1.00 214 1.00
Butter
3-12 mo 726 1.00 0.64-1.55 358 0.87 0.41-1.83 368 1.09 0.63-1.89
Not in first year, reference 315 1.00 125 1.00 190 1.00
Cake
3-8 mo 444 0.75 0.47-1.21 239 0.75 0.37-1.51 205 0.76 0.41-1.44
Not in first 8 mo, reference 597 1.00 244 1.00 353 1.00
Chocolate
3-12 mo 481 0.73 0.47-1.15 251 0.86 0.41-1.82 230 0.67 0.38-1.17
Not in first year, reference 560 1.00 232 1.00 328 1.00
Boldface values are significant (P < .05).
*Adjusted for farmer, center, breast-feeding (duration), and parental history of allergies (ever eczema, hay fever, or asthma).
!Reference 5 no introduction of any cow’s milk in the first year of life.
"Interaction term between parents with atopy and food item (P 5 .08).
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Soluble immunoglobulin A in breast milk is inversely associated with
atopic dermatitis at early age: the PASTURE cohort study
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Summary
Background The role of breastfeeding for the development of atopic diseases in childhood
is contradictory. This might be due to differences in the composition of breast milk and
levels of antimicrobial and anti-inflammatory components.
Objective The objective of this study was to examine whether levels of total immunoglob-
ulin A (IgA) or transforming growth factor-b1 (TGF-b1) in breast milk were associated
with the risk of developing atopic dermatitis (AD), atopic sensitization or asthma at early
age taking breastfeeding duration into account.
Methods The birth cohort study PASTURE conducted in Finland, France, Germany and
Switzerland provided 610 breast milk samples collected 2 months after delivery in which
soluble IgA (sIgA) and TGF-b1 levels were measured by ELISA. Duration of breastfeeding
was assessed using weekly food frequency diaries from month 3 to month 12. Data on
environmental factors, AD and asthma were collected by questionnaires from pregnancy
up to age 6. Atopic status was defined by specific IgE levels in blood collected at the
ages of 4 and 6 years. Multivariate logistic regression models were used for statistical
analysis.
Results Soluble IgA and TGF-b1 levels in breast milk differed between countries, and
sIgA levels were associated with environmental factors related to microbial load, for
example, contact to farm animals or cats during pregnancy, but not with raw milk con-
sumption. sIgA levels were inversely associated with AD up to the of age 2 years (P-value
for adjusted linear trend: 0.005), independent of breastfeeding duration. The dose of sIgA
ingested in the first year of life was associated with reduced risk of AD up to the age of 2
(aOR, 95% CI: 0.74; 0.55–0.99) and 4 years (0.73; 0.55–0.96). No clear associations
between sIgA and atopy or asthma up to age 6 were observed. TGF-b1 showed no consis-
tent association with any investigated health outcome.
Conclusion and Clinical Relevance IgA in breast milk might protect against the develop-
ment of AD.
Keywords asthma, atopic dermatitis, atopy, breast milk, childhood, farming, IgA, TGF-b
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*These authors contributed equally to this work.
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Introduction
Breastfeeding has a variety of beneficial effects on the
development of an infant, but there is conflicting evi-
dence related to its association with the development of
allergic disease at early age [1]. Discrepant findings
might be due to differences in outcome definitions,
assessment of breastfeeding or neglect of considering
genetic predisposition [1–3]. Yet, it might also be
related to differences in the composition of breast milk
that varies greatly between individual mothers [4] and
between mothers with and without allergies [5, 6].
Breast milk contains several antimicrobial and anti-
inflammatory components, such as cytokines and
maternal antibodies against environmental antigens
including food antigens and microbes [7]. These compo-
nents not only protect the child from infections but also
educate the infant’s immune system to tolerate certain
antigens. Components that were identified to possibly
underlie a protective breastfeeding effect on allergic
disease were soluble IgA (sIgA) in colostrum [8], or
mature milk [9], isoforms of transforming growth
factor-beta (TGF-b) [4], or soluble CD14 [10], but find-
ings were inconsistent [11, 12] and mechanisms of
action remain unclear.
It has been suggested that the reduced risk of devel-
oping allergic diseases associated with living on a farm
[13] or in a former socialist country could at least in
part be mediated through constituents in breast milk,
which have been shown to differ between farm and
non-farm mothers [14] or mothers living in Estonia or
Sweden [15].
The PASTURE study (Protection Against Allergy:
Study in Rural Environments) [16] offered the opportu-
nity to prospectively investigate the association of sIgA
and TGF-b1 levels in breast milk and the development
of atopic dermatitis (AD), atopic sensitization and
asthma up to the age of 6 years taking duration of
breastfeeding into account and to evaluate which envi-
ronmental factors determine sIgA and TGF-b1 levels in
breast milk.
Methods
Study population
PASTURE is a large prospective birth cohort study con-
ducted in rural areas in Austria, Finland, France,
Germany and Switzerland. Pregnant women were
recruited during the third trimester of pregnancy.
Women who lived or worked on family-run farms
where any kind of livestock was kept were defined as
farmers. The reference group was composed of women
from the same rural areas not living on a farm. The
study design has been described in detail elsewhere
[17]. Originally, 1133 mothers (64%) from five Euro-
pean countries agreed to participate. For the present
analyses, the cohort is limited to participants of four
countries as no breast milk samples were available
from Austrian mothers, resulting in 913 cohort mem-
bers. Eight hundred and fifty-three (93.4%) of them
provided diary data on breastfeeding up to the age of
1 year. If duration of breastfeeding could not be
derived from the diary because mothers had stopped
breastfeeding before filling in the first diary (125 of
853) or due to missing structures of diaries (51 of 853),
data from the 2-month and 1-year questionnaire were
used to determine the duration of breastfeeding. Breast
milk samples were collected at the age of 2 months
from 622 of 853 (72.9%) mothers who were still breast-
feeding. For 610 (98.1%) samples, measurements of
both TGF-b1 and sIgA were available. Of the 231
mothers who did not provide samples, 66 had not been
breastfeeding at all. Blood samples were taken from
children at the age of 4 (N = 454, 74.4%) and 6 years
(N = 455, 74.6%).
Questionnaires
Extensive questionnaires were administered by inter-
view to the mother of the child within the third
trimester of pregnancy, at 2, 12, 18 and 24 months
of age and then yearly up to the age of 6 years.
Questions were based on previous studies [18–21] and
were designed to assess respiratory and other health
problems of the mother, agricultural exposures and
potential confounders. Mothers kept a weekly diary
starting at the third month of the child’s life and
ending at the first birthday. They recorded breastfeed-
ing behaviour and introduction of complementary
foods.
Pregnancy exposures relevant for this analysis were
farming (living on a farm vs. not), farm milk consump-
tion, contact to stable/barn (stay in stable/barn at least
15 min per week in one trimester), contact to number of
livestock (horse, cow, pig, poultry: 0, 1–2 or 3–4),
smoking during pregnancy (in any trimester), maternal/
paternal history of asthma, hayfever or AD (doctor’s
diagnosis or self-reported symptoms). Exposures during
the first year of the child’s life were farming (child living
on a farm during the first year of life), regular visit to
farm, regular stay in stable (child stayed in stable at least
15 min per week), current smoking at month 2, duration
of any or exclusive breastfeeding (only breast milk, water
or tea [22]) continuously in weeks or categorically: never,
≤ 3 months, 3–6 months or > 6 months; and child’s
farm milk consumption. To describe the introduction of
complementary foods during the first year of life, we
computed a food diversity score including the food items
that were introduced to about 80% of the children or
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more during the first year of life [23]. The score included
vegetables, fruits, cereals, bread, meat, cake and yogurt.
Health outcomes
Children were defined as having cumulative AD up to
the age of 2 or 4 years when the parents reported in
the questionnaires that the child had AD diagnosed by
a doctor (DD) at least once up to 2 years of age (or
4 years of age, respectively) or with a positive SCORAD
[24] score (> 0) assessed at the age of 1 year, during
medical examination. In addition, AD with onset within
the first year of life was defined as AD up to age 1 (DD
or SCORAD) and AD with onset after the first year of
life as onset after age 1 up to age 4 (DD) [23]. Atopy at
age 4 and 6 was defined as positive test results for
specific IgE antibodies (cut-off 0.35 kU/L, 0.7 kU/L, or
alternatively 3.5 kU/L) against at least one of the fol-
lowing allergens (Dermatophagoides pteronyssius, Der-
matophagoides farinae, alder, birch, hazel, grass pollen,
rye, mugwort, plantain, cat, horse, dog, alternaria, hen’s
egg, cow’s milk, peanut, hazelnut, carrot and wheat
flour). Asthma at age of 4 years was defined as a doc-
tor’s diagnosis of asthma or of wheezy bronchitis more
than once in the past 12 months. Asthma at age 6 was
defined as doctor’s diagnosis of asthma or of wheezy
bronchitis after age of 3 years.
Measurement of breast milk samples
Breast milk samples were stored at! 20°C. After thawing,
the samples were centrifuged at 10 000 g for 10 min at
+ 4°C. Layer of fat was removed, and the clear superna-
tant was used for analyses. To activate latent TGF-b1, an
activation procedure using hydrochloric acid was per-
formed. Samples were then neutralized with sodium
hydroxide containing 4-(2-hydroxyethyl)-1-piperazinee-
thanesulfonic acid (HEPES). TGF-b1 values were mea-
sured using ELISA method (Quantikine Human TGF-b1
Immunoassay; R&D Systems, Minneapolis, MN, USA).
IgA values were measured using ELISA modified from
Lehtonen et al. [25]. The antibody used for the primary
coating was rabbit anti-human IgA (DakoCytomation,
Glostrup, Denmark) 1:1000 in carbonate buffer. The plates
were incubated at + 4°C overnight and blocked with 1%
BSA in PBS, 1 hour at + 37°C. 0.5% Tween-20 in PBS was
used for washing the plates. Peroxidase-conjugated rabbit
anti-human IgA (DakoCytomation) 1:5000 in PBS was
used as a conjugate and ortho-phenylenediamine (OPD)
as a substrate (Kem-En-Tec-laboratories, Taastrup, Den-
mark). The reaction was stopped with 1 M H2SO4, and
optical density was read at 492 nm. The immunoglobulin
concentrations were calculated from the control curve,
made from standard with known amounts of human IgA
(Caltag laboratories, Burlingame, CA, USA).
Statistical analyses
Differences in characteristics of mothers regarding
breastfeeding duration were tested by Pearson’s chi-
square test and expressed as P-values. Correlations of
continuous variables were expressed as Pearson’s
coefficient. TGF-b1 and sIgA variables were log-
transformed to obtain approximate normal distribution.
Their levels were expressed as geometric means and
95% confidence intervals. To evaluate factors that were
associated with levels of breast milk constituents, expo-
sures occurring up to month 2 of age were related to
TGF-b1 and sIgA levels by linear regression and
expressed as geometric mean ratios and 95% confidence
intervals. Factors that showed a statistically significant
association with TGF-b1 or sIgA in univariate models
were then entered in multivariate linear regression
models.
The associations of breast milk constituents or breast-
feeding duration with AD, atopy or asthma were
assessed by multivariate logistic regression models
(N = 610). Associations between health outcomes and
breastfeeding duration were also assessed in the whole
cohort with diary data on breastfeeding (N = 853).
TGF-b1 and sIgA were categorized into quintiles. In
agreement with previous analyses [1, 26], centre, sex,
maternal history of allergies and introduction of food
during the first year of life were chosen a priori as
covariates for multivariate models. As no heterogeneity
between centres was found by means of meta-analytical
techniques, centre was included as fixed effect. In addi-
tion, a general farming variable (living on a farm vs.
not) was entered in all models to represent exposure to
any farm-related factor. In sensitivity analyses, we also
tested whether specific exposures such as contact to
stables, barns, raw farm milk consumption and contact
to number of livestock at the respective age or contin-
ued exposure from pregnancy up to the respective age
had a stronger impact on the association between breast
milk constituents and health outcomes. To avoid over-
adjustment, only one farming variable was entered at a
time. Asthma models were calculated with additional
adjustment for the child’s current atopic status.
To test whether the associations between breast milk
constituents and health outcomes might be modified by
maternal history of allergic disease, multiplicative inter-
action terms were included in the final adjusted models.
As breastfeeding duration might act (i) as a confounder
or (ii) as an effect modifier of the association between
levels of breast milk constituents and health outcomes,
the variable was (i) added to the final sIgA or TGF-b1
models and (ii) entered as a multiplicative interaction
term to the final adjusted models. Finally, a dose vari-
able for IgA and TGF-b1 levels was generated by multi-
plying the levels of each constituent with the duration
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of any breastfeeding for each child. These dose vari-
ables represented an estimation of the total amount of
sIgA or TGF-b1 ingested by each infant via breast milk
in the first year of life. Uni- and multivariate smoothed
plots based on generalized additive regression model-
ling were used to graphically display significant associ-
ations of dose variables and health outcomes.
All statistical analyses were performed using STATA/
SE 12.1 (STATACorp, College Station, TX, USA), and
P-values < 0.05 were considered significant.
Ethical approval
The ethical boards of all study centres approved the
study, and written informed consent was obtained from
the children’s parents for questionnaires, blood samples
and breast milk analyses.
Results
Among mothers who provided breast milk samples,
French mothers and smokers were significantly more
likely to breastfeed for shorter duration (Table 1). Moth-
ers with a history of allergic diseases tended to breast-
feed more often for over 6 months compared with
those with no history of allergic diseases. No significant
associations with breastfeeding duration were observed
for farming or any other characteristics.
Mothers not providing breast milk samples at month
2 were significantly more likely to be from France, to
be less educated, to have no history of allergic diseases,
to be smokers and to consume less raw farm milk
(Table S1).
Using the full cohort of 853 participants and mothers
breastfeeding for more than 6 months as a reference
group, children who had not been breastfed were not at
an increased risk of suffering from AD, asthma or to be
sensitized (Table S2). However, a maternal history of
allergic diseases significantly modified the association
between breastfeeding duration and asthma at age
6 years (P for interaction = 0.021), increasing the odds
for asthma among children with a positive maternal
history with increasing duration of breastfeeding (aOR
for the interquartile range of duration of breastfeeding;
95% CI: 2.34; 1.05–5.21). Results were similar when the
analyses were based on exclusive instead of any breast-
feeding.
Transforming growth factor-b1 levels in breast milk
measured at the age of 2 months were significantly
higher in Finnish mothers, smokers and those who were
breastfeeding for a shorter duration (P-value for
adjusted linear trend < 0.001) (Table 2). Except for
smoking, variables remained significant in mutually
adjusted models. Levels of sIgA were significantly asso-
ciated with several of the tested characteristics in unad-
Table 1. Duration of breastfeeding in relation to environmental and
farming characteristics of mothers and their children (N = 610)
Duration of breastfeeding
> 6 months 3–6 months ≤ 3 months
P-value
for
differenceN (%) N (%) N (%)
Population
at birth*
430 (70.5) 153 (25.1) 27 (4.4)
Female 216 (70.8) 75 (24.6) 14 (4.6) 0.962
Male 213 (70.3) 77 (25.4) 13 (4.3)
Centre
Switzerland 143 (77.7) 37 (20.1) 4 (2.2) < 0.001
France 28 (37.8) 40 (54.1) 6 (8.1)
Germany 129 (76.3) 33 (19.5) 7 (4.1)
Finland 130 (71.0) 43 (23.5) 10 (5.5)
Education
Low 60 (65.9) 25 (27.5) 6 (6.6) 0.737
Medium 188 (70.7) 66 (24.8) 12 (4.5)
High 182 (71.9) 62 (24.5) 9 (3.6)
Maternal history of allergic disease
No 327 (72.3) 106 (23.5) 19 (4.2) 0.199
Yes 101 (64.7) 47 (30.1) 8 (5.1)
Siblings
0–1 281 (70.1) 101 (25.2) 19 (4.7) 0.864
2 or more 149 (71.3) 52 (24.9) 8 (3.8)
Maternal exposure during pregnancy
Farming
Non-farmer 233 (73.0) 71 (22.3) 15 (4.7) 0.239
Farmer 197 (67.7) 82 (28.2) 12 (4.1)
Contact to stable
No 213 (74.7) 60 (21.1) 12 (4.2) 0.150
Yes 204 (67.8) 84 (27.9) 13 (4.3)
Contact to animals (horse, cow, pig, poultry)
No 157 (71.4) 53 (24.1) 10 (4.5) 0.152
1–2 species 230 (72.8) 71 (22.5) 15 (4.7)
3–4 species 38 (61.3) 23 (37.1) 1 (1.6)
Any raw farm milk consumption
No 275 (68.9) 105 (26.3) 19 (4.8) 0.538
Yes 153 (73.2) 48 (23.0) 8 (3.8)
Smoking
Never 307 (76.0) 82 (20.3) 15 (3.7) < 0.001
Only before
pregnancy
88 (65.2) 42 (31.1) 5 (3.7)
During
pregnancy
(not at
month 2)
20 (48.8) 19 (46.3) 2 (4.9)
At month 2
assessment
15 (50.0) 10 (33.3) 5 (16.7)
Child’s exposure during first year of life
Child living on a farm
No 226 (72.9) 70 (22.6) 14 (4.5) 0.332
Yes 198 (68.0) 81 (27.8) 12 (4.1)
Regular stay in stable
No 266 (73.1) 82 (22.5) 16 (4.4) 0.169
Yes 136 (66.0) 61 (29.6) 9 (4.4)
(continued)
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justed analyses including contact to barn (more than
5 hours per week; aOR 95% CI: 1.21 [1.06–1.39]) and
contact to one or two species of farm animals (aOR
95% CI: 1.10 [1.01–1.20]) during pregnancy. Contact to
cats during pregnancy was associated with higher levels
of breast milk sIgA in both crude and mutually adjusted
models (aOR 95% CI: 1.10 [1.01–1.19] and 1.01 [1.01–
1.20], respectively). After mutual adjustment, sIgA lev-
els also remained inversely associated with duration of
breastfeeding (P-value for adjusted linear trend
< 0.001), decreased in German mothers and increased
in mothers smoking during pregnancy or at the time
sample was collected, and in those having more than
one child. Farming was not significantly associated
with sIgA or TGF-b1 levels (Table 2).
Soluble IgA and TGF-b1 levels in breast milk were
moderately, but significantly correlated (Pearson’s
coefficient: 0.44, P < 0.001).
Soluble IgA levels in breast milk were significantly
inversely related to AD up to 2 years of age (Table 3).
This association held for adjustment for all potential
confounders and was indicative of a dose–response
relationship (P-value for adjusted linear trend: 0.005).
Similar but weaker associations were found for AD up
to age 4 (Table 3) and AD with onset within the first
year of life (data not shown). Among the children
whose mothers provided breast milk samples, shorter
duration of breastfeeding tended to increase the risk of
AD. Mutual adjustment of duration of breastfeeding
and sIgA did not change their relation with AD, and no
effect modification by breastfeeding duration was
observed.
Transforming growth factor-b1 showed no clear asso-
ciation with any AD phenotype, and no effect modifica-
tion by duration of breastfeeding was observed.
Soluble IgA or TGF-b1 levels in breast milk were not
consistently associated with atopy (Table S4). Duration
of breastfeeding and sIgA or TGF-b1 levels in breast
milk did not show significant associations with asthma
at age 4 or 6 (see Table S3). Maternal history of aller-
gies or duration of breastfeeding did not modify the
association of sIgA or TGF-b1 levels and AD, atopy or
asthma.
Dose of sIgA and TGF-b1 in the first year of life
The estimated dose of sIgA ingested by an infant during
the first year of life (product of sIgA level and breast-
feeding duration) was significantly inversely associated
with AD up to the ages of 2 and 4 years (aOR 95% CI:
0.74 (0.55–0.99) and 0.73 (0.55–0.96), respectively).
TGF-b1 dose showed similar but weaker and non-
significant associations with AD up to the ages of 2
and 4 years (aOR 95% CI: 0.86 (0.65–1.14) and 0.83
(0.63–1.08), respectively) (Table S5). When the dose of
sIgA and TGF-b1 was entered in the same final model,
the associations were held for sIgA levels with border-
line significance. Atopy and asthma were not associated
with dose variables.
The crude and adjusted inverse associations of AD up
to the age of 2 years with dose of breast milk sIgA in
the first year of life are displayed as a smoothed plot in
Fig. 1.
Discussion
The results of this cohort study showed that levels of
sIgA in mature breast milk were inversely associated
with the development of AD up to 2 and 4 years of age
among breastfed infants. This association appeared to
be based on the dose, the estimated total amount of
sIgA that was ingested via breast milk during the first
year of life. Asthma and atopic sensitization were not
consistently associated with sIgA. TGF-b1 levels in
breast milk showed no consistent association with any
of the investigated health outcomes.
Secretory IgA in human milk is an essential mediator
of the passive antimicrobial protection provided by
breastfeeding. In early infancy, when the infant’s intes-
tinal production of secretory IgA is low [27] and the
intestinal barrier has not yet developed, the secretory
IgA in human milk may prevent an excessive uptake of
foreign antigens across the mucosa, thus possibly low-
ering the risk of allergic sensitization [27, 28].
Our finding that increasing levels of sIgA in breast
milk and dose of ingested sIgA during the first year of
life are associated with a decreased risk of AD up to
age 2 and age 4 adds to the ongoing discussion of
allergy-protective effects of breastfeeding. Previous
studies found IgA in breast milk to be inversely related
to asthma-like symptoms in the first year of life [9] and
to atopy at age of 4 years [8], whereas the present
study is the first to report an inverse association with
AD at early age. Other studies, however, did not find
IgA levels in breast milk to be associated with atopic
diseases including AD [12, 29]. The latter studies, how-
ever, took levels of sIgA at a given time-point and not
the total dose into account and were based on relatively
small samples.
Table 1. (continued)
Duration of breastfeeding
> 6 months 3–6 months ≤ 3 months
P-value
for
differenceN (%) N (%) N (%)
Any raw farm milk consumption
No 343 (71.3) 115 (23.9) 23 (4.8) 0.271
Yes 79 (67.5) 35 (29.9) 3 (2.6)
*Minor discrepancies in percentages due to missing variables.
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Table 2. Associations of transforming growth factor-b1 (TGF-b1) and IgA levels in breast milk (measured 2 months after giving birth) and expo-
sures expressed as geometric mean ratios‡
Exposure N
Geometric mean (95%-CI) Crude GMR (95% CI)
Mutually adjusted
GMR (95%-CI)
TGF-b1 [pg/mL]
Centre
Switzerland 184 330.84 (306.72–356.86) 1.00 1.00
France 74 342.44 (309.76–378.57) 1.04 (0.90–1.19) 0.93 (0.81–1.07)
Germany 169 367.19 (339.82–396.76) 1.11 (1.00–1.24) 1.09 (0.98–1.21)
Finland 183 404.52 (372.84–438.89) 1.22 (1.10–1.36)*** 1.16 (1.04–1.29)**
Breastfeeding
Over 6 months 430 342.66 (327.91–358.07) 1.00 1.00
3–6 months 153 396.15 (362.24–433.24) 1.16 (1.05–1.27)** 1.16 (1.05–1.28)**
≤ 3 months 27 561.86 (397.26–794.66) 1.64 (1.34–2.00)*** 1.64 (1.34–2.01)***
Farming
Non-farmer 319 353.93 (333.61–375.50) 1.00 1.00
Farmer 291 373.69 (352.29–396.38) 1.06 (0.97–1.15) 1.05 (0.96–1.14)
Smoking
Never 404 346.77 (330.26–364.11) 1.00 1.00
Only before pregnancy 135 397.20 (363.97–433.47) 1.15 (1.03–1.27)** 1.11 (1.00–1.23)*
During pregnancy
(not at month 2)
41 415.83 (348.33–496.41) 1.20 (1.01–1.42)* 1.14 (0.97–1.35)
At month 2 assessment 30 376.88 (283.47–501.08) 1.09 (0.90–1.32) 1.01 (0.84–1.23)
IgA [mg/L]
Centre
Switzerland 184 183.01 (171.91–194.83) 1.00 1.00
France 74 233.58 (206.30–264.46) 1.28 (1.12–1.46)*** 1.13 (0.97–1.31)
Germany 169 165.86 (153.28–179.47) 0.91 (0.82–1.00)† 0.91 (0.82–1.01)
Finland 183 188.05 (174.84–202.26) 1.03 (0.93–1.14) 1.00 (0.89–1.12)
Education
Low 91 200.75 (178.12–226.25) 1.00 1.00
Medium 266 178.13 (168.21–188.64) 0.89 (0.79–1.00)* 0.94 (0.83–1.05)
High 253 186.78 (175.73–198.53) 0.93 (0.83–1.05) 0.98 (0.87–1.12)
Older siblings
0 193 173.49 (159.92–188.21) 1.00 1.00
1 208 191.57 (180.04–203.85) 1.10 (1.00–1.22)* 1.11 (1.01–1.22)*
2 or more 209 189.42 (177.84–201.75) 1.09 (0.99–1.20) 1.08 (0.98–1.20)
Contact to barn during pregnancy [hours/week]
0 hour 323 177.48 (167.60–187.94) 1.00 1.00
≤ 5 hours 204 186.73 (175.43–198.76) 1.05 (0.96–1.15) 1.02 (0.92–1.13)
> 5 hours 58 215.19 (189.81–243.96) 1.21 (1.06–1.39)** 1.10 (0.94–1.30)
Cats during pregnancy
No 332 177.16 (168.21–186.58) 1.00 1.00
Yes 277 194.49 (182.94–206.76) 1.10 (1.01–1.19)* 1.10 (1.01–1.20)*
Contact to animals during pregnancy (horse, cow, pig, poultry)
No 220 173.24 (162.02–185.24) 1.00 1.00
1–2 species 316 191.34 (181.16–202.09) 1.10 (1.01–1.20)* 1.10 (0.99–1.22)†
3–4 species 62 188.72 (165.63–215.03) 1.09 (0.95–1.25) 1.06 (0.91–1.24)
Breastfeeding
Over 6 months 430 168.01 (161.80–174.46) 1.00 1.00
3–6 months 153 215.30 (197.21–235.04) 1.28 (1.18–1.40)*** 1.20 (1.10–1.32)***
≤ 3 months 27 360.46 (258.27–503.08) 2.15 (1.79–2.57)*** 2.10 (1.73–2.54)***
Farming
Non-farmer 319 178.89 (168.96–189.41) 1.00
Farmer 291 191.80 (181.58–202.59) 1.07 (0.99–1.16) 0.96 (0.86–1.07)
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We have recently reported that the diversity of intro-
duction of complementary food in the first year of life
was associated with a reduction in the risk of having
AD with onset after the first year of life [23]. The
present analysis thus took the diversity of introduced
foods into account and found the inverse association of
sIgA and AD to be independent of the effect of comple-
mentary food introduction.
The exact mechanism mediating the association of
sIgA and AD is unclear. It might be speculated that
sIgA-mediated passive antimicrobial protection could
influence the colonization or maintenance of a bal-
anced gut microbiota [1]. sIgA might, however, also
represent a certain combination of milk ingredients
(that was not assessed in this study) contributing to the
induction of adaptive immune responses or creating a
microenvironment that favours T regulatory cell
development [30].
There was an indication that contact to pets and
increased number of older children were associated with
increased levels of sIgA in breast milk. These factors
Table 3. Adjusted† associations of IgA and transforming growth
factor-beta1 (TGF-b1) levels in breast milk and duration of breastfeed-
ing and atopic dermatitis in early life (N = 610)
N
Atopic dermatitis
Up to age 2 Up to age 4
aOR (95% CI) aOR (95% CI)
IgA: Quintile (Q)
Q 1 124 1.00 1.00
Q 2 123 0.67 (0.35–1.29) 0.69 (0.37–1.31)
Q 3 123 0.44 (0.22–0.88)* 0.62 (0.32–1.18)
Q 4 123 0.43 (0.22–0.85)* 0.46 (0.24–0.88)*
Q 5 117 0.41 (0.20–0.85)* 0.60 (0.31–1.17)
Breastfeeding
Over 6 months 430 1.00 1.00
3–6 months 153 1.28 (0.77–2.13) 1.44 (0.89–2.34)
≤ 3 months 27 1.18 (0.41–3.42) 1.95 (0.74–5.13)
Mutually adjusted model of IgA levels and duration of breastfeeding
IgA: Quintile (Q)
Q 1 124 1.00 1.00
Q 2 123 0.69 (0.36–1.32) 0.70 (0.37–1.34)
Q 3 123 0.42 (0.21–0.85)* 0.57 (0.30–1.10)
Q 4 123 0.41 (0.21–0.81)* 0.42 (0.22–0.82)*
Q 5 117 0.38 (0.18–0.79)** 0.51 (0.25–1.01)
Breastfeeding
Over 6 months 430 1.00 1.00
3–6 months 153 1.45 (0.86–2.45) 1.59 (0.96–2.62)
≤ 3 months 27 1.59 (0.52–4.88) 2.40 (0.87–6.59)
TGF-b1: Quintile (Q)
Q 1 123 1.00 1.00
Q 2 121 0.95 (0.48–1.90) 0.77 (0.40–1.51)
Q 3 126 1.12 (0.58–2.16) 1.13 (0.60–2.12)
Q 4 120 0.64 (0.30–1.34) 0.87 (0.45–1.71)
Q 5 120 1.00 (0.50–1.98) 1.10 (0.57–2.09)
*P < 0.05, **P < 0.01.
†Logistic regression models adjusted for centre, sex, maternal history
of allergies, farming and food score in the first year of life.
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Fig. 1. Smoothed plot of the crude and adjusted association of (IgA)
dose and the probability of atopic dermatitis (AD) up to age 2.
Adjusted for centre, sex, maternal history of allergies, farming and
food score in the first year of life. The estimated dose of soluble IgA
(sIgA) ingested by an infant during the first year of life (product of
sIgA level and breastfeeding duration) was significantly inversely
associated with AD up to age 2.
Table 2. (continued)
Exposure N
Geometric mean (95%-CI) Crude GMR (95% CI)
Mutually adjusted
GMR (95%-CI)
IgA [mg/L]
Smoking
Never 404 175.66 (168.20–183.46) 1.00 1.00
Only before pregnancy 135 189.54 (173.79–206.72) 1.08 (0.98–1.19) 1.04 (0.94–1.14)
During pregnancy
(not at month 2)
41 208.77 (170.44–255.72) 1.19 (1.02–1.39)* 1.22 (1.04–1.43)*
At month 2
assessment
30 280.58 (216.69–363.31) 1.60 (1.33–1.91)*** 1.40 (1.17–1.69)***
†Borderline significance: P ≤ 0.07, *P < 0.05, **P < 0.01, ***P < 0.001.
‡Associations of TGF-b1 and IgA with all variables in Table 1 were tested; only significant associations plus farming variable shown and included
in mutually adjusted models.
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may represent increased microbial stimuli for the
maternal immune system and might thus induce
increased levels of sIgA in breast milk. It is thus possi-
ble that sIgA levels in breast milk reflect the environ-
mental microbial load, which modifies the development
of allergic diseases, such as AD, rather than sIgA in
breast milk. We did not find association between breast
milk sIgA and atopy later in life, which suggests that
sIgA does not directly affect IgE induction to environ-
mental antigens.
Interestingly, breast milk sIgA was not associated
with asthma later in life, suggesting that an effect spe-
cific to AD may be involved.
The present study did not find any consistent associa-
tion between the dose of TGF-b1 in breast milk and
atopic outcomes in the child, nor were there differences in
TGF-b1 levels in breast milk of atopic and non-atopic
mothers. Other studies [31], but not all [11], found TGF-b
in breast milk to reduce the risk of atopic disease in early
life or to be present in lower concentrations in breast
milk of mothers with a history of atopic diseases [6, 8].
Interestingly, we observed that long breastfeeding
increased the risk of asthma in children of mothers with
allergic history. In our study, however, we did not see
association between breast milk TGF-b1 or sIgA and
maternal history of allergy. In a large cohort of children
with family history of allergy, long exclusive breastfeed-
ing was associated with allergic eczema [32]. However, in
some studies, long breastfeeding has been protective
against AD, particularly in children of family with aller-
gic history [33]. A recent meta-analysis by Oddy [4] con-
cluded that a majority of studies reported a positive
association between immunological parameters and TGF-
b1 or TGF-b2, indicating protection against allergy-
related outcomes in infancy and early childhood. It
appeared that the levels of TGF-b1 measured in breast
milk were relatively high in the studies in which the asso-
ciation of TGF-b1 and atopy was found. Levels of TGF-
b1 in our study were comparable with the low median
levels according to Oddy, and therefore, our findings of
no association of breast milk TGF-b1 with atopic diseases
may be related to the sensitivity of the method for the
detection of TGF-b1 as suggested by Oddy. However, the
number of prospective studies investigating the effect of
TGF-b on clinical allergy outcomes is still very limited,
and the results are mixed.
A recent study in Italy comparing TGF-b1 levels in
colostrum (day 3) and mature milk (1st month) of 45
farm and 69 urban mothers found significantly higher
levels of TGF-b1 in both types of milk samples among
farming mothers [14]. The authors suggested that the
higher cytokine concentration in breast milk may influ-
ence early modulation of an immune response leading to
a reduced prevalence of allergy-related diseases in farm
children. However, the present study did not confirm this
assumption. It contrasted rural mothers living or not liv-
ing on farms, and it may well be that the difference in
TGF-b1 levels might be higher when farm mothers are
compared with urban ones. However, the contrast in
allergy prevalence of farm and non-farm children has
always been found among rural populations [13].
Current smoking at month 2 assessment (which was
strongly related to smoking during pregnancy as 88%
also smoked while pregnant) was related to increased
levels of sIgA in breast milk. Smoking during preg-
nancy or only before pregnancy was associated with
increased levels of TGF-b1. Cigarette smoke contains
toxins and trace amounts of microbial cell components,
inducing chronic inflammation at mucosal surfaces and
influencing host immunity in a complex way [34]. Yet,
the mechanism of how cigarette smoke affects TGF-b1
and sIgA levels in breast milk is not known.
Significant country differences in the levels of TGF-
b1 and sIgA were found. TGF-b1 levels were found to
be highest in Finland, whereas sIgA levels were highest
in France. Country differences in the levels of these
breast milk components have previously been reported
when breast milk of Swedish and Estonian mothers was
compared [15]. Higher sIgA levels, but lower TGF-b lev-
els, were found in mature milk of Estonian as compared
to Swedish mothers, but underlying reasons for these
differences are not clear.
The strong inverse dose–response relationship
between the duration of breastfeeding and levels of
sIgA or TGF-b1 in mature breast milk found in this
study has previously been reported by Savilahti et al.
[35] with colostrum. It has been shown that bacteria-
induced mastitis increased milk TGF-b1 levels [36]. It is
thus possible that TGF-b1 and IgA in breast milk are
induced by microbial stimuli, and the association of
high levels of TGF-b1 and IgA in breast milk with the
short duration of breastfeeding is due to subclinical
inflammation in the breast tissue. Animal models have
also shown that TGF-b can inhibit ductal and alveolar
development in breast tissue [37]. It is, however, note-
worthy that the inverse association between the dose of
sIgA and AD was observed despite the fact that high
levels of sIgA measured at month 2 were associated
with shorter breastfeeding.
We only had a 1-point measurement of the two
breast milk components measured at month 2. However,
it has been shown that after a drop in sIgA concentra-
tions in breast milk 10 days post-partum, the levels did
not change significantly during the first year of life
[38, 39], and TGF-b levels have been shown to be rela-
tively constant at least throughout the first 3 months
after birth [40]. It thus can be assumed that the
2-month measurements are representative of the levels
the infants consumed during lactation. A further limita-
tion of this study was the lack of information on
© 2013 John Wiley & Sons Ltd, Clinical & Experimental Allergy, 44 : 102–112
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current infections during the period of breast milk sam-
pling, thus not allowing to assess their influence on
breast milk levels of sIgA or TGF-b1. Our sample with
objective measurements was restricted to mothers who
were still breastfeeding during the sampling period,
thus restricting the external validity of our findings
based on objective measurements to women breastfeed-
ing for longer than 2 months after birth. Methodologi-
cal limitations may be related to the sensitivity of the
detection of breast milk TGF-b1 as discussed above and
on the isoform of TGF-b detected. We did not measure
breast milk TGF-b2, which was shown to be in associa-
tion with probiotic treatment, that is, microbial expo-
sure [41]. The definition of allergic diseases is always a
concern in the follow-up studies when the definition is
based not only on doctor’s diagnosis, but also on symp-
toms reported by the parents. The questionnaires used
in our study have previously been used for studies with
equivalent samples sizes [42, 43], and they were based
on the internationally validated ISAAC study questions
to have as reliable data as possible.
Strengths of the present study are its sample size and
the longitudinal design. This large transnational birth
cohort ranging from pregnancy up to the age of 6 years
and including repeated standardized [24, 44] and par-
tially objective measures of allergic diseases (such as
allergen-specific IgE), objective measurements of breast
milk components and a comprehensive assessment of
environmental exposures allowed to establish sound
temporal relationships. To our knowledge, this is the
first study investigating breastfeeding and atopic dis-
eases that also took the introduction of complementary
foods in the first year of life into account and addition-
ally addressed potential confounders adequately [1].
Our study is aimed to dissect the possible factors of
breast milk that could be important in the modulation
of atopy. The results support the protective effects of
breastfeeding on AD, but emphasize the fact that the
protective effect is dependent on breast milk composi-
tion, such as sIgA, which may explain the variation in
the results of the epidemiological studies on breastfeed-
ing in which the duration of breastfeeding is the only
determinant. Our results suggest that high sIgA in
breast milk may reduce the risk to develop AD at early
age. Identification of factors modulating breast milk
composition towards higher levels of components pro-
moting immune development such as sIgA might be a
contribution to allergy prevention research [45].
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Food, drug, insect sting allergy, and anaphylaxis
Increased food diversity in the first year of life is inversely
associated with allergic diseases
Caroline Roduit, MD, MPH,a Remo Frei, PhD,b Martin Depner, PhD,c Bianca Schaub, MD,c Georg Loss, PhD,d
Jon Genuneit, MD,e Petra Pfefferle, PhD,f Anne Hyv€arinen, PhD,g Anne M. Karvonen, PhD,g Josef Riedler, MD,h
Jean-Charles Dalphin, MD, PhD,i Juha Pekkanen, MD,g Erika von Mutius, MD, MSc,c Charlotte Braun-Fahrl€ander, MD,d,k
Roger Lauener, MD,j and the PASTURE study group* Zurich, Basel, and Davos, Switzerland, Munich, Ulm, and Marburg,
Germany, Kuopio, Finland, Schwarzach, Austria, and Besanc¸on, France
Background: The role of dietary factors in the development of
allergies is a topic of debate, especially the potential associations
between infant feeding practices and allergic diseases.
Previously, we reported that increased food diversity introduced
during the first year of life reduced the risk of atopic dermatitis.
Objective: In this study we investigated the association between
the introduction of food during the first year of life and the
development of asthma, allergic rhinitis, food allergy, or atopic
sensitization, taking precautions to address reverse causality.
We further analyzed the association between food diversity and
gene expression of T-cell markers and of Cε germline transcript,
reflecting antibody isotype switching to IgE, measured at 6 years
of age.
Methods: Eight hundred fifty-six children who participated in a
birth cohort study, Protection Against Allergy Study in Rural
Environments/EFRAIM, were included. Feeding practices were
reported by parents in monthly diaries during the first year of
life. Data on environmental factors and allergic diseases were
collected from questionnaires administered from birth up to
6 years of age.
Results: An increased diversity of complementary food
introduced in the first year of life was inversely associated with
asthma with a dose-response effect (adjusted odds ratio with
each additional food item introduced, 0.74 [95% CI, 0.61-0.89]).
A similar effect was observed for food allergy and food
sensitization. Furthermore, increased food diversity was
significantly associated with an increased expression of forkhead
box protein 3 and a decreased expression of Cε germline
transcript.
Conclusion: An increased diversity of food within the first year
of life might have a protective effect on asthma, food allergy,
and food sensitization and is associated with increased
expression of a marker for regulatory T cells. (J Allergy Clin
Immunol 2014;133:1056-64.)
Key words: Asthma, food allergy and sensitization, food diversity,
children
Nutrition is an important environmental factor in early life that
influences the development of the child’s immune system. The
role of nutrition during infancy on the development of allergies
later in childhood remains controversial. Moreover, reverse
causality is always a matter of concern.
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During the early postnatal period, the infant gut is first exposed to
different food antigens, and these exposures might influence the
development of immune tolerance. Mechanisms could include the
acquisition of the microbiota through the diet or diet-microbiota
interactions.1-3 It has been suggested that modern changes in the
postnatal environment, such as early dietary exposure, might not
optimally support induction of immune tolerance because the inci-
dence of allergic diseases during the last decades shows a strong in-
crease.4 However, current guidelines no longer recommend food
allergen avoidance or delaying introduction in the infant diet to pre-
vent allergic diseases because no clear benefit has been shown.5
Recent studies have suggested a protective effect of early introduc-
tion of complementary food on allergic diseases, even though the
underlying mechanism on the maturation of the mucosal
immune system remains unknown.6-12 However, it is widely
accepted that oral tolerance mechanisms include regulatory
T cells. Forkhead box protein 3 (Foxp3) is a key transcription
factor for regulatory T cells, and it was shown that depletion of
Foxp31 cells inhibited oral tolerance.13 Our recent findings on the
protective effect of an increased diversity of food introduced in the
first year of life on atopic dermatitis are in agreement with the hy-
pothesis that exposure to a variety of food antigens during early
life might be important for the development of immune tolerance.14
Here we studied whether complementary food introduced in
the first year of life was associated with asthma, food allergy,
allergic rhinitis, and atopic sensitization up to 6 years of age in the
prospective birth cohort study Protection Against Allergy Study
in Rural Environments (PASTURE/EFRAIM).15 Similar to our
previous analyses on atopic dermatitis, we took into account
potential reverse causality. We further examined whether food
diversity introduced in the first year of life had an effect on
gene expression of the T-cell markers T-box transcription
factor (T-bet) and Gata-3, transcription factors related to the
development of TH1 and 2 TH2 cells, respectively, and Foxp3, a
transcription factor driving the development of regulatory cells
T, and expression of Cε germline transcript, a marker for antibody
isotype switching to IgE, at 6 years of age.
METHODS
Study design and population
The PASTURE/EFRAIM study is a prospective birth cohort involving
children from rural areas in 5 European countries (Austria, Finland, France,
Germany, and Switzerland) designed to evaluate risk factors and preventive
factors for atopic diseases.15 Pregnant women were recruited during the third
trimester of pregnancy between August 2002 and March 2005 and divided
into 2 groups.Womenwho livedon family-run farmswhere any kind of livestock
was kept were assigned to the farm group.Women from the same rural areas not
living on a farmwere in the referencegroup. In total, 1133 childrenwere included
in this birth cohort. The studywas approved by the local research ethics commit-
tees in each country, andwritten informed consent was obtained from all parents.
Children with data available on allergic diseases up to 6 years of age,
farming status, parental allergic history, maternal educational status, number
of siblings, and feeding practices in the first year of life (n 5 856) were
included in the current study.
Definitions
Questionnaires were administered in interviews or self-administered to the
mothers within the third trimester of pregnancy and when the children were 2,
12, 18, and 24 months of age and then yearly up to age 6 years. Children were
defined as having asthma when the parents reported at least once that the child
had either doctor-diagnosed asthma or at least 2 doctor-diagnosed episodes of
obstructive bronchitis in the last 12 months in the year 4, 5, or 6 questionnaires
independent of a diagnosis reported in the first 3 years of life. Obstructive
bronchitis is commonly used to define the first occurrence of asthmatic
symptoms. Food allergy was defined when the parents reported up to age 6
years that the child had at least once been given a diagnosis of food allergy by a
doctor. Allergic rhinitis was defined by the presence of symptoms (itchy,
runny, or blocked nose without a cold and associated with red itchy eyes) or
doctor-diagnosed allergic rhinitis ever reported in the 6-year questionnaire.
Levels of allergen-specific IgE antibodies (Dermatophagoides pteronyssius,
Dermatophagoides farinae, alder, birch, hazel, grass pollen, rye, mugwort,
plantain, cat, horse, dog, Alternaria species, hen’s egg, cow’s milk, peanut,
hazelnut, carrot, and wheat flour) were measured in blood among children
at age 4.5 and 6 years, as well as their mothers and fathers. Sensitization
was defined as a specific IgE level of 3.5 kU/L or greater and as being strongly
associated with allergic diseases.
Parents indicated the food item that was given to the child in the last 4
weeks in each monthly diary between the 3rd and 12th months of life. For the
introduction of complementary food, we used the same diversity score, as
previously described, based on major food items, which were defined as the
items introduced in the first year of life to at least 80% of the children.14
The food diversity score is a total count of the number of different food
items included in the child’s diet. Diversity scores were calculated as follows:
(1) with major food items introduced in the first year of life (n5 6, including
vegetables or fruits, cereals, bread, meat, cake, and yogurt); (2) with the same
major food items but introduced in the first 6 months of life; and (3) with all
food items introduced in the first year of life (n 5 15, including any cow’s
milk, yogurt, other milk product, eggs, nuts, vegetables or fruits, cereals,
bread, meat, fish, soy, margarine, butter, cake, and chocolate) reported in
the monthly diary. The latter was calculated to include potentially allergenic
food items.
Farmer children were defined as children who were living on a farm where
livestock was held and whose family ran the farm, according to parental
reports. Information on parental atopic status, maternal education, smoking
during pregnancy, mode of delivery, birth weight, gestational age, sex, number
of siblings, and duration of breast-feeding was recorded in questionnaires
during pregnancy, 2 months after birth, and at 1 year of age. Positive parental
history of allergies was defined as ever having asthma, allergic rhinitis, or
atopic dermatitis.
Gene expression of T-cell markers
Blood samples were collected at birth (cord blood) and at 1, 4.5, and 6 years
of age for assessment of mRNA expression. The method for these measure-
ments was described in detail elsewhere.16 The data presented are normalized
values for the endogenous controls (18S rRNA and b2-microglobulin)
determined by using the comparative (DD cycle threshold) method, according
to the manufacturer’s instructions (Applied Biosystems, Foster City, Calif).
Statistical analysis
Differences in characteristics of children regarding the diversity food score
were tested by using the x2 test. Logistic regression was used to investigate the
association between food exposure and asthma, food allergy, allergic rhinitis,
and atopic sensitization.We performed and compared differentmodels.Model
1 was the crude model, and model 2 included adjustment for the potential
confounders: farmer, center, duration of breast-feeding (categorized according
to the number of months children were breast-fed, not exclusively), parents
with allergy, maternal education, sex, and number of siblings. To take into
account reverse causality, we used model 3, which included the same
adjustment as model 2 but additionally excluded children with doctor-
diagnosed food allergy within the first year of life. For asthma, children
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with at least 1 episode of doctor-diagnosed obstructive bronchitis or asthma
within the first year of life were also excluded. Sensitivity analysis with
additional exclusions for wheeze, atopic dermatitis, or both within the first
year of life was performed. Parental allergic status is potentially a strong
confounder because it might influence infant feeding practices; therefore we
performed additional analysis using different definitions based on atopic
sensitization and/or history of allergies among the mother, father, or both.
Atopic dermatitis might also be a confounder and potentially on the causal
pathway between food diversity and asthma, and therefore we performed
analyses with additional adjustment to control for this. Sensitivity analyses
were performed with modified food scores, removing 1 of the items to
determine the influence of a single item in this score. Smooth plots were
performed with generalized additive models by using R statistical
software to graphically display the dose-response effect of the food diversity
score on allergic diseases. Test for linear trend between the food diversity
score and health outcomes was performed by using the Cochran-Armitage
trend test.
The gene expression data were analyzed by using the comparative
threshold method of Giulietti et al.17 This method expresses the measured
number of PCR cycles of the participants relative to 1 participant. We chose
as a reference the cord blood values for a nonfarmer child whose expression
of all genes was greater than the detection limit. The results are expressed
as a gene expression multiplication factor compared with the reference.
Because the distribution of the gene expression levels was skewed, the
variables were log transformed (natural logarithm), resulting in an
approximately normal distribution. We used linear regressions to calculate
associations between food diversity scores and mRNA expression (expressed
as geometric mean ratios). Interaction terms were included in the multivariate
models to test for effect modification between the diversity food score and
parental history of allergy, center, and farming status on allergic diseases.
Data analysis was conducted with SAS software, version 9.2 (SAS Institute,
Cary, NC).
RESULTS
Characteristics and prevalence of allergic diseases
Among the 856 children included in this study, 51.5% were
farmer children, and 53.6% had at least 1 allergic parent (Table I).
The description of food diversity was mentioned in our previous
study.14 Farmer children received a higher number of different
food items in the first year of life compared with nonfarmer
children. Differences between centers were observed regarding
the diversity score, with a higher proportion of French and
German children having a low score. A higher proportion of
children with at least 1 parent with a history of atopy had a low
score compared with children with parents with no history of
atopy. No association between the diversity score and sex, number
of siblings, duration of breast-feeding, and maternal education
was found. Approximately half of the children (47.4%) were
breast-fed for more than 6 months (not exclusively), and no
association between duration of breast-feeding and asthma,
allergic rhinitis, food allergy, and atopic sensitization
was observed (data not shown). Characteristics of children
excluded from the analysis because of missing data (n 5 277)
did not differ from those of the included children, except for a
higher proportion of nonfarmer children (58.5%) among the
excluded children.
There were 848 and 809 subjects with available data for
allergic rhinitis and food allergy, respectively. The cumulative
prevalence of asthma between 3 and 6 years of age was 8.6%,
the cumulative prevalence of allergic rhinitis up to 6 years of
age was 7.6%, and the cumulative prevalence of food allergy up
to 6 years was 7.4%. These proportions were significantly
higher in children with 2 allergic parents than among children
with nonallergic parents (asthma, 10.7% vs 6.3%; allergic
rhinitis, 11.0% vs 3.6%; and food allergy, 10.6% vs 3.7%,
respectively).
Data on atopic sensitization were available for 596 children at
age 4.5 years, 6 years, or both. Sensitization to any allergen was
present in 25.5% of children, sensitization to food allergens was
present 10.7%, and sensitization to inhalant allergens was present
in 22.1%, as measured at 4.5 or 6 years.
Association between food diversity score and
allergic diseases and atopic sensitization
Dividing the diversity score into 3 categories with the highest
(all 6 food items) as reference, we observed a significant inverse
dose-response associationwith asthma in crude analysis (model 1)
and after adjustment for potential confounders (model 2,
Table II). The test for linear trend was significant for asthma,
food allergy, and food sensitization (P < .001, P < .001, and
P 5 .006, respectively). We observed a significant reduction of
26% for the development of asthma, with each additional food
item introduced in the first year of life. This inverse association
between the food diversity score and asthma remained stable after
exclusion of children with a doctor’s diagnosis of food allergy and
defined as having asthma, obstructive bronchitis, or both within
the first year of life (model 3). Sensitivity analyses with additional
exclusion of children with wheezing (n 5 223 [26.1%]), atopic
dermatitis (n 5 119 [14.4%]), or both within the first year of
life were performed and showed similar results (crude analysis
only among children with no wheeze and no atopic dermatitis
in the first year of life: odds ratio [OR] for 0-3 vs 6 items of
3.83 [95% CI, 1.02-14.41] and OR for 4-5 vs 6 items of 1.63
[95% CI, 0.74-3.61]). Moreover, analysis excluding children
(n 5 30) among those parents who reported that they avoided
introducing food within the first year of life because of child’s
allergy showed similar associations.
Additional adjustment for atopic dermatitis showed similar
results (see Table E1 in this article’s Online Repository at
www.jacionline.org), and the negative association between food
diversity score and asthma was stronger for children having
both diseases (n 5 29) compared with those having neither
disease (OR for food diversity score, continuous: 0.61 [95% CI,
0.49-0.76]). For children with asthma but no atopic dermatitis
up to 6 years (n 5 40), a similar association was observed with
an increasing diversity food score (OR for food diversity score,
continuous: 0.80 [95% CI, 0.62-1.04]). Additional analyses
were performed for children defined as having asthma based
only on a doctor’s diagnosis of asthma between 3 and 6 years of
age (n 5 36), which showed similar results (see Table E2 in
this article’s Online Repository at www.jacionline.org). Recently
published results from this birth cohort showed that late-onset and
persistent wheeze phenotypes were best correlated with
clinical phenotypes of asthma.18 We observed that the strongest
association between the food diversity score and different
phenotypes of wheeze was with late-onset and persistent wheeze
phenotypes (OR for transient wheeze, 1.08 [95% CI, 0.86-1.35];
OR for intermediate wheeze, 0.91 [95% CI, 0.68-1.21]; OR for
late-onset wheeze, 0.75 [95% CI, 0.53-1.08]; and OR for
persistent wheeze, 0.76 [95% CI, 0.55-1.07]).
A smoothed plot of the relationship between the food diversity
score and asthma was performed, which showed a decrease in
the log odds of asthma with an increasing score (Fig 1, A).
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The analysis restricted to children for whom no food
avoidance was reported within the first year of life because
of child’s allergy showed the same pattern (Fig 1, B). To
also include allergenic foods, we additionally analyzed the
association between another food diversity score with all
the food items (n 5 15) and asthma. The same inverse dose-
response effect was observed (Fig 1, C). The same analyses
were performed with food allergy (Fig 2), and similar
patterns were observed. Additionally, we calculated a diversity
score with food items introduced within the first 6 months of
life and observed the same tendency of a negative association
between a higher score compared with a lower score on asthma
risk (OR for food diversity score, continuous: 0.83 [95% CI,
0.68-1.03]), although with a test for linear trend of borderline
significance (P 5 .08, see Fig E1 in this article’s Online
Repository at www.jacionline.org).
The children with a low food diversity score (with the major
food items) had an increased risk of food allergy up to 6 years of
age and sensitization to food allergens at age 4.5 or 6 years
compared with children with the highest score (Table II). The
analysis with children having doctor-diagnosed food allergy
combined with positive food sensitization (n 5 18) showed an
even stronger negative association with food diversity (OR for
food diversity score, continuous: 0.55 [95%CI, 0.40-0.76]). After
exclusion of children with food allergy within the first year of life,
the associations were no longer statistically significant, even
though estimates for the continuous variable remained similar
(model 3). There was a tendency toward a negative association
between the food diversity score and allergic rhinitis or
sensitization to inhalant allergens, although this was not
statistically significant. There was no interaction between the
food diversity score and parental allergies or farming status on
TABLE I. Characteristics of the study population and prevalence of allergic diseases
All
Food diversity score
P value*
0-3 items 4-5 items 6 items
No. Percent No. Percent No. Percent No. Percent
Characteristics
All 856 100 37 4.3 263 30.7 556 65.0
Farmer <.001
Yes 415 51.5 9 24.3 112 57.4 294 52.8
No 441 48.5 28 75.7 151 42.6 263 47.2
Center .01
Austria 161 18.8 1 2.7 58 22.1 102 18.3
Switzerland 187 21.9 9 24.3 57 21.7 121 21.8
France 150 17.5 12 32.4 48 18.2 90 16.2
Germany 203 23.7 12 32.4 63 23.9 128 23.0
Finland 155 18.1 3 8.1 37 14.1 115 20.7
Sex .66
Girls 424 49.5 20 54.0 125 47.5 279 50.2
Boys 432 50.5 17 46.0 138 52.5 277 49.8
Siblings .10
0 310 36.2 9 24.3 100 38.0 201 36.1
1-2 459 53.6 27 73.0 140 53.2 292 52.6
>_3 87 10.2 1 2.7 23 8.8 63 11.3
Parents with atopy history .005
Yes 459 53.6 26 70.3 156 59.3 277 49.8
No 397 46.4 11 29.7 107 40.7 279 50.2
Breast-feeding .70
Never 80 9.4 5 13.5 26 9.9 49 8.8
>0-2 mo 132 15.4 5 13.5 40 15.2 87 15.7
3-6 mo 238 27.8 6 16.2 75 28.5 157 28.2
7-9 mo 180 21.0 9 24.3 48 18.3 123 22.1
>_10 mo 226 26.4 12 32.4 74 28.1 140 25.2
Maternal education .16
Low 140 16.4 11 29.7 40 15.2 89 16.0
Mid 370 43.2 10 27.0 109 41.4 251 45.1
Mid-high 251 29.3 10 27.0 82 31.2 159 28.6
High 95 11.1 6 16.2 32 12.2 57 10.3
Outcome prevalences
Asthma (doctor-diagnosed asthma and/or >_2 obstructive
bronchitis episodes 3-6 y)
74/856 8.6 7 18.9 33 12.6 34 6.1 <.001
Allergic rhinitis (doctor-diagnosed hay fever or allergic
rhinitis OR symptoms [nasal AND eye] ever at age 6 y)
64/848 7.6 4 10.8 24 9.2 36 6.6 .31
Food allergy up to 6 y (doctor-diagnosed food allergy) 60/809 7.4 7 21.9 23 9.2 30 5.7 .001
Any sensitization at 4.5 or 6 y (cutoff: 3.5 kU/L) 152/596 25.5 12 46.2 44 24.2 96 24.7 .05
Food sensitization at 4.5 or 6 y (cutoff: 3.5 kU/L) 62/580 10.7 7 26.9 23 13.1 32 8.5 .006
Inhalant sensitization 4.5 or 6 y (cutoff: 3.5 kU/L) 131/594 22.1 9 34.6 39 21.4 83 21.5 .29
*Based on the x2 test.
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allergic diseases. Moreover, similar results were obtained in
separate analyses stratified by parental history of allergy or by
farming status, as well as after additional adjustment for
consumption of unboiled farm milk (data not shown).
The analysis with different definitions of asthma, both atopic
and nonatopic (defined with or without positive sensitization to
inhalant allergens at 4.5 or 6 years of age: n 5 23 and n 5 30,
respectively) showed the same tendencies (adjusted OR for each
additional food items introduced in the first year of life, 0.70 [95%
CI, 0.52-0.94] and 0.77 [95% CI, 0.59-1.00], respectively).
Analysis for a subgroup excluding children with a low score of
food diversity showed similar results (see Table E3 in this article’s
Online Repository at www.jacionline.org). Sensitivity analyses
with modified scores, excluding 1 of the food items to evaluate
the influence of the excluded item in this score, showed similar
associations between reduced scores and allergic diseases
(data not shown).
To analyze the association between single food items and
allergic outcomes, we also performed different models to take
into account the reverse causality effect. The results from the
analyses between single food items and asthma showed a strong
negative association with milk products, such as yogurt and
butter, introduced within the first year of life, compared with
reference children who did not consume these foods in the first
year of life (see Table E4 in this article’s Online Repository at
www.jacionline.org). The analysis among a subgroup excluding
children with food allergy or asthma within the first year of life
(model 3) showed similar results, although these were weaker
for introduction of yogurt. The analysis with the 2 predictor
variables of yogurt and butter in the model showed the same
protective effect, as well as stratified analysis by parental history
of allergy (data not shown). The risk of food allergy was reduced
by a factor of 0.5 among children who consumed fish within
the first year of life compared with children who did not
(see Table E5 in this article’s Online Repository at www.
jacionline.org). This effect remained significant after adjustment
for potential confounders, such as atopic dermatitis, and after
exclusion of children with food allergy within the first year of
life. The stratified analysis showed an inverse association only
among the children with allergic parents (data not shown). The
negative association between fish introduced within the first
year of life and sensitization to food allergens was only significant
in the crude analysis (see Table E6 in this article’s Online
Repository at www.jacionline.org).
Association between food diversity score and gene
expression for marker of IgE antibody isotype
switching and for T-cell markers
Among children with a low food diversity score within the first
year of life, we observed a significantly increased level of Cε
germline transcript at age 6 years by a factor of 1.8 compared with
TABLE II. Association between diversity score within the first year of life and allergic diseases and atopic sensitization
Model 1 Model 2 Model 3
No. OR 95% CI No. OR 95% CI No. OR 95% CI
Asthma
Food diversity score within 1st year
0-3 items 7/37 3.58 1.47-8.75 7/37 3.15 1.24-8.05 5/32 3.77 1.23-11.53
4-5 items 33/263 2.20 1.33-3.64 33/263 2.01 1.24-3.46 16/215 1.60 0.80-3.20
6 items, reference 34/556 1 34/556 1 21/487 1
Diversity score, continuous 74/856 0.73 0.61-0.87 74/856 0.74 0.61-0.89 42/734 0.76 0.60-0.96
Allergic rhinitis
Diversity score major food within 1st year
0-3 items 4/37 1.73 0.58-5.15 4/37 1.78 0.56-5.67 2/34 0.94 0.21-4.26
4-5 items 24/261 1.45 0.84-2.48 24/261 1.35 0.77-2.38 20/252 1.14 0.63-2.06
6 items, reference 36/550 1 36/550 1 36/547 1
Diversity score, continuous 64/848 0.83 0.68-1.01 64/848 0.80 0.64-1.00 58/833 0.93 0.71-1.22
Doctor-diagnosed food allergy
Food diversity score within 1st year
0-3 items 7/32 4.65 1.86-11.61 7/32 4.43 1.62-12.10 4/29 2.61 0.77-8.88
4-5 items 23/249 1.69 0.96-2.97 23/249 1.85 1.02-3.35 13/239 1.13 0.56-2.31
6 items, reference 30/528 1 30/528 1 26/524 1
Diversity score, continuous 60/809 0.71 0.58-0.85 60/809 0.70 0.57-0.86 43/792 0.79 0.60-1.03
Sensitization to food allergens at 4.5 or 6 y
Food diversity score within 1st year
0-3 items 7/26 3.99 1.56-10.19 7/26 5.47 1.91-15.67 6/23 5.22 1.70-16.04
4-5 items 23/176 1.63 0.92-2.87 23/176 1.52 0.83-2.76 22/167 1.53 0.83-2.84
6 items, reference 32/378 1 32/378 1 31/376 1
Diversity score, continuous 62/580 0.76 0.62-0.93 62/580 0.72 0.57-0.90 59/566 0.72 0.56-0.91
Sensitization to inhalant allergens at 4.5 or 6 y
Food diversity score within 1st year
0-3 items 9/26 1.93 0.83-4.49 9/26 1.79 0.74-4.37 7/23 1.50 0.57-3.95
4-5 items 39/182 1.00 0.65-1.53 39/182 0.87 0.56-1.37 36/172 0.84 0.53-1.34
6 items, reference 83/386 1 83/386 1 83/384 1
Diversity score, continuous 131/594 0.94 0.78-1.13 131/594 0.97 0.80-1.18 126/579 1.01 0.82-1.25
Diversity scores with major food items are shown. Boldface values are significant (P < .05).
Model 1, Crude;Model 2, model 1 plus adjusted for center, farmer, parents with allergy, sex, breast-feeding, siblings, and maternal education;Model 3, model 2 plus exclusion of food
allergy at 1 year (n 5 17) and only with asthma: exclusion of at least 1 episode of obstructive bronchitis and/or asthma, both doctor diagnosed and reported at 1 year (n 5 102).
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children with the highest score (Table III). Moreover, those
children with a low food diversity score showed a significantly
lower level of gene expression for Foxp3, a transcription factor
driving development of regulatory T cells, measured at 6 years
after adjustment for potential confounders and the valuemeasured
in cord blood (Table IV). Analysis stratified by parental allergic
status showed similar results. We did not find an indirect effect
of Foxp3 or Cε germline transcript expression on the associations
between food diversity and allergic diseases or sensitization
(data not shown). We did not observe an association between
the food diversity score and mRNA expression of T-bet and
Gata-3, transcription factors related to the development of TH1
and TH2 cells, respectively.
DISCUSSION
Our data show that an increased diversity of food introduced in
children’s diet within the first year of life is negatively associated
with the development of asthma and food allergy up to 6 years of
age and on sensitization to food allergens at 4.5 or 6 years of age.
Moreover, among children with a low food diversity score, we
found an increased expression of marker for antibody isotype
switching to IgE and a reduced expression of the regulatory
T cell–associated gene Foxp3 measured at 6 years of age.
To our knowledge, the present findings are the first showing an
inverse association of an increased diversity of exposures to food
antigens in the first year of life on the development of allergic
diseases later in childhood. Previous studies on the diversity of
food introduced in infants’ diets and allergies focused on the first
4 or 6 months of life.19-21 Only 1 study reported an increased risk
of doctor-diagnosed eczema up to 6 years of age in association
with an increased diversity of solid food introduced within the
first 4 months.20 However, this effect was seen neither with
eczema up to 4 years nor with a definition based on symptoms,
and a tendency of protective effect on asthma up to 6 years was
observed with an increased diversity of food introduced within
the first 4 months. In our study a diversity score with food items
introduced within the first 6 months of life was calculated, and
FIG 1. Association between increasing diversity of food introduced within the first year of life and asthma.
A, Diversity score with major food for the entire study population. B, Diversity score with major food
restricted to children without food avoidance within the first year of life because of allergies. C, Diversity
score with all different food items for the entire study population. The solid line represents the predicted
value of asthma as a function of the score, and dashed lines represent the CI. The y-axis is the linear logit
of asthma, and the values are centered on 0 (50/50 odds) and extended to both positive and negative values.
All models are adjusted for farmer, center, duration of breast-feeding, parents with allergy, maternal edu-
cation, sex, and siblings.
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children with a higher score had a lower risk of asthma compared
with those with a lower score. Moreover, the analysis with mutual
adjustment for the score within the first 6 months and the score
within the first year of life showed a persistent significant
protective effect of the first year’s score, meaning that exposure
to food proteins in the time period between 6 and 12 months of
age might be an important time window for protection against
the development of later allergic diseases. The new guidelines
on early nutrition and allergy prevention recommend that
complementary foods should not be introduced before 4 months
of age but should be introduced for all infants by 6 months of
age.5,22 Even though more evidence is required, because our
TABLE III. Association between diversity food score within the first year of life and gene expression for marker of IgE antibody
isotype switching (Cε germline transcript) measured at 6 years
Diversity score, major food items within 1st y
Cε germline transcript (6 y)
All No allergic parents >_1 Allergic parent
No. GMR* 95% CI No. GMR* 95% CI No. GMR* 95% CI
0-3 items 22 1.81 1.21-2.70 7 1.81 0.84-3.88 15 1.78 1.13-2.79
4-5 items 161 1.18 0.99-1.40 61 1.26 0.94-1.69 100 1.14 0.93-1.39
6 items, reference 336 1 156 1 180 1
Boldface values are significant (P > .05).
*Geometric mean ratios are adjusted for center, farmer, parents with allergy, sex, breast-feeding, maternal education, and cord blood value for the respective gene.
FIG 2. Association between increasing diversity of food introduced within the first year of life and food
allergy.A,Diversity score withmajor food for the entire study population. B, Diversity score withmajor food
restricted to children without food avoidance within the first year of life because of allergies. C, Diversity
score with all different food items for the entire study population. The solid line represents the predicted
value of asthma as a function of the score, and dashed lines represent the CI. The y-axis is the linear logit
of food allergy, and the values are centered on 0 (50/50 odds) and extended to both positive and negative
values. All models are adjusted for farmer, center, duration of breast-feeding, parents with allergy, maternal
education, sex, and siblings.
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findings form the basis for a new hypothesis, an increased
diversity of food in the second part of the first year of life might
be an interesting strategy to prevent allergic diseases.
The strengths of this study are the prospective design and
collection of data on the introduction of complementary food
within the first year of life, which avoid recall bias. One major
concern with the association between feeding practices and atopic
diseases is the potential bias caused by reverse causality. Among
children with early symptoms of the disease, those with allergic
parents, or both, introduction of certain complementary foods,
especially allergenic foods, tends to be delayed. With analyses
performed in a subgroup of children, excluding those with food
allergy, respiratory disorders, or both within the first year of life,
significant results remained with asthma, and there was a similar
tendency, although weaker, with food allergy and food
sensitization. Moreover, all multivariate models were addition-
ally adjusted for atopic dermatitis, and the negative association
between food diversity and asthma seems to be independent of the
effect on atopic dermatitis. Sensitivity analysis with models
adjusted for parental allergic status using different definitions
based on atopic sensitization and/or history of allergies among the
mother, father, or both showed similar results, as did stratified
analysis (data not shown). Our results provide strong support to
conduct a randomized clinical trial, which is essential to
completely exclude the reverse causality effect. Selection bias
is unlikely in this study because the excluded and included
children did not differ significantly. The definition of the health
outcomes based on a doctor’s diagnosis might lead to an
underestimation of the prevalence and, despite this, could lead
to an underestimation of the association by a dilution effect;
however, we still found a significant association. Information on
asthma medications was not included in the definition and might
be considered a limitation. Moreover, a child might be defined as
having asthma if the reported doctor’s diagnosis was made
between 3 and 4 years of age and not later and therefore related
to wheeze that resolves by school age. In any case, the strongest
negative association between food diversity and wheeze
phenotypes was with late-onset and persistent wheeze, which
both were shown to be related to clinical phenotype of asthma.18
Another limitation of this study is the selected study population,
from rural areas in Europe, so that our findings might not be
applicable to other populations and also the lack of information
on lactose or other food intolerance and on conditions that could
affect infant feeding or could represent subclinical manifestations
of food allergy, such as colic and gastroesophageal reflux. The
latter could induce a reverse causality effect and is a major
limitation in this study. Therefore reverse causality cannot be
completely excluded. Another reason that reverse causality
cannot be excluded is that reasons for the variability in food
introduction in the first year of life are not well understood.
Our findings highlight the role for diversity of environmental
exposures on the development of allergic diseases. We have
shown previously that the diversity of exposures might play a role
in the development of allergic disease, even during pregnancy,
with contact with different farm animal species.16 Similarly,
recent findings showed that the increased diversity of microbial
exposures had a protective effect on asthma.23 Our results support
the hypothesis that exposure in early life to diverse food antigens,
such as food proteins, could increase the maturation of the
mucosal immune system and induce tolerance networks.24
Moreover, it is believed that regulatory T cells are involved in
tolerance acquisition. In this study we showed decreased
expression of a marker for regulatory T cells using the
transcription factor Foxp3 at the age of 6 years among children
with a low food diversity scores within the first year of life.
However, this transcription factor does not assess the functional
activity of regulatory T cells. The protective effect of exposure
to an increased diversity of food in early life might be associated
with the induction of regulatory T cells rather than a shift in the
TH1/TH2 balance. One of the mechanisms that might be involved
in the inhibition of allergy development by regulatory T cells is
the inhibition of isotype switching to IgE25; interestingly, our
results showing a decrease in Cε germline transcript with an
increased food diversity are in agreement with this hypothesis.
The negative association was observed between increased food
diversity and asthma and food sensitization. However, no
significant association was found with sensitization to inhalant
allergens and allergic rhinitis, even though this is difficult to
evaluate because of the low numbers. One explanation might be
that early food sensitization is a better predictor for allergic
diseases and asthma than inhalant sensitization because this
was already shown in previous studies.26,27 Moreover, the same
TABLE IV. Association between diversity food score within the first year of life and gene expression for T-cell markers measured
at 6 years
Diversity score, major
food items within 1st
year
All No allergic parents >_1 Allergic parent
No. GMR* 95% CI No. GMR* 95% CI No. GMR* 95% CI
T-bet
0-3 items 22 0.94 0.71-1.25 7 1.13 0.61-2.12 15 0.90 0.70-1.16
4-5 items 163 0.96 0.85-1.09 63 0.98 0.77-1.24 100 0.95 0.85-1.07
6 items, reference 339 1 157 1 182 1
Gata-3
0-3 items 22 0.93 0.74-1.18 7 0.93 0.56-1.56 15 0.98 0.79-1.21
4-5 items 163 1.06 0.96-1.17 63 1.10 0.91-1.34 100 1.03 0.94-1.14
6 items, reference 339 1 157 1 182 1
Foxp3
0-3 items 22 0.70 0.51-0.96 7 0.78 0.41-1.51 15 0.69 0.50-0.96
4-5 items 163 0.99 0.87-1.14 63 0.92 0.72-1.18 100 1.03 0.89-1.20
6 items, reference 339 1 157 1 182 1
Boldface values are significant (P > .05).
*Geometric mean ratios are adjusted for center, farmer, parents with allergy, sex, breast-feeding, maternal education, and cord blood value for the respective gene.
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tendency toward a negative association with an increased food
diversity was observed with both atopic and nonatopic asthma
(even though it is not significant, this might be due to small
numbers). Even though the underlying mechanism for the protec-
tive effect on asthma remains unclear, it might involve an induc-
tion of regulatory T cells, which are known to play a role in
constraining inflammation.28 Moreover, some dietary compo-
nents, such as short-chain or long-chain fatty acids, as well as pre-
biotics, are known to have immunoregulatory properties.3
A potential mechanism for the protective effect of an increased di-
versity in the infant’s diet on allergic diseases might involve the
gut microbiota, its metabolites, or both. It has been shown that
diet, gut microbiota, and immune responses are connected.2,29
Human studies examining the gut microbiota and allergies have
shown conflicting results; however, an inverse association be-
tween the bacterial diversity of the gut microbiota in the first
months of life and the development of eczema in early life was
previously reported.30
In conclusion, this is the first study showing that infants
exposed to an increased diversity of food items within the first
year of life have a reduced risk of asthma, food allergy, and
sensitization to food allergens up to age 6 years.
We thank all the fieldworkers and other PASTURE/EFRAIM team
members.
Clinical implications: An increased diversity of complementary
foods introducedwithin the first year of lifemight have a protec-
tive effect on the development of allergic diseases, such as
asthma, in children.
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FIG E1. Association between increasing diversity of food introduced within
the first 6 months of age and asthma. A, Diversity score with major food
introduced within the first 6 months of life for the entire study population.
B, Diversity score with all food items introduced within the first 6 months of
life for the entire study population. The solid line represents the predicted
value of asthma as a function of the score, and dashed lines represent
the CI. The y-axis is the linear logit of asthma, and the values are centered
on 0 (50/50 odds) and extended to both positive and negative values.
All models are adjusted for farmer, center, duration of breast-feeding,
parents with allergy, maternal education, sex, and siblings.
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TABLE E1. Association between diversity score within the first
year of life and allergic diseases and atopic sensitization, with
additional adjustment for atopic dermatitis
No. OR* 95% CI
Asthma
Food diversity score within 1st year
0-3 items 7/35 3.36 1.28-8.84
4-5 items 32/243 2.15 1.25-3.70
6 items, reference 30/521 1
Diversity score, continuous 69/799 0.73 0.60-0.88
Allergic rhinitis
Diversity score major food within 1st year
0-3 items 4/35 1.83 0.56-5.94
4-5 items 22/242 1.23 0.68-2.23
6 items, reference 34/518 1
Diversity score, continuous 60/795 0.81 0.64-1.02
Doctor-diagnosed food allergy
Food diversity score within 1st year
0-3 items 7/32 4.64 1.63-13.24
4-5 items 22/239 1.68 0.90-3.14
6 items, reference 27/513 1
Diversity score, continuous 56/784 0.71 0.57-0.89
Sensitization to food allergens at 4.5 or 6 y
Food diversity score within 1st year
0-3 items 5/24 3.67 1.15-11.68
4-5 items 21/163 1.44 0.77-2.71
6 items, reference 31/355 1
Diversity score, continuous 57/542 0.77 0.60-0.99
Sensitization to inhalant allergens at 4.5 or 6 y
Food diversity score within 1st year
0-3 items 8/24 1.65 0.64-4.21
4-5 items 36/169 0.84 0.52-1.35
6 items, reference 78/362 1
Diversity score, continuous 122/555 1.01 0.82-1.25
Boldface values are significant (P > .05).
*Adjusted for center, farmer, parents with allergy, sex, breast-feeding, siblings,
maternal education, and atopic dermatitis up to 6 years.
J ALLERGY CLIN IMMUNOL
APRIL 2014
1064.e2 RODUIT ET AL
TABLE E2. Association between diversity score within the first
year of life and doctor’s diagnosis of asthma*
Doctor’s diagnosis of asthma
Model 1 Model 2 Model 3
OR 95% CI OR 95% CI OR 95% CI
Food diversity score
within 1st year
0-3 items 5.80 1.77-19.06 5.78 1.64-20.35 6.57 1.52-28.35
4-5 items 3.78 1.82-7.87 3.83 1.81-8.12 2.55 0.95-6.86
6 items, reference 1 1 1
Diversity score,
continuous
0.68 0.60-0.88 0.69 0.54-0.85 0.68 0.51-0.91
Diversity scores with major food items are shown. Boldface values are significant
(P < .05).
Model 1, Crude; Model 2, model 1 plus adjusted for center, farmer, parents with
allergy, sex, breast-feeding, siblings, and maternal education; Model 3, model 2 plus
exclusion of food allergy at 1 year (n5 17) and only with asthma: exclusion of at least
1 episode of obstructive bronchitis and/or asthma, both doctor diagnosed and reported
at 1 year (n 5 102).
*Definition of asthma based only on doctor’s diagnosis of asthma between 3 and
6 years of age (n 5 36).
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TABLE E3. Association between diversity score within the first year of life and allergic diseases and atopic sensitization: analysis
among a subgroup with exclusion of children with low diversity scores (n 5 819)
No.
Model 1 Model 2
No.
Model 3
OR 95% CI OR 95% CI OR 95% CI
Asthma
Diversity score, continuous 67/819 0.58 0.41-0.82 0.61 0.43-0.87 37/702 0.82 0.49-1.37
Allergic rhinitis
Diversity score, continuous 60/811 0.69 0.47-1.00 0.72 0.48-1.06 56/799 0.85 0.55-1.31
Doctor-diagnosed food allergy
Diversity score, continuous 53/777 0.58 0.40-0.86 0.58 0.39-0.86 39/763 0.82 0.50-1.36
Sensitization to food allergens at 4.5 or 6 y
Diversity score, continuous 55/554 0.82 0.54-1.24 0.86 0.55-1.34 53/543 0.84 0.53-1.32
Sensitization to inhalant allergens at 4.5 or 6 y
Diversity score, continuous 122/568 1.05 0.76-1.44 1.14 0.81-1.60 119/556 1.21 0.85-1.73
Diversity scores with major food items are shown. Boldface values are significant (P < .05).
Model 1, Crude; Model 2, model 1 plus adjusted for center, farmer, parents with allergy, sex, breast-feeding, siblings, and maternal education; Model 3, model 2 plus exclusion of
food allergy at 1 year (n 5 17) and only with asthma: exclusion of at least 1 episode of obstructive bronchitis and/or asthma , both doctor diagnosed and reported at 1 year
(n 5 102).
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TABLE E4. Association between introduction of single food items in the first year of life and asthma
Asthma
Model 1 Model 2 Model 3
OR (95% CI) OR (95% CI) OR (95% CI)
Cow’s milk
3-12 mo 0.64 (0.40-1.04) 0.67 (0.40-1.14) 0.96 (0.49-1.90)
>12 mo, reference 1 1 1
Shop milk
3-12 mo 0.69 (0.37-1.29) 0.55 (0.28-1.08) 0.96 (0.42-2.20)
>12 mo, reference (reference 5 no cow’s milk) 1 1 1
Farm milk
3-12 mo 0.61 (0.34-1.08) 0.82 (0.40-1.69) 0.89 (0.35-2.26)
>12 mo, reference (reference 5 no cow’s milk) 1 1 1
Farm milk, unboiled
3-12 mo 0.67 (0.28-1.59) 0.95 (0.37-2.40) 1.61 (0.50-5.16)
>12 mo, reference 1 1 1
Yogurt
3-12 mo 0.42 (0.25-0.70) 0.47 (0.26-0.84) 0.55 (0.26-1.18)
>12 mo, reference 1 1 1
Other milk products
3-12 mo 0.40 (0.24-0.64) 0.37 (0.22-0.64) 0.65 (0.32-1.33)
>12 mo, reference 1 1 1
Vegetables or fruits
<6 mo 0.95 (0.59-1.54) 0.98 (0.53-1.82) 0.93 (0.41-2.11)
>_6 mo, reference 1 1 1
Fish
3-12 mo 0.72 (0.44-1.15) 0.76 (0.44-1.31) 0.80 (0.39-1.63)
>12 mo, reference 1 1 1
Nuts
3-12 mo 0.80 (0.45-1.42) 0.69 (0.36-1.34) 0.80 (0.36-1.80)
>12 mo, reference 1 1 1
Eggs
3-12 mo 0.46 (0.28-0.74) 0.47 (0.28-0.80) 0.65 (0.33-1.31)
>12 mo, reference 1 1 1
Meat
<9 mo 1.28 (0.75-2.18) 1.47 (0.80-2.70) 1.44 (0.67-3.12)
>_9 mo, reference 1 1 1
Cereals
<9 mo 1.34 (0.78-2.28) 1.13 (0.62-2.05) 1.05 (0.64-2.17)
>_9 mo, reference 1 1 1
Bread
<9 mo 1.10 (0.67-1.80) 1.06 (0.62-1.80) 1.17 (0.58-2.35)
>_9 mo, reference 1 1 1
Soja
3-12 mo 1.42 (0.54-3.72) 1.27 (0.46-3.46) 1.45 (0.40-5.21)
>12 mo, reference 1 1 1
Margarine
3-12 mo 1.44 (0.86-2.41) 1.16 (0.65-2.09) 1.17 (0.55-2.48)
>12 mo, reference 1 1 1
Butter
3-12 mo 0.49 (0.30-0.79) 0.45 (0.26-0.77) 0.43 (0.21-0.86)
>12 mo, reference 1 1 1
Cake
<9 mo 0.72 (0.44-1.19) 0.71 (0.40-1.26) 0.64 (0.30-1.34)
>_9 mo, reference 1 1 1
Chocolate
3-12 mo 0.47 (0.28-0.78) 0.45 (0.25-0.79) 0.41 (0.19-0.88)
>12 mo, reference 1 1 1
Boldface values are significant (P < .05).
Model 1, Crude; Model 2, model 1 plus adjusted for center, farmer, parents with allergy, maternal education, sex, breast-feeding, siblings, atopic dermatitis up to 6 years, and
maternal education; Model 3, model 2 plus exclusion of food allergy within the first year (n 5 17) and of asthma within the first year (n 5 102).
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TABLE E5. Association between introduction of single food items in the first year of life and food allergy
Food allergy
Model 1 Model 2 Model 3
OR (95% CI) OR (95% CI) OR (95% CI)
Cow’s milk
3-12 mo 0.71 (0.42-1.21) 0.64 (0.35-1.16) 0.98 (0.49-1.96)
>12 mo, reference 1 1 1
Shop milk
3-12 mo 0.71 (0.36-1.42) 0.56 (0.26-1.20) 1.01 (0.44-2.31)
>12 mo, reference (reference 5 no cow’s milk) 1 1 1
Farm milk
3-12 mo 0.71 (0.38-1.33) 0.82 (0.35-1.91) 1.16 (0.44-3.08)
>12 mo, reference (reference 5 no cow’s milk) 1 1 1
Farm milk, unboiled
3-12 mo 1.46 (0.69-3.07) 1.30 (0.52-3.26) 1.46 (0.50-4.24)
>12 mo, reference 1 1 1
Yogurt
3-12 mo 0.39 (0.23-0.69) 0.39 (0.20-0.75) 0.69 (0.31-1.60)
>12 mo, reference 1 1 1
Other milk products
3-12 mo 0.46 (0.27-0.79) 0.36 (0.19-0.67) 0.54 (0.26-1.14)
>12 mo, reference 1 1 1
Vegetables or fruits
<6 mo 1.39 (0.82-2.36) 1.08 (0.53-2.21) 1.01 (0.45-2.29)
>_6 mo, reference 1 1 1
Fish
3-12 mo 0.54 (0.32-0.91) 0.34 (0.18-0.66) 0.41 (0.19-0.88)
>12 mo, reference 1 1 1
Nuts
3-12 mo 0.55 (0.27-1.10) 0.55 (0.24-1.25) 0.71 (0.30-1.66)
>12 mo, reference 1 1 1
Eggs
3-12 mo 0.55 (0.32-0.-93) 0.50 (0.28-0.91) 0.82 (0.40-1.69)
>12 mo, reference 1 1 1
Meat
<9 mo 0.80 (0.46-1.38) 0.53 (0.27-1.05) 0.43 (0.20-0.93)
>_9 mo, reference 1 1 1
Cereals
<9 mo 1.41 (0.78-2.55) 1.03 (0.51-2.10) 1.11 (0.50-2.46)
>_9 mo, reference 1 1 1
Bread
<9 mo 0.69 (0.41-1.17) 0.77 (0.43-1.40) 0.70 (0.35-1.40)
>_9 mo, reference 1 1 1
Soja
3-12 mo 2.27 (0.92-5.63) 1.80 (0.66-4.87) 1.92 (0.60-6.13)
>12 mo, reference 1 1 1
Margarine
3-12 mo 1.09 (0.63-1.88) 0.78 (0.41-1.50) 0.87 (0.41-1.82)
>12 mo, reference 1 1 1
Butter
3-12 mo 0.51 (0.30-0.87) 0.60 (0.32-1.11) 0.83 (0.39-1.75)
>12 mo, reference 1 1 1
Cake
<9 mo 0.62 (0.35-1.08) 0.77 (0.40-1.49) 0.89 (0.43-1.85)
>_9 mo, reference 1 1 1
Chocolate
3-12 mo 0.56 (0.33-0.98) 0.60 (0.32-1.12) 0.69 (0.34-1.42)
>12 mo, reference 1 1 1
Boldface values are significant (P < .05).
Model 1, Crude; Model 2, model 1 plus adjusted for center, farmer, parents with allergy, maternal education, sex, breast-feeding, siblings, and atopic dermatitis up to 6 years;
Model 3, model 2 plus exclusion of doctor’s diagnosis of food allergy within the first year (n 5 17).
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TABLE E6. Association between introduction of single food items in the first year of life and sensitization to food allergens
Sensitization to food allergens
Model 1 Model 2 Model 3
OR (95% CI) OR (95% CI) OR (95% CI)
Cow’s milk
3-12 mo 0.77 (0.46-1.31) 0.83 (0.46-1.50) 0.90 (0.49-1.67)
>12 mo, reference 1 1 1
Shop milk
3-12 mo 0.73 (0.35-1.51) 0.73 (0.32-1.64) 0.88 (0.38-2.02)
>12 mo, reference (reference 5 no cow’s milk) 1 1 1
Farm milk
3-12 mo 0.80 (0.44-1.45) 0.80 (0.38-1.66) 0.83 (0.39-1.77)
>12 mo, reference (reference 5 no cow’s milk) 1 1 1
Farm milk, unboiled
3-12 mo 0.60 (0.23-1.55) 0.53 (0.17-1.64) 0.55 (0.18-1.71)
>12 mo, reference 1 1 1
Yogurt
3-12 mo 0.47 (0.26-0.84) 0.69 (0.35-1.39) 0.72 (0.35-1.50)
>12 mo, reference 1 1 1
Other milk products
3-12 mo 0.50 (0.29-0.88) 0.67 (0.36-1.27) 0.71 (0.36-1.37)
>12 mo, reference 1 1 1
Vegetables or fruits
<6 mo 0.94 (0.56-1.61) 1.03 (0.52-2.02) 1.04 (0.52-2.06)
>_6 mo, reference 1 1 1
Fish
3-12 mo 0.49 (0.29-0.84) 0.69 (0.38-1.26) 0.71 (0.38-1.34)
>12 mo, reference 1 1 1
Nuts
3-12 mo 0.70 (0.35-1.39) 0.48 (0.23-1.01) 0.48 (0.23-1.02)
>12 mo, reference 1 1 1
Eggs
3-12 mo 0.68 (0.40-1.17) 0.70 (0.38-1.29) 0.70 (0.37-1.32)
>12 mo, reference 1 1 1
Meat
<9 mo 0.72 (0.41-1.25) 0.97 (0.51-1.84) 1.04 (0.54-2.01)
>_9 mo, reference 1 1 1
Cereals
<9 mo 0.79 (0.45-1.36) 0.71 (0.38-1.33) 0.68 (0.36-1.29)
>_9 mo, reference 1 1 1
Bread
<9 mo 1.08 (0.62-1.85) 0.89 (0.48-1.65) 0.93 (0.49-1.77)
>_9 mo, reference 1 1 1
Soja
3-12 mo 1.05 (0.31-3.58) 1.32 (0.36-4.84) 1.47 (0.39-5.50)
>12 mo, reference 1 1 1
Margarine
3-12 mo 0.83 (0.49-1.41) 0.71 (0.38-1.32) 0.68 (0.36-1.29)
>12 mo, reference 1 1 1
Butter
3-12 mo 0.83 (0.48-1.46) 0.73 (0.39-1.39) 0.85 (0.43-1.66)
>12 mo, reference 1 1 1
Cake
<9 mo 0.46 (0.26-0.84) 0.30 (0.15-0.62) 0.31 (0.15-0.64)
>_9 mo, reference 1 1 1
Chocolate
3-12 mo 0.37 (0.21-0.67) 0.39 (0.21-0.75) 0.36 (0.19-0.70)
>12 mo, reference 1 1 1
Boldface values are significant (P < .05).
Model 1, Crude; Model 2, model 1 plus adjusted for center, farmer, parents with allergy, maternal education, sex, breast-feeding, siblings, and atopic dermatitis up to 6 years;
Model 3, model 2 plus exclusion of doctor’s diagnosis of food allergy within the first year (n 5 17).
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